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ABSTRACT 
Amy Jo Casbon 
 
DISTINCT LOCALIZATION OF NADPH OXIDASE FLAVOCYTOCHROME B IN 
RESTING AND INTERFERON GAMMA ACTIVATED MACROPHAGES 
 
 Flavocytochrome b558, the catalytic core of the phagocytic NADPH oxidase, 
mediates the transfer of electrons from NADPH to molecular oxygen to generate 
superoxide for host defense.  Flavocytochrome b is a membrane heterodimer consisting 
of a large subunit gp91phox (NOX2) and a smaller subunit, p22phox.  Localization of 
flavocytochrome b to the phagosome is essential for microbial killing, yet the subcellular 
distribution of flavocytochrome b in macrophages and how it is incorporated into 
macrophage phagosomes is not well characterized.  In neutrophils, flavocytochrome b 
localizes primarily to specific granules that are rapidly mobilized to the phagosome upon 
stimulation.  In contrast to neutrophils, macrophages do not contain specific granules, and 
trafficking of membrane proteins to the phagosome is more dynamic, involving fission 
and fusion events with endosomal compartments.  We hypothesized that in macrophages, 
flavocytochrome b localizes to both plasma membrane and endosomal compartments that 
deliver flavocytochrome b to the phagosome.  We generated fluorescently tagged 
versions of both p22phox and gp91phox, and rigorously verified their functionality in 
Chinese Hamster Ovary cells.  Localization of flavocytochrome b was then examined in 
both RAW 264.7 murine macrophages and primary murine bone marrow derived 
macrophages (BMDM) in the presence and absence of interferon gamma (IFNγ).  We 
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found that in “resting” macrophages, flavocytochrome b localizes primarily to the Rab11-
positive endosome recycling compartment that recycles to the plasma membrane.  In 
addition, phagocytosis assays showed flavocytochrome b is incorporated into the 
phagocytic cup and colocalized with Rab11 at the base of the cup, suggesting Rab11-
positive endosomes may be involved in trafficking of flavocytochrome b between 
intracellular membranes and forming or nascent phagosomes.  However, in IFNγ 
activated macrophages, flavocytochrome b was localized predominantly in the plasma 
membrane, with little present in endosomal compartments.  This shift in flavocytochrome 
b distribution occurred following sustained exposure to IFNγ and correlated with 
increased flavocytochrome b protein expression and increased extracellular production of 
superoxide.  Taken together, our results suggest the IFNγ-induced redistribution of 
flavocytochrome b may be important for enhancing the production of superoxide at the 
cell surface and may be a potential new mechanism by which IFNγ enhances 
antimicrobial activity in macrophages.   
 
Mary C. Dinauer, MD, Ph.D. 
Committee Chair 
. 
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CHAPTER ONE:  INTRODUCTION 
 
I. The immune system 
We are constantly exposed to infectious agents and it is our immune system that 
enables us to resist infection (Nester, 2007).  Our immune system combats invading 
microorganisms, such as bacteria, viruses, fungi, and parasites.  All cells of the immune 
system originate from the bone marrow and include myeloid (neutrophils, basophils, 
eosinophils, macrophages, dendritic cells) and lymphoid (B and T lymphocytes, and 
Natural Killer cells) cells.  Our immune system is divided into two parts: (i) innate and 
(ii) adaptive (Janeway and Travers, 1997).  The innate immune system is the first line of 
defense and confers immediate protection against many different pathogens without 
requiring prior exposure.  In contrast, the adaptive immune system responds more slowly 
upon first exposure, but “learns” to recognize a specific epitope, or antigen, of a pathogen 
during infection.  Upon reinfection, B and/or T cells will become activated following 
recognition of this specific antigen.  Activated B cells secrete antibodies that bind to 
additional antigens on the pathogen resulting in a rapid and more efficient removal of the 
pathogen.  Activated T cells become effector cells that can kill cells infected with 
pathogens directly (cytotoxic T cells) or enhance killing of pathogens by activating 
macrophages or B cells (helper T cells).  While the systems perform different functions, 
the systems are interlinked and together provide a remarkable defense system (Janeway 
and Travers, 1997).   
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II. Phagocytic leukocytes 
Phagocytic leukocytes are cells of the innate immune system highly proficient in 
ingesting and killing microorganisms (Kantari et al., 2008).  Phagocytic leukocytes or 
“professional” phagocytes, primarily neutrophils and macrophages, express a multitude 
of cell surface receptors that recognize particles coated in opsonins, such as complement 
or immunoglobulin (IgG), or pathogen-associated-molecular-patterns (PAMPs).  
Receptors that initiate and/or enhance phagocytosis include, but are not limited to, Fcγ-
receptors and different members of the integrin and complement family (Table I) 
(Underhill and Ozinsky, 2002).  These receptors confer upon phagocytes the ability to 
recognize and respond to pathogen-associated motifs or opsonized particles in the 
absence of additional stimuli.  Following recognition, macrophages and neutrophils kill 
invading microorganisms through the release of toxic products, such as reactive oxygen 
species (ROS), proteolytic enzymes, and antimicrobial peptides.  In addition to removal 
of pathogens, phagocytes also survey their environment and alert the adaptive immune 
system when an inflammatory or immune response is required (Hoebe et al., 2004).  
Thus, phagocytes are essential not only for innate immunity, but also for linking the 
innate to the adaptive immune system.   
 
1. Neutrophils 
Neutrophils are short-lived cells that are usually the first cells of the immune 
system recruited to a site of infection.  Neutrophils make up the majority of circulating  
white blood cells (40 - 80%, (Lacy, 2005).  Neutrophils are endowed with preformed 
granules carrying antimicrobial peptides, granzymes, perforins, and oxidants and are  
  
3 
Table I.  Phagocytosis-promoting receptorsa 
Receptor Target Ligand 
FcγR1 (CD64) IgG-opsonized bacteria Fc portion of IgG 
FcγRIIa (CD32) IgG-opsonized bacteria Fc portion of IgG 
FcγRIIIA (CD16) IgG-opsonized bacteria Fc portion of IgG 
FcεRI IgE-opsonized bacteria Fc portion of IgE 
FcαRI (CD89) IgA-opsonized bacteria Fc portion of IgA 
FcεRII (CD23) IgE-opsonized bacteria Fc portion of IgE 
CR1 (CD35) Complement-opsonized bacteria C3b, C4b 
CR3 
(CD11b/CD18;αMβ2) 
Complement-opsonized bacteria 
Gram-negative bacteria 
Bordetella pertussis 
Yeast 
C3b 
Lipopolysaccharide 
Filamentous hemagglutinin 
β-Glucan 
CR4 (CD11c/CD18) Complement-opsonized bacteria C3b, C4b 
Mannose receptor Pneumocystis carinii 
Candida albicans 
Mannosyl/fucosyl residues 
Scavenger receptor Apoptotic lymphocytes 
Gram-positive cocci 
Bacteria, LPS, 
Lipoteichoic acid 
β1 integrins Yersinia Invasin 
αVβ3 integrins Vitronectin-coated apoptotic cells Vitronectin 
 
aReceptors and their ligands that initiate or enhance phagocytosis in phagocytic 
leukocytes are listed.  This table was adapted from (Underhill and Ozinsky, 2002). 
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specialized for rapid antimicrobial killing.  Granule formation develops via a “targeting 
and timing” mechanism (Borregaard and Cowland, 1997), which basically means there is 
a sequential order in the expression of granule proteins and the formation of the different 
granule populations.  The three major granule populations were first named primary, 
secondary, and tertiary following their order of synthesis.  They are distinguished by size 
and content (see Table II).  The primary or azurophilic granules are the largest granules 
and contain numerous antimicrobial compounds, such as myleoperoxidase, defensins, and 
lysozyme that are important for killing in the phagosome.  The secondary or specific 
granules are much smaller than the azurophilic granules, but are the major population of 
granules in neutrophils, based on number.  Secondary and tertiary granules are 
comparable in size, but differ in their contents.  In addition to granules, neutrophils also 
contain a novel secretory compartment, the ‘secretory vesicle,’ and store a multitude of 
cytokine and chemokine receptors (listed in Table II), which are absent or expressed at 
low levels on the surface of  “quiescent” neutrophils (Borregaard et al., 2007).  Secretory 
vesicles quickly fuse with the plasma membrane following minor elevations in calcium 
and deliver these receptors to the cell surface (Borregaard et al., 2007). 
The importance of neutrophils to combat infection is clearly illustrated in the 
human disease severe congenital neutropenia (SCN).  SCN is a genetically heterogeneous 
disease that is characterized by a reduction in circulating neutrophils to less than 0.5 
x109/ L (Welte et al., 2006).  SCN patients present with recurrent infections, often life-
threatening, during the first 6 months of life including pneumonia, skin, and deep organ 
abscesses, as well as septicemia (Welte et al., 2006).  In the majority of patients, the 
cause of SCN (reviewed in (Ward and Dale, 2009) is a mutation in the ELA2 gene  
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Table II.  Neutrophil granule proteinsa,b,c 
 
Primary/    
Azurophil granules 
Secondary/ 
Specific granules 
Tertiary/Gelatinase 
granules Secretory vesicles 
Membrane 
proteins 
TNFR, uPAR 
CD63, CD68, 
presenilin 
CD11b/CD18, 
CD66 
CD67 
CD11b/CD18,  
CD66,  
CD67 
CD11b/CD18,  
CD66,  
CD67 
  gp91phox, p22phox gp91phox, p22phox gp91phox, p22phox 
  SNAP23, 
VAMP2, 
Stomatin,  
MMP25 
TNFR 
SNAP23, VAMP2, 
Nrampl 
 
 
MMP25 
CD35, CD16, C1q-R, 
MyD88, MD2, fMLPR, 
TREM1, Ig(G,A,E)FcR           
TNFR1 and R2  
CXCR-1, -2, -4,   
CCR-1, -2, -3           
IFN-αR1 and R2   
IFN-γR1 and R2                    
IL(1,4,6,10,13,17,18)R 
TLR-1,-2,-4,-6, 
LIR1-4,6,7,9 
SNAP23, VAMP2, 
Nrampl, alkaline 
phosphatase, DAF, 
CD10, CD13 
Matrix 
proteins 
Elastase,  
cathepsin G, 
proteinase 3, 
Defensins,  
BPI, 
Myeloperoxidase, 
lysozyme, 
Sialidase 
Azurocidin      
β-glucoronidase 
Collagenase, 
Gelatinase, 
cystatin C & F, 
uPA, 
NGAL, vitamin 
B12 binding 
protein, 
Lysozyme, 
lactoferrin, 
haptoglobin, 
prodefensin, 
α1-anti-trypsin, 
orosomucoid, 
heparanase,  
β2-
microglobuin, 
CRISP3 
Gelatinase,  
arginase1, 
β2-microglobuin, 
CRISP3 
Plasma proteins 
 
 aLocalization of proteins in the matrix and membrane of neutrophil granules and 
secretory vesicles.   
 bAbbreviations; CRISP, cysteine-rich secretory protein; DAF; decay-accelerating factor; 
LIR, immunoglobulin-like receptor; uPA, urokinase plasminogen activator.  
 cTable was adapted from (Borregaard et al., 2007) 
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(encoding neutrophil elastase), which has been shown to induce the unfolded protein 
response and lead to apoptosis of neutrophils (Kollner et al., 2006).   
 
2. Macrophages 
Macrophages are a heterogeneous population of long-lived cells, distributed 
throughout virtually all host tissues that are essential not only for killing pathogens but 
also for maintaining tissue homeostasis (Gordon and Taylor, 2005; Mosser and Edwards, 
2008).  Macrophages express a plethora of receptors that enable them to respond to their 
environment and that program or “activate” them for specialized functions (Gordon and 
Taylor, 2005; Mosser and Edwards, 2008).  In the absence of inflammation, macrophages 
differentiate from circulating peripheral blood mononuclear cells that migrate into tissues 
to replenish long-lived tissue-specific macrophages of the bone (osteoclasts), alveoli, 
central nervous system (microglial cells), connective tissue (histiocytes), gastrointestinal 
tract, liver (Kupffer cells), spleen, and peritoneum (Mosser and Edwards, 2008).  
Quiescent tissue-specific or resident macrophages act as “janitors” to remove cellular 
debris generated during tissue remodeling and apoptotic cells (Mosser and Edwards, 
2008). 
In marked contrast, during an infection, macrophages take on a different 
phenotype, functioning as an immune effector cells programmed to kill pathogens and 
alert the immune system through the release of chemokines, cytokines, and antigen 
presentation (Mosser and Edwards, 2008).  In addition to the microbicidal activity of 
macrophages during the onset of an infection, macrophages also aid in tissue repair and 
turning off the immune response, mainly through the release of IL-10, at later stages 
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(Mosser and Edwards, 2008).  In summary, macrophages survey their environment, 
remove dead cells and potential pathogens, and then alert the immune system through the 
release of cytokines and/or antigen presentation.  
 
III. Phagocyte NADPH oxidase 
1. Superoxide production is essential to innate immunity 
Activation and appropriate localization of superoxide production by the 
phagocytic NADPH oxidase is essential to host defense.  The NADPH oxidase is a 
multicomponent enzyme, comprised of a membrane-bound heterodimer, 
flavocytochrome b558, which consists of a large subunit, gp91phox (NOX2), and a small 
subunit, p22phox, and cytosolic regulatory subunits, p67phox, p47phox, p40phox, and Rac 
(Nauseef, 2004).  The NADPH oxidase transfers electrons from NADPH to molecular 
oxygen to produce superoxide, which serves as a precursor for the formation of an 
arsenal of reactive oxygen species (ROS), such as hydrogen peroxide (H202), hydroxyl 
radical (OH•), and hypochlorous acid (HOCl-).  Superoxide has a relatively weak 
antimicrobial activity, in contrast to the secondary products formed, and thus, confers its 
toxicity through the generation of these highly reactive products.  The importance of 
superoxide production was first evident when the clinical syndrome, chronic 
granulomatous disease (CGD), was linked to the inability of neutrophils from CGD 
patients to produce a “respiratory burst” (Baehner and Nathan, 1967, 1968).  CGD is a 
rare genetic disease with an incidence of approximately 1 in 250,000 live births 
(Winkelstein et al., 2000), which results from a mutation in any 1 of the 4 subunits 
(gp91phox, p22phox, p47phox, p67phox) of the phagocytic NADPH oxidase.  CGD is usually 
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diagnosed by the age of 1 year due to persistent and recurrent bacterial or fungal 
infections, such as Aspergillus fumimatus, Salmonella typhimurium, Staphylococcus 
aureus, Serratia marcescens, and Burkholderia cepacia and has been estimated to have 
an overall mortality rate of approximately 17.6% (Winkelstein et al., 2000).  
 
2. Biosynthesis and subcellular distribution of flavocytochrome b 
The biosynthesis and subcellular distribution of flavocytochrome b has been well 
characterized in neutrophils (Figure 1).  gp91phox and p22phox are synthesized as separate 
polypeptides in the endoplasmic reticulum (ER).  Human gp91phox is generated from a 
core protein of 58 kDa (Parkos et al., 1987) that is subsequently glycosylated to gp65, a 
high mannose 65 kDa form in the ER which binds to heme, allowing for heterodimer 
formation with p22phox (Porter et al., 1994; Yu et al., 1997; Yu et al., 1999; DeLeo et al., 
2000).  The heterodimer then traffics to the Golgi, and gp91phox is further glycosylated to 
the mature, 91 kDa form (DeLeo et al., 2000).  Studies of neutrophils and promyelocytic 
cells, PLB-985, have shown that the individual subunits of flavocytochrome b, gp91phox 
and p22phox, are unstable and targeted to the proteasome in absence of their heterodimer 
partner (DeLeo et al., 2000).  In contrast, the individual subunits are stable when 
exogenously expressed in cell lines such as Chinese Hamster Ovary (CHO-K1) and 
monkey kidney (COS-7) (Yu et al., 1997; Biberstine-Kinkade et al., 2002; Price et al., 
2002), which have provided model systems for identifying regions within both p22phox  
and gp91phox that are important for heterodimer formation and assembly of the NADPH 
oxidase. 
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Figure 1.  Biosynthesis of flavocytochrome b (in neutrophils).  Flavocytochrome b is a 
heterodimer consisting of a large subunit, gp91phox, and a smaller subunit, p22phox.  gp91phox is first 
synthesized as a 58 kD core protein in the endoplasmic reticulum that is subsequently 
gylcosylated to a high mannose 65 kD form which binds heme.  Heme binding enables binding of 
p22phox, and the newly formed heterodimer traffics to the Golgi where gp91phox is further 
glycosylated to a mature 91 kD form.  In neutrophils, flavocytochrome b then traffics to specific 
granules, secretory vesicles, and the plasma membrane.  
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While the biosynthesis of flavocytochrome b is believed to be the same in both 
neutrophils and macrophages, the location of flavocytochrome b following biosynthesis 
is different in the two cell types.  In neutrophils, the mature flavocytochrome is found 
primarily in the membrane of secondary granules, but also is present in secretory 
vesicles, a type of endosome, and in the plasma membrane (Borregaard et al., 1983; 
Jesaitis et al., 1990).  Upon activation, these intracellular compartments fuse with the 
plasma membrane or phagosome where superoxide is produced.  In contrast to 
neutrophils, macrophages do not contain specific granules, and the subcellular 
distribution of flavocytochrome b is not well characterized.  Studies using immuno-
electron microscopy showed that relatively little flavocytochrome b localized to the 
plasma membrane in resting human monocytes, and was mainly in small peroxidase-
negative granules and vesicles, which, as in neutrophils, appears to be a pool that is 
rapidly mobilized to the plasma membrane upon cellular activation (Ginsel et al., 1990; 
Calafat et al., 1993; Borregaard and Cowland, 1997).  Further characterization of these 
intracellular flavocytochrome b compartments in monocytes has not been reported.  
Studies in macrophages are even more limited.  In human monocyte-derived 
macrophages, p22phox and gp91phox have been detected in the plasma membrane, as well 
as reticulo-vesicular intracellular structures that were not further characterized 
(Johansson et al., 1995; Gallois et al., 2001), and in the plasma membrane of murine 
peritoneal macrophages (Vazquez-Torres et al., 2000).   
In addition to differences in the distribution, neutrophils highly express gp91phox 
and p22phox subunits and produce a strong oxidative burst, while unactivated or “resting” 
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macrophages produce less superoxide and express much lower levels of these NADPH 
oxidase subunits (Yagisawa et al., 1996).  
 
3. Flavocytochrome b is the catalytic core of the NADPH oxidase   
At rest, flavocytochrome b exists in an inactive conformation that requires 
binding of the cytosolic subunits to induce conformational changes required for 
superoxide production (Nisimoto et al., 1999; Paclet et al., 2000).  Two main events are 
required for the assembly and activation of the cytosolic subunits (p47phox, p67phox, 
p40phox, and Rac) onto the flavocytochrome, p47phox phosphorylation and Rac activation 
(reviewed in (Groemping and Rittinger, 2005).  p47phox acts as a carrier protein for 
shuttling p67phox and p40phox to the membrane.  Beginning at its N-terminus, p47phox 
contains a PX (Phox homology) domain, followed by two Src homology 3 (SH3) 
domains that target a proline-rich region (PRR) in p22phox of flavocytochrome b, an auto-
inhibitory region (AIR) that masks the SH3 domains in the resting state, and a PRR that 
binds the C-terminus SH3a domain of p67phox.  p67phox contains an N-terminal 
tetratricopeptide repeat (TPR) domain, a PRR, and two SH3 domains (referred to as 
SH3a and SH3b) that are separated by a PB1 (Phox and Bem1) motif that binds to a 
similar C-terminal PB1 domain in p40phox.  In addition to the PB1 domain, p40phox has an 
N-terminal PX domain followed by an SH3 domain.  Serine phosphorylation of p47phox at 
the AIR unmasks the SH3 domains within p47phox, permitting binding to p22phox and 
driving translocation of the cytosolic subunits p47phox, p67phox, and p40phox to membrane-
bound flavocytochrome b.  Rac is a member of the Rho GTPase family and cycles from a 
GDP inactive state to an active GTP-bound state.  Activation of Rac to the GTP-bound 
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state requires dissociation of Rho guanine-nucleotide-dissociation-inhibitor (Rho-GDI) 
that otherwise sequesters Rac in the cytosol, which unmasks the geranylgeranyl moiety of 
Rac important for membrane insertion, and binding by a guanine nucleotide exchange 
factor (GEF) to catalyze the exchange of GDP to GTP.  Rac-GTP inserts into the 
membrane and binds to gp91phox and p67phox.  Binding of Rac to p67phox and to the 
flavocytochrome directly regulates electron transfer through the flavocytochrome.  In 
summary (Figure 2), the membrane-bound flavocytochrome is the catalytic core of the 
oxidase, but requires the translocation and assembly of the cytosolic subunits to form an 
active complex (Groemping and Rittinger, 2005). 
 
4. Regulation of superoxide production  
A. Regulation of cytosolic subunits 
Superoxide has the potential to harm the host, thus, multi-faceted levels of 
regulation control enzymatic activity, yet permit an immediate, localized response to 
invading pathogens.  As described above, the spatial and temporal separation of the 
membrane-bound and cytosolic subunits of the NADPH oxidase is one method of 
regulation (Babior et al., 2002) and was the first level to be recognized.  In addition, the 
individual cytosolic subunits possess domains (or features) that are regulated via 
interactions with regulatory proteins.  The NADPH oxidase is activated during 
phagocytosis and can be stimulated by various soluble and particulate stimuli, including 
chemoattractants, certain cytokines, different lectins, opsonized as well as various un- 
opsonized microorganisms, and pharmacological agents such as phorbol esters, calcium 
ionophores and arachidonic acid (AA).  Many receptors can enhance and/or activate the  
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Figure 2.  NADPH oxidase assembly and activation.  In resting cells, the membrane-bound 
heterodimer flavocytochrome b is segregated spatially from the cytosolic subunits, Rac, p47phox, 
p67phox, and p40phox.  Upon stimulation, two events result in translocation of the cytosolic subunits 
to the membrane-bound heterodimer, leading to assembly and activation of the NADPH oxidase:  
phosphorylation of p47phox and activation of Rac.  Cartoon was adapted from (Nauseef, 2007).  
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NADPH oxidase to produce superoxide (Underhill and Ozinsky, 2002).  Following 
binding of its ligand, the different receptors then regulate NADPH oxidase activity 
through activation of kinases and guanine exchange factors (GEFs) that are important for 
p47phox phosphorylation and Rac activation.  Several kinases are known to regulate 
phosphorylation of p47phox, including protein kinase C, p21-activated kinase (PAK), 
protein kinase B/Akt, casein kinase 2, and p38-activated protein kinases (Groemping and 
Rittinger, 2005).  Rac activation is regulated by at least two GEFs, Vav and P-Rex1 
(Dinauer, 2003).  
 
B. Localization of flavocytochrome b 
In addition to the regulatory mechanisms governing activation of the NADPH 
oxidase, the assembly of the NADPH oxidase and the production of superoxide must be 
localized to either the plasma membrane or the phagosome for microbial killing.  In 
neutrophils, flavocytochrome b is delivered to the phagosome and plasma membranes via 
granules and secretory vesicles (Nauseef, 2004).  In macrophages, the mechanism by 
which flavocytochrome b is delivered to the phagosome is not known.   
 
IV. Pathogen evasion of the oxidative burst 
More recently, the importance of superoxide has been illustrated in studies 
showing that pathogenicity of some microorganisms is owed in part to their ability to 
evade oxidative killing by targeting the NADPH oxidase (Carlyon et al., 2004).  
Examples include Anaplasma phagocytophilum, Salmonella enterica serovar 
typhimurium (S. typhimurium), and Helicobacter pylori (H. pylori).  Anaplasma 
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phagocytophilum inhibits NADPH oxidase assembly and downregulates NADPH oxidase 
subunits by inhibiting interferon (IFN)γ-mediated expression of IRF-1 (Thomas et al., 
2005).  S. typhimurium was the first pathogen to be described to evade oxidative killing 
not by targeting activation of the NADPH oxidase, but by preventing localization of 
flavocytochrome b to the phagosome.  Studies by two groups (Vazquez-Torres et al., 
2000; Gallois et al., 2001) found trafficking of flavocytochrome b to the Salmonella 
containing vacuole (SCV) to be impaired.  In vivo studies found that a mutant of             
S. typhimurium carrying a mutation in the Salmonella pathogenicity island (SPI)-2 was 
virulent in the gp91phox knockout mouse but not in wild-type mice, suggesting SPI-2 was 
important for targeting the NADPH oxidase flavocytochrome b (Vazquez-Torres et al., 
2000).  Further in vitro studies found an increase in localization of flavocytochrome b to 
the SCV containing the SPI-2 mutant (Vazquez-Torres et al., 2000; Gallois et al., 2001).  
In addition, Vazquez-Torres and collaborators (Vazquez-Torres et al., 2000) showed 
localized production of superoxide in vacuoles containing avirulent E. coli 
(approximately 50% positive), but vacuoles containing pathogenic S. typhimurium were 
devoid of superoxide.  Notably, superoxide was produced following infection with         
S. typhimurium but was localized to vesicles and the plasma membrane (Figure 3).  More 
recently, H. pylori was also found to prevent oxidase assembly at the phagosome (Allen 
and McCaffrey, 2007).  Taken together, these data show that the ability of some 
pathogens to disrupt trafficking of flavocytochrome b to the phagosome is key to its 
virulence.   
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Figure 3.  Location of superoxide production in murine macrophages.  Superoxide production 
was detected by cerium perhydroxide precipitate in studies of macrophages (purple) infected with 
bacteria (grey).  Superoxide production (black) colocalized with phagosomes cotaining E. coli 
(left, black arrows) but not wild-type S. typhimurium, where superoxide localized to vesicles 
discrete from phagosomes (right, black arrows) and to the plasma membrane.  Cartoon was 
adapted from (Vazquez-Torres et al., 2000). 
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V. Phagocytosis 
Phagocytosis is the cellular engulfment of large particles.  While first discovered 
as a mechanism of innate immune defense by Elie Methcnikoff in 1893 (Stossel, 1999), 
phagocytosis is not unique to cells of the immune system.  In primitive organisms, 
phagocytosis primarily serves as a means of nutrient uptake (Aderem, 2003), while in 
higher organisms, phagocytosis is the main mechanism by which specialized cells of the 
immune system kill invading microorganisms or remove apoptotic cells from the 
extracellular milieu (Groves et al., 2008).  Phagocytosis is an integrated process that 
requires the activation of cell surface receptors.  Activation of these receptors initiates 
signaling cascades that regulate internalization and subsequent phagosome maturation.  
As mentioned earlier, there are many receptors that regulate phagocytosis (Table II).  In 
addition to these phagocytosis-inducing receptors, many other receptors are engaged 
during phagocytosis that can regulate a variety of processes such as cell proliferation, 
removal of dead cells, motility, apoptosis, and antigen presentation (Underhill and 
Ozinsky, 2002).  Due to the complexity of the many signals generated during 
phagocytosis, the functional roles of individual receptors have been dissected in simpler 
experimental systems.  For example, the signaling pathways of the Fcγ-receptor (Downey 
et al., 1999) and the dectin-1 receptor (Underhill et al., 2005) have been elucidated in cell 
lines expressing the receptor from a transgene. 
 
1. Internalization 
The initial engulfment or “uptake” process of phagocytosis seems to universally 
require actin remodeling (May and Machesky, 2001), but different signaling cascades 
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seem to regulate the process of engulfment, which appears to be receptor and cell-type 
specific.  One of the best studied phagocytic receptor is the Fcγ-receptor (FcγR).  IgG-
opsonized particles/pathogens crosslink FcγRs upon engagement, leading to 
phosphorylation of intrinsic tyrosine activation motifs (ITAMS) by Src kinase family 
members, which provide docking sites that lead to activation of Syk family kinases 
(Greenberg and Grinstein, 2002).  In addition to Syk, activation of phosphoinositide 3-
kinase (PI3K), protein kinase C (PKC), phospholipase C (PLC), and Rho GTPases are 
also important regulators of early stages of phagocytosis (Underhill and Ozinsky, 2002).  
Activation of Src kinases are essential for local actin polymerization and phagocytosis.  
Recent studies suggest Src kinases may also play a role in receptor clustering and 
subsequently particle binding (Groves et al., 2008).  Src, Syk, and Rho GTPases, such as 
Rac and Cdc42, are all involved in regulating actin dynamics at phagocytic cups and are 
essential for uptake.  PI3K is involved in membrane remodeling and is necessary for 
phagosome closure (Swanson and Hoppe, 2004).  PLC activates PKC, which is important 
for phagosome formation (Larsen et al., 2000), and PLC regulates membrane fusion 
which is suggested to be an additional mechanism by which PLC regulates phagocytosis 
(Swanson and Hoppe, 2004). 
 
2. Phagosome maturation 
After internalization, a particle and/or pathogen is sealed off from the 
extracellular milieu in a vacuole called the phagosome.  The phagosome undergoes 
maturation, a process by which phagosomes change their functional capacity as they as 
age (Griffiths, 2004).  Phagosome maturation involves the combination of membrane 
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remodeling, fusion events, and cell signaling, which ultimately lead to pathogen 
destruction (Scott et al., 2003) or removal of dead cells (Kinchen et al., 2008).  Hence, 
phagosome maturation can also be viewed as the degradative stage of phagocytosis.  
Until recently, a more simplistic view of phagosome maturation was theorized in which a 
pathogen was engulfed into one vacuole, which fused with early endosomes, then late 
endosomes, and ended with fusion with the acidic lysosomes to form a phago-lysosome 
(Mayorga et al., 1991).  Due to emerging novel techniques, such as the use of 
fluorescently tagged proteins for live imaging and the identification of molecules 
important in endosome fusion, such as members of the Rab family and SNARE proteins, 
this model is now disputed with clear evidence revealing phagosome maturation is more 
complex and dynamic.  
 The new model of phagosome maturation, named “Kiss and Run” (Desjardins, 
1995), involves fusion and fission, where vacuoles or endosomal compartments come 
into contact with the phagosome forming a pore between the compartments (the Kiss) to 
acquire selected sets of proteins and lipids through fusion, and then disengage (the Run) 
from the developing phagosome (Vieira et al., 2002).  
  
VI. Similar mechanisms regulate endocytosis and phagocytosis 
Receptor-mediated endocytosis and phagocytosis are similar in their requirement 
of a specific ligand to initiate internalization and in their machinery that regulates the 
internalization and/or degradation of the ligand (Scott et al., 2003; Kinchen et al., 2008).  
A plethora of receptors are regulated by endocytosis and include, but are not limited to, 
the following receptors:  β2-adrenergic, dopamine, muscarinic acetylcholine, epidermal 
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growth factor, V2 vasopressin, δ-opioid, nutrient (low density lipoprotein and 
transferrin), integrins, and glucose transporter GLUT4, which all have their own unique 
ligand (Sorkin and Von Zastrow, 2002; Gaborik and Hunyady, 2004).  In the case of 
phagocytosis, the ligand is bacteria, yeast, or apoptotic cells.  In both processes, the 
binding of the ligand to specific receptors regulates not only the fate of the ligand but also 
regulates a cellular reaction.  In phagocytosis of bacteria, the ligand is degraded (or 
killed) and the main reaction is an inflammatory response.   
 
1. Internalization and degradation 
Endocytosis and phagosome maturation are processes that require vesicular 
fission and fusion events that are regulated by the Rab family of GTPases (Scott et al., 
2003; Kinchen et al., 2008).  Rab GTPases serve as molecular switches, which cycle 
between an inactive GDP bound state to an active GTP bound state (recently reviewed in 
(Brumell and Scidmore, 2007).  Different Rab proteins have been shown to regulate 
distinct intracellular membrane trafficking pathways and hence define key steps during 
endocytosis and phagocytosis (Figure 4).  During receptor-mediated endocytosis, the 
binding of a ligand to its receptor initiates internalization of the ligand:receptor complex 
into early endosomes, which is regulated by Rab5.  From the Rab5-positive compartment, 
the ligand and receptor are then destined to one of two pathways: degradation or 
recycling back to the cell surface (Figure 4).   
Many receptors are downregulated following binding to their ligands and are 
targeted for degradation.  One of the best characterized receptors that is downregulated 
following ligand binding is the epidermal growth factor (EGF) receptor (recently  
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Figure 4.  Receptor-mediated endocytosis and phagosome maturation.  Receptor-mediated 
endocytosis is shown on the left panel and phagosome maturation is shown on the right panel.  
Both processes are regulated by members of the Rab family of GTPases.  Left panel: Upon 
binding of a ligand to a receptor, the ligand:receptor complex is internalized into vesicles which 
quickly fuse with Rab5-positive early endosomes (shown in blue).  From early endosomes or 
sorting endosomes, receptors are targeted to one of two pathways.  If targeted to the degradative 
pathway, receptors will traffic to Rab7-positive late endosomes (yellow), and then traffic to 
lysosomes, where they will be degraded.  In contrast, receptors not targeted for degradation will 
traffic along the recycling pathway and localize to Rab4-(green) or Rab11-(purple) positive 
endosomes.  Rab4- and Rab11-positive endosomes are considered the “fast” track and “slow” 
track, respectively.  Receptors that traffic back to the cell surface via Rab11-positive endosomes 
accumulate in a perinuclear compartment called the endocytic recycling compartment.  Right 
panel: Similar to receptors destined for degradation, phagosomes also sequentially fuse with 
Rab5-, Rab7-positive endosomes, and finally will fuse with lysosomes to form phagolysosomes.  
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reviewed (Sorkin and Goh, 2008).  Receptors and/or ligands destined for degradation are 
trafficked from the early (or sorting) Rab5-positive endosome to late endosomes, which 
are regulated by Rab7.  Rab7-positive endosomes then fuse with acidic lysosomes and 
degradation occurs.  Targeting of receptors to lysosomes functions to terminate signaling 
and make the cells unresponsive to further signal input (Katzmann et al., 2002).    
Similar to the pathway of receptor downregulation, a maturing phagosome will 
first interact with early Rab5-positive endosomes, then Rab7-, and finally with lysosomes 
to form the phagolysosome (Figure 4)(Scott et al., 2003).  Described as a unique hybrid 
organelle, phagolysosomes contain hydrolytic enzymes, defensins, bactericidal peptides, 
proteases, and a very low pH (Vieira et al., 2002), and thus, are programmed to destroy 
microorganisms.  The drop in pH during maturation of the phagosome is not only 
important for harming the phagocytosed pathogen, but is also required to activate many 
of the enzymes within the phagolysosome, such as the cathepsin family of proteases, and 
thus, is often considered a marker for a “functional” phagosome (Kinchen et al., 2008).  
The ability of many intracellular pathogens to prevent phagosome-lysosome fusion and 
survive within macrophages clearly illustrates that formation of the phagolysosome is 
essential for killing.  Examples include Mycobacterium tuberculosis and Legionella 
pneumophila (reviewed in (Brumell and Scidmore, 2007).  
 
2. Recycling of membrane proteins 
Instead of degradation, receptors can also be recycled back to the cell surface and 
re-used up to several hundred times (Maxfield and McGraw, 2004).  Interestingly, 
recycling of membrane proteins is not limited to receptors and is essential for maintaining 
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the composition of various organelles and returning important molecules back to specific 
compartments (Maxfield and McGraw, 2004).  Receptors can recycle either directly from 
the early Rab5-positive endosomes or indirectly through the endocytic recycling 
compartment (ERC).  Rab4 regulates direct trafficking back to the plasma membrane, 
while Rab11 regulates trafficking from an endocytic recycling compartment (ERC) back 
to the cell surface (Figure 4).  Recycling of receptors via the Rab4 and Rab11 pathways 
have been shown to be important for many receptor tyrosine kinases and G-protein-
coupled receptors (Sorkin and Von Zastrow, 2002).  The biological role of the ERC has 
been best illustrated in studies of GLUT4, which regulates the intake of glucose.  In the 
presence of stimulus (insulin), GLUT4 traffics through the ERC to the plasma membrane 
to increase cell surface expression of GLUT4.  In the absence of insulin, GLUT4 is 
transported from the ERC to an insulin-regulated compartment (IRC) to maintain a 
predominant intracellular distribution of GLUT4.  Thus, the ERC is involved in sorting of 
GLUT4 and serves as a reservoir for insulin-recruited GLUT4 (Maxfield and McGraw, 
2004). 
 
3. Recycling endosomes and phagocytosis 
Less is known about the role of recycling endosomes in regulating internalization 
and phagosome maturation, yet interestingly some of the first studies of recycling of 
membrane proteins utilized phagocytosis in macrophages as their model system 
(Steinman, Cohn, 1983).  After only 30 min of phagocytosis, its estimated that 
macrophages can engulf the equivalent of 48 - 145% of their surface area (Cox et al., 
2000), yet the surface area of the plasma membrane does not decrease, but rather 
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increases during phagocytosis (Hackam et al., 1998).  While many intracellular 
compartments, such as the Golgi, lysosomes, or ER, could provide additional membrane 
to the newly forming phagosome, endosomes are suggested to be more likely involved 
since disruption of the Golgi does not inhibit phagocytosis, lysosomes are not required 
for phagocytosis, and endosomes accumulate at the base of newly forming phagosomes 
(Cox et al., 2000).  Specifically, recycling endosomes are believed to be one resource of 
membrane to the phagosome.  Inhibition of recycling using a GTP-binding deficient 
Rab11 mutant, Rab11 25N, reduced both the rate and extent of phagocytosis, while a 
GTPase-deficient Rab11, Rab11 70L enhanced phagocytosis, suggesting recycling 
endosomes are important in the initial stages of phagocytosis (Cox et al., 2000).  
Recycling of Texas-Red labeled antibodies from phagosomal compartments to the plasma 
membrane has been shown and the recycling of these antibodies to be reduced in the 
presence of a dominant negative mutant of the Rab coupling protein (RCP), an effector of 
Rab11 (Damiani et al., 2004).  In addition, a proteomic analysis of phagosomes in 
macrophages localized Rab4 and Rab11 to early phagosomal membranes (Garin et al., 
2001).  These data, along with more recent studies showing recycling of membrane 
proteins from the Salmonella containing phagosome (Smith et al., 2005), suggest 
recycling endosomes may be involved in phagosome maturation.   
In addition to removal of proteins from the nascent phagosome, recycling 
endosomes provide a direct route for localizing key proteins to the phagocytic cup.  For 
example, tumor necrosis factor-α (TNFα) localizes to the ERC and, following 
stimulation with interferon gamma (IFNγ) and lipopolysaccharide (LPS) in macrophages, 
is targeted to the phagocytic cup via vesicle-associated membrane protein 3 (VAMP3)-
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positive recycling endosomes (Murray et al., 2005).  Transgenic expression of GFP-
tagged VAMP3 was shown to increase TNFα secretion (Murray et al., 2005), illustrating 
the role of recycling endosomes in localizing the release of a proinflammatory cytokine 
during phagocytosis.   
While the mechanisms that regulate phagosome maturation are quite similar to 
those regulating receptor-mediated endocytosis, the two processes are distinct.  Key 
differences are that phagocytosis involves engulfment of particles greater than 0.5 µm 
and requires actin cytoskeleton rearrangements (May and Machesky, 2001). 
 
VII. Enhanced antimicrobial activity in IFNγ and LPS stimulated macrophages 
1. Classical activation of macrophages 
While macrophages have the ability to phagocytose and kill microorganisms 
without requiring exogenous stimuli, these functions are greatly enhanced following 
stimulation with certain cytokines.  The major “classical” activators of macrophages are 
two cytokines, IFNγ and TNFα, and bacterial LPS (Mosser and Edwards, 2008).   
Classically activated macrophages have increased antimicrobial activity and enhanced 
antigen presentation.  Thus, classically activated macrophages are not only important for 
killing but are also essential for eliciting an inflammatory response.  In contrast, other 
states of activation of macrophages such as alternatively and/or M2 activated do not 
result in release of inflammatory cytokines (Benoit et al., 2008; Mosser and Edwards, 
2008).   
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2. Interferon gamma (IFNγ) 
IFNγ was first identified as the macrophage activating factor released by 
lymphocytes that enhanced the secretion of superoxide and the ability to kill intracellular 
microbial pathogens, referred to as the “cardinal criterion” of macrophage activation by 
C. Nathan (Nathan et al., 1983).  Currently, IFNγ is still believed to be the most 
important stimulus to activate antimicrobial mechanisms in macrophages, which include 
(i) superoxide produced by the NADPH oxidase, (ii) nitric oxide (NO) generated from 
inducible NO synthetase (iNOS), and (iii) up-regulation of immunomodulating genes that 
recruit or activate T and/or NK cells, or monocyte/macrophages  (Schroder et al., 2004).  
Additionally, IFNγ up-regulates antigen processing and presentation pathways in 
macrophages which correlate with increased transcription of MHCII (Schroder et al., 
2004).   
The importance of IFNγ is illustrated in human disease and mouse models with 
defects in IFNγ signaling.  In humans, defects in IFNγ signaling cause selective 
deficiencies in innate and adaptive immunity that typically manifest as recurrent and 
relapsing nontuberculous mycobacterial infections among infected individuals 
(Haverkamp et al., 2006).  In mouse models in which IFNγ signaling is disrupted by 
monoclonal antibodies to IFNγ or by germline mutations of the IFNγ-receptor (Huang et 
al., 1993), mice are more susceptible to infections by certain pathogens, such as 
Leishmania major (Belosevic et al., 1989; Muller et al., 1989), and in the case of 
infection with avirulent Bacillus Calmette-Guerin (BCG), the vaccine strain of 
Mycobacterium bovis, are unable to combat infection and die (Kamijo et al., 1993). 
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Many different cells of the immune system can produce IFNγ, including CD4+ T 
helper cell type 1 (Th1) lymphocytes, CD8+ cytotoxic lymphocytes, NK and NKT cells, 
monocytes, macrophages, and dendritic cells (Schroder et al., 2004).  IFNγ activates 
macrophages mainly through gene regulation and signals through the Janus kinase – 
signal transduction and activator of transcription (Jak-Stat) pathway, but it is not the only 
pathway identified (Gough et al., 2008).  Jak-Stat signaling is used by over 50 cytokines, 
growth factors, and hormones (Subramaniam et al., 2001).  Upon binding to the IFNγ-
receptor (IFNGR), consisting of two signal transducing IFNGR1 and IFNGR2 chains, 
IFNγ induces Jak2 autophosphorylation and consequent transphorylation of Jak1.  
Phosphorylated Jak2 phosphorylates tyrosine residues on the IFNGR1 chains, which 
provide adjacent docking sites for the SH2 domains of Stat1 and subsequent Stat1 
homodimer formation.  Stat1 homodimers quickly dissociate from the receptor and travel 
to the nucleus to initiate/suppress gene transcription at IFNγ-activation site (GAS) 
elements.  It is important to note that some of the genes activated via GAS elements 
encode transcription factors (such as IFNγ regulatory factor-1, IRF-1) that further drive 
transcription alone or in combination with Stat1, leading to “waves” of transcription 
(Schroder et al., 2004).   
 
3. IFNγ increases CYBB gene expression.   
IFNγ induces CYBB expression, the gene encoding gp91phox, in neutrophils and 
macrophages (Newburger et al., 1988), which is Jak/Stat regulated (Kakar et al., 2005).  
Transcription factors PU.1, IRF1, and ICSBP were found to act cooperatively to induce 
CYBB expression following IFNγ stimulation in a promyelocytic cell line, U937 (Eklund 
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et al., 1998).  In addition to CYBB, the genes encoding p47phox and p67phox, NCF1 
(Cassatella et al., 1990; Levy et al., 1990; Amezaga et al., 1992) and NCF2 (Levy et al., 
1990; Gupta et al., 1992), have also been found to be regulated by IFNγ.  Currently, it is 
believed that the primary mechanism by which IFNγ stimulation amplifies superoxide 
production is through increased transcription of CYBB and NCF2 genes, leading to 
increased protein expression of gp91phox and p67phox subunits (Schroder et al., 2004).  
  
4. Lipopolysaccharide (LPS)  
 LPS, the major structural component of the outer membrane of Gram-negative 
bacteria, has also been shown to activate macrophages to release a plethora of cytokines 
and chemokines important for pathogen clearance (Guha and Mackman, 2001).  Through 
activation of the Toll-like-receptor 4 (TLR4), LPS has been shown to activate two major 
transcription factors, AP-1 and NFκB, through MyD88-dependent signaling and to 
activate STAT1 through a MyD88-independent mechanism.  These transcription factors 
increase expression of TNFα, IL-1β, IL-6, and iNOS (Kopydlowski et al., 1999).  In 
neutrophils, it has been shown that LPS can increase protein expression of gp91phox 
(Cassatella et al., 1990), but little or no data exists on the regulation of CYBB by LPS in 
macrophages. 
In addition, activation of macrophages with IFNγ and LPS decreases the rates of 
fluid phase pinocytosis, phagocytosis, and delays the progression of phagosomes to late 
endosomes and lysosomes, which was suggested to enhance killing and antigen 
processing (Tsang et al., 2000).   
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VIII. SCOPE OF THIS WORK 
In macrophages, many intracellular pathogens avoid oxidative killing by targeting 
the NADPH oxidase.  Studies of Salmonella typhimurium suggest localization of the 
membrane-bound heterodimer, flavocytochrome b, to the phagosome is essential for 
microbial killing, yet the subcellular distribution of flavocytochrome b in macrophages is 
not well characterized.  The goal of our studies was to more fully characterize the 
distribution and trafficking of flavocytochrome b in resting and IFNγ and LPS stimulated 
macrophages.  We generated fluorescently tagged p22phox and gp91phox probes and 
rigorously tested their functionality in Chinese Hamster Ovary cells (CHO).  Initial 
studies in CHO cells also investigated the role of the individual subunits in directing 
trafficking of the heterodimer.  Localization of flavocytochrome b was then examined in 
both RAW 264.7 murine macrophages and primary murine bone marrow derived 
macrophages (BMDMs) in the presence and absence of IFNγ and/or LPS stimulation.  
Our results show that endogenous and transfected flavocytochrome b localizes to similar 
intracellular compartments in these three cell types in the absence of stimuli and 
demonstrate for the first time that macrophage flavocytochrome b is present in 
intracellular compartments that recycle to the plasma membrane.  In the presence of 
IFNγ, but not LPS, we found a time-dependent increase in the cell surface expression of 
flavocytochrome b, which correlated with increased flavocytochrome b protein 
expression and NADPH oxidase activity.  The enhanced release of superoxide in IFNγ 
activated cells was found to be inhibited by superoxide dismutase (SOD), which suggests 
an extracellular release of superoxide.  Our results suggest the change in distribution of 
flavocytochrome b may be important for the production of extracellular superoxide in 
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macrophages and that the change in trafficking of flavocytochrome b may be a potential 
new mechanism by which IFNγ enhances antimicrobial activity in macrophages.  
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CHAPTER TWO:  MATERIALS AND METHODS 
 
I. Antibodies and Reagents  
Anti-gp91phox monoclonal antibodies (mAbs) 54.1 and CL5 (Burritt et al., 1995; 
Baniulis et al., 2005), and anti-p22phox mAbs NS2 and 44.1 (Taylor et al., 2004) were 
kindly provided by A.J. Jesaitis (Montana State University).  7D5 mAb (anti-gp91phox), 
collected from hybridoma cells kindly provided by M. Nakamura (Nagasaki University) 
(Yamauchi et al., 2001), and a rabbit polyclonal anti-p22phox (Dinauer et al., 1991) were 
described previously.  The following antibodies were purchased: anti-calnexin 
(StressGene, Victoria British Columbia, Canada), anti-Rab11 (Zymed Laboratories, San 
Francisco, CA,), anti-β-actin (Sigma-Aldrich St. Louis, MO), anti-GFP (Santa Cruz 
Biotechnology, Santa Cruz, CA, Cat#sc-8334), secondary HRP-conjugated antibodies 
(Promega, Madison, WI) and R-Phycoerythrin (PE)-conjugated Rat anti-mouse IgG1, Rat 
anti-mouse CD16/C32, and Rat anti-mouse MHCII-I-A/I-E (BD Pharmingen, San Jose, 
CA).  Alexa Fluor labeled secondary antibodies, and Alexa Fluor 647-labeled Dextran 
(10,000 MW) and labeled human transferrin were from Molecular Probes (Invitrogen, 
Carlsbad, CA).  Mouse transferrin (Sigma-Aldrich) was iron loaded and tagged to Alexa 
Fluor 647 (Molecular Probes) to generate mTfn-AF647 as previously described 
(Yamashiro et al., 1984).  Phosphate buffered saline (PBS, pH 7.2), 
penicillin/streptomycin, neomycin, trypsin/ethylene diamine tetra-acetate (EDTA), 
Dulbecco’s modified Eagle’s medium (DMEM) with low glucose, α-Minimum Essential 
Medium (αMEM), Ham’s F12K medium, cell dissociation Buffer, and LipofectamineTM 
2000 were purchased from Invitrogen Life Technologies.  Fetal calf serum (FCS) and 
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bovine growth serum (BGS) were purchased from HyClone Laboratories (Logan, UT).  
Murine macrophage colony stimulating factor (M-CSF) and recombinant IFNγ (>1x107 
units/mg) were purchased from Peptrotech (Rocky Hill, NJ).  LPS of S. typhimurium, was 
obtained from Calbiochem.  All other reagents were from Sigma-Aldrich. 
 
II. Labeling of cells with fluorescently tagged ligands 
Cells plated on coverslips were washed once in their corresponding media (37°C, 
no serum) and then incubated with Alexa Fluor 647-labeled transferrin (Tfn-AF647) or 
Alexa Fluor 647-labeled Dextran (Dex-AF647) diluted in the same media for the times 
indicated.  For live cell imaging, cells plated on Mat-tek® coverslip dishes were washed 
once in PBS (37°C) and then incubated with fluorescently tagged ligands diluted in 
0.01M HEPES buffer in PBSG (PBS plus 0.5 mM MgCl2, 0.9 mM CaCl2 and 7.5 mM 
dextrose).  20 µg/ml Tfn-AF647 was used for labeling recycling endosomes in CHO cells 
and 5 µg/ml for labeling recycling endosomes in macrophages.  10 µg/ml Dex-AF647 
was used for labeling lysosomes in CHO cells.  In some experiments, cells were chased 
with media (37°C) as described. 
 
III. Mouse strains 
Homozygous nmf333 mice (A.B6-Tyr+/J genetic background), which harbor a T 
to C point mutation in the Cyba gene encoding p22phox and lack expression of p22phox, 
were kindly provided by Botond Banfi (University of Iowa, Iowa City, IA) (Nakano et 
al., 2008).  The C57BL/6Ai p47phox-/- mouse, purchased from Taconic (Hudson, New 
York), was originally generated by Jackson and colleagues (Jackson et al., 1995) by 
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insertion of a neomycin (neo) resistant cassette into exon 7 of the mouse p47phox gene 
(NCF1) in embryonic stem (ES) cells.  gp91phox-/- (referred to as CGD) mice were also 
generated by gene targeting and a neo cassette was placed into exon 3 of the gp91phox 
gene (CYBB) (Pollock et al., 1995).  C57BL/6J and A.B6-Tyr+/J mice were obtained 
from the Jackson Laboratory (Bar Harbor, ME).   
 
IV. Differentiation of bone marrow derived macrophages 
1. BMDM Protocol One 
Three days following intraperitoneal injection of 150 mg/kg 5-fluorouracil (5-
FU), BM cells were harvested from femurs and tibias by flushing with αMEM.  The day 
of BM harvest was considered Day 0.  BM cells were pelleted and re-suspended in 
prestimulation media, αMEM with 20% heat inactivated fetal calf serum, 100 ng/ml stem 
cell factor (SCF), 100 U/ml Interleukin-6 (IL-6), 10 U/ml penicillin, and 100 µg/ml 
streptomycin) for 96 hr.  On day 4, the combined suspended and adherent cells were 
collected using cell dissociation buffer and differentiated into BMDMs as described 
previously  (Racoosin and Swanson, 1989) with some minor changes.  5 x 105 BM cells 
were suspended in 3 ml of αMEM media containing 20% heat inactivated FCS, 25 ng/ml 
murine M-CSF (Peprotech), 10 U/ml penicillin, and 100 µg/ml streptomycin (referred to 
as differentiation media).  In addition, we initially plated BM cells in one well of a 6-well 
tissue culture dish for 3 days in differentiation media and then aspirated the non-adherent 
cells (Day 3 of differentiation) and transferred them to a 150 mm Petri dish, whereas 
adherent cells were discarded.  Following 3 more days of differentiation (Day 6 of 
differentiation), adherent cells were then collected, or new differentiation media was 
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added for an additional 3 more days.  To collect adherent BMDMs, the media was 
aspirated and discarded, and cold PBS (10 ml) was added to the dish.  The dish was 
placed on ice, or at 4°C, for 10 - 15 min.  Cells were then collected by aspirating the PBS 
and adding it back to the dish, repeating this multiple times until the cells were lifted, 
which was monitored using a light microscope.  Day 6- to Day 9-differentiated BMDMs 
were plated according to the experiment, as described in the methods.     
 
2. BMDM Protocol Two 
Bone marrow derived macrophages were obtained using conditions adapted from 
Racoosin and Swanson (Racoosin and Swanson, 1989).  Total bone marrow cells flushed 
from mouse femurs were washed twice in αMEM media (4°C).  Total bone marrow cells 
from each mouse were suspended in 20 ml αMEM with 20% HI FCS, 25 ng/ml M-CSF, 
10 units/ml penicillin, and 100 µg/ml streptomycin and plated onto a single 150 mm Petri 
dish (non-tissue culture plastic) (Day 0).  Following 2 hr at 37°C, non-adherent cells were 
aspirated and transferred to a new 150 mm Petri dish, whereas adherent cells were 
discarded.  After 3 days of differentiation, non-adherent cells were collected, centrifuged, 
re-suspended in fresh differentiation media, and added back to the 150 mm Petri dish.  
On Day 6 of differentiation, adherent cells were either collected using cold PBS, as 
described above, or new media was added.  Day 6- to Day- 9 differentiated BMDMs 
were plated according to the experiment, as described in the following methods.  
 
 
 
  
35 
V. Expression vectors 
1. Generation of fluorescently tagged p22phox and gp91phox constructs 
For generation of p22phox full length (wild-type) and p22phox C-terminal deletion 
fragments, primers specific to p22phox (listed in Table III) were developed to amplify the  
desired region of p22phox and to add HindIII and EcoRI restriction sites at the 5’ and 3’ 
regions of the amplified human p22phox cDNA.  Amplified fragments were cloned into the  
HindIII and EcoRI sites of the mammalian expression vector eYFP-N1 (Clontech, Palo 
Alto, CA) to generate p22phox (1-195)/eYFP-N1 (referred to as 22YFP), p22phox (1-
171)/eYFP-N1 (referred to as 172YFP), p22phox (1-148)/eYFP-N1 (referred to as 
149YFP), and p22phox (1-130)/eYFP-N1 (referred to as 131YFP) constructs.  Full length 
p22phox (1-195), p22phox (1-148), and p22phox (1-130) cDNA were also subcloned from 
22YFP into the mDsRED-N1 (Clontech), the mCFP-N1, or the mCIT-N1 (both were 
kindly provided by J. Swanson, University of Michigan) vectors using the HindIII and 
EcoRI restriction sites to generate 22RED, 22CFP, 22CIT, 22C149CIT, and 22C131CIT.  
Fluorescently tagged probes utilized in our studies are listed in Table IV. 
The human gp91phox cDNA was excised from gp91phox/KS+Bluescript (Zhen et 
al., 1993) using BamHI, and ligated into the BamHI site in pcDNA3.1+ (Invitrogen) to 
generate gp91/pcDNA3.1+.  The cDNA gp91phox was then subcloned into the HindIII and 
SalI sites of peCFP-C1 by digesting gp91/pCDNA3.1+ with HindIII and XhoI to generate 
peCFP-C1/gp91 (referred to as CFP91, sequence available upon request).  This construct 
expressed gp91phox tagged at its N-terminus with CFP, with an intervening 31 amino 
acids, where 22 were derived from polylinker sequence carried over from the insert in 
gp91phox/KS+Bluescript and 9 were from the multiple cloning site within pECFP-C1.   
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Table III.  Primers designed for 22YFP constructionsa 
cDNA fragment generated Primer sequence 
HindIII-p22phox(1-585)_EcoRI 
22YFP 
Fwd:  5’_TATACAAGCTTCAATGGGGCAGATCGAG_3’ 
Rev:   5’_TGAATTCTCACGACCTCGTCGGTCA_3’ 
HindIII-p22phox(1-513)_EcoRI 
172YFP 
Fwd:  5’_TATACAAGCTTCAATGGGGCAGATCGAG_3’ 
Rev:    5’-TGAATTCTCTCCTCCTCGCTG-3’ 
HindIII-p22phox(1-444)_EcoRI 
149YFP 
Fwd: 5’_TATACAAGCTTCAATGGGGCAGATCGAG_3’ 
Rev:    5’-TGAATTCTGATGGTGCCTCCGATC-3’ 
HindIII-p22phox(1-390)_EcoRI 
131YFP 
Fwd:  5’_TATACAAGCTTCAATGGGGCAGATCGAG_3’ 
Rev:    5’-TGATTCTCTGCTCGCCACGCAC-3’ 
 
aPrimers designed for generation of fluorescently tagged human p22phox full length and C-
terminal truncated proteins are listed above (right column) along with the cDNA fragments 
generated (left column).  Coding sequences within the primers for p22phox are underlined, while 
restriction enzymes are in bold. 
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Table IV.  Fluorescently tagged proteins used in this studya  
Fluorescently tagged proteins Abbreviation 
p22phox (1-195)/eYFP 22YFP 
p22phox (1-171)/eYFP 172YFP 
p22phox (1-148)/eYFP 149YFP 
p22phox (1-130)/eYFP 131YFP 
p22phox/eCFP 22CFP 
p22phox/mDsRED 22RED 
p22phox/mCIT 22CIT 
p22phox (1-148)/mCIT 149CIT 
p22phox (1-130)/mCIT 131CIT 
eCFP/gp91phox eCFP91 
mCFP/gp91phox mCFP91 
mCIT/gp91phox YFP91 
Rab5/eGFP Rab5GFP 
Rab7/eGFP Rab7GFP 
Rab11/eCFP * CFPRab11 
eGFP/Rab11a* GFPRab11 
PH(PLCγ)/eGFP PHGFP 
FcγR11a/eGFP FcγRGFP 
(1-72)GAD65-eGFP mGAD65GFP 
 
aThe fluorescently tagged proteins used in this study (left column) are shown along with 
the abbreviated nomenclature (right column).  All transgenes were of human origin except those 
marked by *, which are of rabbit origin.  For constructs expressing YFP-tagged p22phox and C-
terminal deleted derivatives, the amino acids present in full length (amino acids 1-195) and 
truncated forms are indicated.  
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gp91phox was further subcloned from pECFP-C1/gp91phox into mCFP-C1 (provided by J. 
Swanson, University of Michigan) and mCIT-C1 to generate pmCFP-C1/gp91phox and 
pmCIT-C1/gp91phox using the HindIII and XhoI multiple cloning sites to maintain the 
same linker between the fluorescent tag and gp91phox.  mCIT-N1 is a  
derivative of YFP with a single amino acid change that reduces potential changes in 
fluorescence due to low pH, but otherwise functions essentially the same as YFP  
(Griesbeck et al., 2001) for simplicity pmCIT-C1/gp91phox will be referred to as YFP91 
(see Table IV).  
pEF- and pRK5-based vectors for expression of p47phox and p67phox were 
described previously (Price et al., 2002).  Rab11eCFP (Babbey et al., 2006) and 
Rab11eGFP (Wang et al., 2001) were described previously.  The following expression 
vectors were generous gifts: Rab5eGFP (G. Li, Washington University), Rab7eGFP (A. 
Wandinger-Ness, University of New Mexico), 1-72GAD65(C30,45A)-GFP (referred to 
as mGAD65GFP, S. Baekkeskov, University of California San Francisco), and FcγRIIa-
GFP and PH-(PLCγ)-GFP (S. Grinstein, Hospital for Sick Children, Toronto). 
 
2. Retroviral vectors 
A YFP-expressing retroviral vector MSCV-eYFPN1 was generated by subcloning 
the eYFP cDNA and the multiple cloning sites up to and including BglII at the 5’ end of 
eYFP from peYFP-N1 (Clontech) into the MSCV-pac vector backbone (Clontech) after 
removing the puromycin expression cassette.  Human p22phox was then subcloned from 
p22eYFP-N1 (described above) using the HindIII and EcoRI sites and inserted into 
pMSCV-eYFP-N1 to generate pMSCV-p22eYFP-N1 (referred to as MSCV-22YFP).   
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Retroviruses were packaged using the Pantropic Retroviral Expression System (Clontech) 
and stored at -80°C until use, according to the manufacturer's instructions.   
 
3. Transgene expression in CHO-K1 cell lines    
CHO-K1 (CHO) cell lines utilized in these studies are listed in Table V.  Parental 
CHO cells or derivatives expressing NADPH oxidase transgenes were transfected using  
LipofectamineTM 2000 according to manufacturer’s instructions.  CHO-22 and CHO-91-
67-47 [which will be referred to as CHO-22 and CHO-91 (Biberstine-Kinkade et al., 
2002), respectively] were previously generated for stable expression of untagged p22phox 
and gp91phox.  Similarly, CHO cells were transfected with YFP91 or co-transfected with 
p47phox and p67phox to generate CHO-YFP91 and CHO-47-67 cell lines.  22YFP was 
transfected in the CHO-91 cell line to generate CHO-91-22YFP cells.  CHO-91-22YFP 
cells express p47phox and p67phox, but for the purposes of these experiments, the absence 
or presence of p47phox and p67phox has no significant effect on the localization of p22phox, 
which is illustrated by the similar distributions of 22CFP, expressed in CHO-YFP91 cells 
that lack p47phox and p67phox, and 22YFP, expressed in CHO-91-22YFP cells that express 
p47phox and p67phox (Figures 11C and 14C).  For stable expression of YFP-tagged proteins 
in CHO-YFP91 and CHO-91-22YFP cell lines, cells were selected in 1.6 mg/ml 
neomycin for at least two weeks, followed by flow cytometric cell sorting (FacsAria, 
Becton Dickinson Biosciences) to collect strongly fluorescent cells and to discard cells 
with little to no fluorescence.  Cell sorting increased the percent positive 22YFP cells 
from 18% to 75% in the CHO-91-22YFP cell line and 22% to 70% in CHO-YFP91 cell 
line.  After sorting, CHO-YFP91 cells were maintained in 0.8 mg/ml neomycin, and  
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Table V.  CHO-K1 and RAW 264.7 cell lines used in this studya 
Cell line Parental cells Transgene (s) 
CHO-WT CHO-K1 -- 
CHO-22* CHO-K1 p22phox/PGKneo 
CHO-YFP91 CHO-K1 mCIT/gp91phox 
CHOf-22-YFP91 CHO-K1 MFG-FcγRIIa+p22phox/PGKneo+ mCIT/gp91phox  
CHO-91 CHO-K1 MFG-S/gp91phox+p47phox/PGKhygro+p67phox/PGKpuro 
CHO-91-22YFP CHO-91 p22phox (1-195)/eYFP 
CHO-91,67,47,22 CHO-K1 MFG-S/gp91phox+p47phox/PGKhygro+p67phox/PGKpuro+p22phox/PGKneo 
CHO-47-67* CHO-K1 p47phox/PGKhygro+p67phox/PGKpuro 
RAW-WT RAW 264.7 -- 
RAW-22YFP* RAW 264.7 p22phox (1-195)/eYFP 
RAW-YFP91 RAW 264.7  mCIT-C1/gp91phox 
RAW-91,22* RAW 264.7 gp91phox/pEFpacpuro+p47phox/PGKhygro+ p22phox/PGKneo 
RAW-22CIT RAW 264.7 p22phox(1-195)/mCIT 
RAW-22C149CIT RAW 264.7 p22phox (1-148)/mCIT 
RAW-22C131CIT RAW 264.7 p22phox (1-130)/mCIT 
 
aThe nomenclature for CHO-K1 and RAW 264.7 cell lines used in this study (left 
column) are shown, along with the parental cell line and transgenes (right columns).  *denotes a 
clonal cell line. 
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CHO-91-22YFP cells were maintained in 0.8 mg/ml neomycin, 1 µg/ml puromycin, and 
0.2 mg/ml hygromycin.  CHO cells were co-transfected with expression vectors for 
p47phox and p67phox, and clones were obtained by limiting dilution in medium containing  
puromycin and hygromycin as described previously (Price et al., 2002).  CHO parental 
and derivative cell lines were maintained in Ham’s F12 medium, 10% BGS, 0.15% 
sodium bicarbonate, 10 units/ml penicillin, and 100 µg/ml streptomycin as previously 
described (Zhu et al., 2006).    
 
4. Transgene expression in RAW 264.7 cell lines    
RAW264.7 cell lines utilized in these studies are listed in Table V.  RAW 264.7 
macrophages were transfected using AMAXA (Cell Line Nucleofactor Solution Kit V, 
Gaithersburg, MD), according to the manufacturer’s instructions. RAW 264.7 cells were 
transfected with the 22YFP vector to generate a RAW-22YFP stable cell line.  After at 
least two weeks in selection in 1.6 mg/ml neomycin, RAW-22YFP clones were selected 
by limiting dilution in 96 well plates followed by screening using flow cytometry for 
YFP.  RAW 264.7 cells were also transfected with YFP91, FcγRIIa-GFP, PH-(PLCγ)-
GFP, 22CIT, 22C149CIT, or 22C131CIT and selected in 0.8 mg/ml neomycin to generate 
RAW-mCIT-C1/gp91phox (referred to as RAW-YFP91), RAW-FcγRIIa-GFP (referred to 
as RAW-FcγR-GFP), RAW-PH-(PLCγ)-GFP (referred to as RAW-PH-GFP), RAW-
22CIT, RAW-22C149CIT, and RAW-22C131CIT cell lines.  RAW 264.7 cells were also 
transfected with gp91phox/pEFpacpuro, p47phox/PGKhygro, p22phox/PGKneo using Fugene-
6 transfection reagent (Roche Diagnostics) to generate RAW-91,22,47 cells, which will 
be referred to as RAW-91,22 for simplicity in these studies.  RAW-91,22,47 cells were 
  
42 
made sequentially by first generating RAW-47, then RAW-91,47, and then RAW-
91,22,47 cells, clones were selected from each cell line by limiting dilution.  RAW 264.7 
cells were maintained with or without selection antibiotics in low glucose DMEM, 10% 
heat inactivated FCS, 10 units/ml penicillin, and 100 µg/ml streptomycin. 
For passaging of cells in culture or collecting cells for analysis, CHO and RAW 
264.7 cells were harvested using trypsin (0.05% in EDTA) as described previously for 
CHO cells (Zhu et al., 2006). 
 
  5. Retroviral transduction of primary murine bone marrow cells 
Retroviral transduction of murine bone marrow (BM) cells with MSCV-22YFP 
was performed as previously described (Yamauchi et al., 2005).  Briefly, three days 
following intraperitoneal injection of 150 mg/kg 5-fluorouracil (5-FU), BM cells were 
harvested from femurs and tibias by flushing with αMEM.  The day of BM harvest was 
considered Day 0.  BM cells were pelleted and re-suspended in prestimulation media 
αMEM with 20% heat inactivated fetal calf serum, 100 ng/ml stem cell factor (SCF),  
100 U/ml Interleukin-6 (IL-6), 10 U/ml penicillin, and 100 µg/ml streptomycin) for 48 hr.  
On days 2 - 4, cells were transduced every 24 hr with retrovirus supernatant for 4 hr.  
After the 4 hr transduction, the retroviral supernatant was removed and “fresh” media and 
cytokines (IL-6 and SCF) were added.  On day 4, after the last 4 hr of transduction, the 
combined suspended and adherent cells were collected using cell dissociation buffer and 
differentiated into BMDMs as described for BMDM Protocol One.    
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VI. Cytokine stimulation 
After 6 - 9 days of differentiation, as indicated in M-CSF, following Protocol One 
(page 33), BMDMs were counted, centrifuged, re-suspended in the presence or absence 
of differentiation media or stimuli as described, and re-plated onto 100 mm Petri dishes at 
1x106 cells/dish.  
RAW 264.7 cells proliferate in culture, but proliferation of many cells is inhibited 
by IFNγ treatment (Maher et al., 2007).  Thus, to obtain approximately 60 - 90% 
confluency for RAW 264.7 cells cultured in the presence or absence of IFNγ and to 
prevent cells cultured in the absence of IFNγ from overgrowing, the following cell 
numbers were plated in 100 mm culture treated dishes for the indicated times: 1.2x106 
(no IFNγ and IFNγ 24 hr), 6x105 (no IFNγ and IFNγ 48 hr), 3x105 cells (no IFNγ 72 hr) 
and 6x105 (IFNγ 72 hr).  Following treatment, RAW 264.7 macrophages were collected 
by trypsinization from tissue culture treated plates, while primary transduced BMDMs  
(Protocol One) were collected from Petri dishes with cold PBS.   
Stimulants were used at the following working concentrations: murine IFNγ (0.1 -
500 ng/ml), murine TNFα (20 - 200 ng/ml), or LPS of S. typhimurium (0.02 - 1.0 µg/ml) 
in DMEM (for RAW) and αMEM (for BMDMs) with 10% heat inactivated FCS and P/S 
for 24 - 72 hr.  For IFNγ studies with multiple concentrations of IFNγ, serial dilutions of 
IFNγ were prepared.  IFNγ (0.1 - 0.5 mg/ml) was stored in aliquots at -20°C for up to 6 
months, and LPS (2.5 mg/ml) was stored at 4°C for up to 1 year.  A blocking antibody for 
TNFα was used at 0.2 - 10 µg/ml and stored at 4°C for up to 1 year.  
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VII. Analysis of protein expression 
1. SDS/PAGE and Western blotting 
Ten to thirty micrograms of total protein from Triton X-100 cell extracts was 
added to each well of a 9% or 12% SDS-polyacrylamide gel, electrophoresed, transferred 
to nitrocellulose membranes and probed for protein expression by immunoblotting as 
described (Price et al., 2002; Zhu et al., 2006).  Primary antibodies were used at the 
following dilutions in Tris buffered saline with 0.1% Tween 20 (TBST): Rabbit anti-
GFP, which also recognizes YFP, (1:1,000), mouse anti-gp91phox (1:1-5,000 for either 
54.1 or CL5), rabbit anti-p22phox (1:5-10,000), mouse anti-p22phox (1:500-1,000), mouse 
β-actin (1:10,000), rabbit anti-p67phox (1:5,000), rabbit anti-p47phox (1:15,000), rabbit anti-
p40phox (1:3,000), mouse anti-iNOS TypeII (1:2,000), and secondary HRP-conjugated 
antibodies (1:10,000). 
 
2. Flow Cytometry   
gp91phox cell surface expression and the transfection efficiency of fluorescently 
tagged proteins were evaluated by flow cytometry.  CHO and RAW 264.7 cells were 
suspended at 0.5 - 1.0 x106 cells/ ml in FACS buffer (0.1% BSA in PBS) with 10% 
normal goat serum for 30 min and kept at 4°C throughout the staining procedure. 7D5 
supernatant (1:20 dilution) and PE-conjugated primary (1:100) or secondary antibodies 
(1:200) were diluted in FACS buffer and incubated with cells for 30 min.  Fluorescence 
was measured by FAC-Scan (Becton Dickinson, San Jose, CA).  In some experiments, 
stained cells were fixed with 1% paraformaldehyde at 4°C overnight, and subsequently 
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analyzed 24 - 48 hr later, with results the same as those obtained with freshly stained, 
unfixed cells.  
 
3. Isolation of biotinylated proteins 
Immunoprecipitation of biotinylated cell surface proteins was performed using the 
EZ Link Sulfo-NHS-SS-Biotin kit from Pierce (Catalog #89881) per manufacturer’s 
instructions with minor changes.  The manufacturer’s instructions suggested biotinylation 
assays be performed in 75 mm flasks with a maximum of 1x107cells /flask per condition.  
RAW 264.7 cells were plated in quadruplicate flasks for each condition for 72 hr.  One 
set of duplicate flasks was combined following biotinylation of surface proteins.  The 
other set of duplicate flasks was combined without biotinylating the cell surface and was 
used as a control to biotinylate total proteins in the cell lysate as described previously 
(Turvy and Blum, 2001).  To compensate for differences in proliferation, as described 
above, 9x105 cells were plated in the presence of IFNγ and 3x105 cells in the absence of 
IFNγ for 72 hr. 
 Following biotinylation of the cell surface or cell lysate, biotinylated proteins 
were immunoprecipitated using the Neuravidin columns and eluted in a total volume of 
200 µl.  Due to the substantial increase in gp91phox isolated from IFNγ stimulated 
samples, the amount of each sample was optimized to result in approximately the same 
density following Western blotting for gp91phox protein expression.  Densitometric 
analysis was performed and any differences in the amount of sample added to the well 
was included in the calculation and is described in the figure legend. 
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VIII. NADPH Oxidase Activity  
1. Isoluminol 
NADPH oxidase activity in CHO cells was measured by isoluminol-enhanced 
chemiluminescence following stimulation with arachidonic acid (AA) as described 
previously (Zhu et al., 2006).  Briefly, 1x105 cells/well of a 96-well plate were pre-
incubated at 37°C in PBSG, horseradish peroxidase (HRP, 20 U/ml), and isoluminol (50 
µM) for 10 min.  For each experiment, one well containing all solutions but no cells was 
used to calculate background luminescence.  Relative light units (RLU) were recorded 
every 100 sec for 30 min by the Fast Kinetic module in an Lmax microplate luminometer 
from Molecular Devices (Sunnyvale, CA) following stimulation with AA.  Integrated 
RLU values (area under the curve) were calculated by SOFTmax software (Molecular 
Devices) and background chemiluminescence was subtracted to report superoxide 
production.  The number of cells per assay was increased from 1x105 cells/well to 2x105 
cells/well for CHO-22 cells transfected with p47phox, p67phox, CFP91, or CFP (Figure 9, 
middle panel) due to lower transfection efficiency when introducing three plasmids. 
 
2. Luminol 
NADPH oxidase activity was assessed using luminol-enhanced 
chemiluminescence in RAW 264.7 cells and BMDMs (Protocol One). 1x105 cells, unless 
stated differently in the figure description, were suspended in PBSG with horseradish 
HRP and luminol (final concentrations of 20 U/ml and 50 µM) and plated into each well 
of a 96 well plate in the presence or absence of superoxide dismutase (SOD, 75 µg/ml).  
Cells were pre-heated at 37°C for 10 min before addition of phorbol 12-myristate 13-
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acetate (PMA, 300 ng/ml) or serum opsonized zymosan (SOZ, 0.4 mg/ml).  To 
synchronize SOZ stimulated superoxide production, chemiluminescence was measured 
immediately following centrifugation at 700 rpm for 30 sec.  RLUs were monitored at 
60- to 90-sec intervals for 30 or 50 min by the Long Kinetic module in an Lmax 
microplate luminometer from Molecular Devices (Sunnyvale, CA).  Integrated RLU 
values were calculated by SOFTmax software (Molecular Devices) and background 
chemiluminescence was subtracted (described above).   
 
3. Nitroblue tetrazolium 
BMDMs (Protocol Two) were plated in 8-well glass chamber slides for 24 to 72 
hr to detect superoxide production using Nitroblue tetrazolium (NBT) as described 
previously (Ochs and Igo, 1973).  1x104  BMDMs were plated to each well for 24 to 72 
hr.  Following 24 or 72 hr, NBT diluted in sterile αMEM with no FCS, was added to cells 
and incubated for 30 min at 37°C.  Cells were then placed on ice, washed twice with cold 
PBS, fixed with cold methanol for 1 min, and dried overnight at room temperature.  
Finally, cells were counterstained with 0.2% safrinin.  NBT is reduced in the presence of 
superoxide and forms an insoluble purple formazan deposit, which can be evaluated by 
light microscopy.    
 
IX. Phagocytosis Assays 
1. Serum opsonization of zymosan 
 Human serum was collected from 6 donors as described previously (Quinn et al., 
2007) using a protocol approved by the Institutional Review Board of Indiana University, 
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and all donors provided informed consent.  Zymosan A (from Saccharomyces cerevisiae, 
Sigma) was suspended at 20 mg/ml in PBS, sonicated at max speed on ice for 10 sec 
intervals (repeated 5 times), washed in PBS, and resuspended to 20 mg/ml.  Sonicated 
zymosan was opsonized with human serum as described previously (Quinn et al., 2007). 
 
2. Synchronized phagocytosis  
 RAW 264.7 cells and BMDMs (Protocol One) were plated on coverslips at 
approximately 50-70% confluency 24 hrs before phagocytosis assay.  SOZ was diluted 
1:100-1:500 in DMEM (for RAW) or αMEM (for BMDM) and added at approximately 3 
- 5 zymosan particles per cell.  Immediately after adding SOZ, cells were centrifuged at 
RT for 2 min at 800 g and then fixed immediately or incubated for an additional 13 min 
at 37°C for a total of 2 or 15 min to allow for internalization.  Cells were then washed 
twice with PBS (RT) and then fixed, permeabilized, and stained as described below. 
 
 3. Frustrated phagocytosis  
BSA (3 mg/ ml), followed by anti-BSA (Rabbit polyclonal, Sigma, 0.3 mg/ml) 
were coated onto acid-washed coverslips.  Frustrated phagocytosis assays were 
performed as described previously (Takemura et al., 1986).  Briefly, RAW 264.7 cells 
were plated on coverslips coated with BSA-Rabbit IgG complexes, incubated for 60 min 
at 4°C for adherence, and then warmed to 37°C in cell incubator for 15 or 60 min.  Cells 
were then fixed, permeabilized, and immunolabeled for confocal analysis as described 
below.  BSA in the absence of rabbit IgG was used as our negative control. 
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X. Indirect immunofluorescence and confocal microscopy 
1. Indirect immunofluorescence 
CHO cells were plated on glass coverslips coated with 0.01% gelatin.  RAW 
264.7 cells were initially plated on glass coverslips coated with 0.01% gelatin for studies 
in the absence of IFNγ, but changed to uncoated, acid-washed coverslips for later 
experiments comparing the distribution of flavocytochrome b in the absence and presence 
of IFNγ.  No difference in the distribution of flavocytochrome b on the different 
coverslips was observed (see Figures 23 and 39).  BMDMs (Protocol One) were plated 
on uncoated, acid-washed coverslips for all experiments.  Following 24 - 48 hr 
incubation, when cells were 50 - 80% confluent, monolayers were washed once in PBS, 
fixed in 4% paraformaldehyde for 10 min at room temperature, permeabilized in 
methanol:acetone (50:50) for 5 min at 4°C as described (Allen, 2008), washed in PAB 
(2% BSA, 0.05 g/L NaN3 in PBS), and then blocked in 10% goat serum in PAB for 30 
min at room temperature or overnight at 4°C.  Primary antibodies were diluted in 5% 
goat serum in PAB at the following concentrations:  anti-calnexin (1:400), anti-Rab11 
(1:400), 54.1 mAb anti-gp91phox (1:1,000), 44.1 mAb anti-p22phox (1:2), and anti-
CD16/CD32-PE (1:50).  After 1 hr incubation, coverslips were washed and incubated 
with Alexa Fluor secondary Abs (1:600) in 10% goat serum in PAB for 45 - 60 min at 
room temperature.  Coverslips were washed and mounted with Dako fluorescent 
mounting media (DakoCytomation).  The specificity and optimal concentration of mAbs 
NS5 (anti-human p22phox), 44.1 (anti-human p22phox), and 54.1 (anti-gp91phox) for 
immunofluorescence microscopy was evaluated in CHO parental, CHO-22, or CHO-
91,67,47,22 cells (Figures 5A and 5B).  In addition, the specificity of 54.1 for  
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Figure 5.  Validation of the specificity of p22phox and gp91phox antibodies in CHO cells.             
(A) CHO-WT and CHO-22 cells were fixed in 4% paraformaldehyde (10 min RT), permeabilized 
with 0.02% saponin (30 min RT), immunolabeled for p22phox using monoclonal antibodies NS5 
(left panels) or 44.1 (right panels), and stained with the nuclear dye DAPI (10 µg/ml, 10 min RT).  
(B) CHO-WT and CHO-91,67,47,22 cells were fixed in 4% paraformaldehyde (10 min RT), 
permeabilized with methanol:acetone (5 min at 4°C), immunolabeled for gp91phox using 
monoclonal antibody 54.1, and stained with the nuclear dye DAPI (10 µg/ml, 10 min RT). 
  
51 
immunofluorescent staining of gp91phox in macrophages was analyzed by comparing 
wild-type BMDMs to BMDMs obtained from gp91phox-null CGD mice (Pollock et al., 
1995)(not shown).  Preliminary experiments were also conducted in both CHO and RAW 
264.7 cells to determine the optimal permeabilization method for immunofluorescent 
staining of flavocytochrome b subunits.  In CHO cells, methanol:acetone appeared to be 
the best method based on the clear reticular distribution of p22phox and surface expression 
of gp91phox in CHO-91,67,47,22 cells (Figure 6A), which will be described in detail in the 
results section.  In addition, a preliminary experiment in RAW 264.7 cells compared 
three methods of permeabilization (Triton, Saponin, and Methanol/Acetone) and found 
the combination of methanol and acetone to result in the highest fluorescent intensity 
(Figure 6B) and was used for all experiments in both RAW 264.7 cells and BMDMs 
(Protocol One). 
 
2. Live cell imaging 
Cells were plated onto Mat-tek® coverslip dishes 24 - 72 hr before imaging to 
result in approximately 50 - 70% confluency at the time of analysis.  Cells were washed 
with PBSG (Price et al., 2002) and then imaged in 0.01M HEPES buffer (Sigma) in 
PBSG at 37°C.   
  
3. Confocal microscopy  
Images from cells grown on coverslips or Mat-tek® coverslip dishes were 
acquired on one of two confocal systems:  a Zeiss LSM510 (Carl Zeiss, Inc., Thornwood, 
NY) or a Perkin-Elmer Cetus Ultraview (Norwalk, CT) mounted on a Nikon TE 2000U  
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Figure 6.  Optimal immunofluorescent staining of flavocytochrome b subunits in CHO and RAW 
264.7 cells following methanol:acetone permeabilization.  Cells were fixed in 4% 
paraformaldehyde for 10 min at room temperature (RT), permeabilized, immunostained for 
gp91phox (mAb 54.1) or p22phox (mAb 44.1) and then stained with the nuclear dye Dapi (10 µg/ml, 
10 min RT).  (A) Immunofluorescent staining of p22phox and gp91phox in CHO-91,67,47,22 cells.  
Cells were permeabilized with methanol:acetone (top panel) or 0.02% saponin (bottom panel).  
(B) Immunofluorescent staining of gp91phox in RAW 264.7 cells.  From left to right:  cells were 
permeabilized with 0.02% Saponin, 0.1% TritonX-100, or methanol:acetone.  Images were 
collected using the same settings to compare fluorescent intensity of p22phox and gp91phox staining 
using the methods described.
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inverted microscope equipped with an Andor CCD camera.  On both systems, a vertical 
series of images was collected using a Nikon 100X, NA 1.4x oil immersion 
planapochromatic objective (Melville, NY).  For most images, the optimal single plane 
for each subcellular compartment is shown as follows: for the ER or the plasma 
membrane, the substrate-adherent surface is shown, and for the endocytic recycling 
compartment, the middle of the cell is shown.   
 
4. Image analysis using ImageJ 
Images acquired from confocal systems were opened in ImageJ and single plane 
images (0.16 – 0.5 µm Z sections) were saved as individual TIFF files after only cropping 
or adjusting the brightness and/or contrast; no other modifications were performed.  For 
some images acquired from BMDMs, a vertical stack was merged using the Z stack 
projection tool of ImageJ (Rasband, 1997-2004).  A total of at least 50 cells from at least 
three independent experiments were analyzed unless otherwise stated in the figure 
legend. 
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CHAPTER THREE:  RESULTS 
 
I. Generation of a model system in CHO cells for evaluating localization of 
flavocytochrome b 
1.   Construction of functional fluorescently tagged p22phox and gp91phox 
chimeras  
In neutrophils, the stability of the individual flavocytochrome b subunits (gp91phox 
and p22phox) is dependent on heterodimer formation, and free monomers are rapidly 
degraded by the proteasome.  However, in CHO cells, which lack detectable endogenous 
gp91phox or p22phox, the individual subunits are stable, and can be highly expressed 
(Biberstine-Kinkade et al., 2002; Zhu et al., 2006).  In the absence of p22phox, gp91phox is 
expressed in CHO cells predominantly as gp65, with little detected on the cell surface.  
Co-expressed gp91phox and p22phox form heterodimers and co-immunoprecipitate in CHO 
cells, which correlates with carbohydrate maturation of gp91phox resulting in an increase 
in size to 91 kDa and a marked increase in gp91phox cell surface expression (Zhu et al., 
2006).  These results suggest that either p22phox or the heterodimer harbor localization 
signals that direct trafficking of flavocytochrome b to the cell surface, although the 
intracellular compartments where each subunit was localized in the absence or presence 
of its binding partner was not well defined in these studies.   
To examine the subcellular distribution of individual subunits and the 
flavocytochrome b heterodimer, we developed constructs to express fluorescently tagged 
derivatives of p22phox and gp91phox to visualize their location by confocal microscopy.  
YFP-, CFP-, and RED-tagged constructs were generated (Figure 7A) to allow analysis of  
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Figure 7.  Fluorescently tagged p22phox and gp91phox are expressed at the correct molecular 
weights.  (A) Schematic of constructs encoding fluorescently tagged p22phox and gp91phox.   
(B) 22YFP or CFP91 were transiently expressed in CHO-WT cell lines.  Cell lysates prepared 48 
hr post-transfection were analyzed by Western blotting using polyclonal anti-p22phox and 
monoclonal anti-gp91phox (CL5) antibodies.  Cell lysates from CHO-22 and CHO-91 cells were 
used as controls.  (C) Cell lysates from CHO-91 cells transiently expressing YFP or 22YFP, and 
CHO-WT cells expressing CFP91 or co-expressing CFP91 and 22YFP were analyzed by Western 
blotting at 48 hr post transfection for maturation of untagged and CFP-tagged gp91phox (mAb 
CL5).  YFP and 22YFP protein expression were validated with an antibody to YFP.  Data shown 
are representative of at least 3 independent experiments. 
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subcellular targeting and the extent of subunit colocalization.  Tags were placed on the C-
terminus of p22phox and the N-terminus of gp91phox, as depicted in Figure 7A.  We 
hypothesized tags at these positions would less likely impair protein function based on 
previous studies that found the N-terminus of p22phox and the C-terminus of gp91phox were 
sensitive to mutagenesis and/or placement of an epitope tag (Zhen et al., 1998; Zhu et al., 
2006).  Fluorescently tagged subunits were each expressed in parental CHO cells 
following transient transfection, and Western blotting of cell lysates confirmed that the 
chimeras were expressed at the predicted molecular weights (Figure 7B and not shown).  
For example, with the addition of the YFP or CFP tag (~25 kDa), 22YFP was expressed 
at 47 kDa (Figure 7B) and CFP91 was expressed predominantly as a 91 kDa protein, 
corresponding to gp65 detected in CHO-91 cells (Figure 7B). 
It was essential that the tagged subunits were capable of heterodimer formation.  
As mentioned earlier, this correlates with increased molecular weight of gp91phox as a 
result of carbohydrate maturation, and increased gp91phox cell surface expression.  In 
CHO-91 cells, transient expression of 22YFP but not YFP induces formation of the 91 
kDa form of gp91phox, consistent with heterodimer formation between 22YFP and 
gp91phox (Figure 7C, left panel).  Conversely, transient expression of CFP91 and 22YFP 
resulted in increased maturation of CFP91 to the 115 kDa form of CFP91 showing 
CFP91 is capable of heterodimer formation with fluorescently tagged p22phox (Figure 7C, 
right panel).  In addition, untagged and fluorescently tagged gp91phox cell surface 
expression increased when co-expressed with tagged or untagged p22phox (Figure 8).  
Thus, fluorescent tags on p22phox or gp91phox do not interfere with heterodimer formation.  
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Figure 8.  gp91phox and CFP91 surface localization in CHO cells.  Cells were stained for cell 
surface expression of gp91phox or CFP91 (mAb 7D5) followed by a PE-labeled secondary 
antibody and analyzed by flow cytometry.  CHO-91 cells (grey fill) transiently expressing (A) 
untagged p22phox (black line) or (B) 22YFP (black line).  (C) CHO-WT cells (grey fill) transiently 
expressing CFP91 (black line).  (D) CHO-22 cells (grey fill) transiently expressing CFP91 (black 
line). 
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  Next, we analyzed whether flavocytochrome b containing the fluorescent-tagged 
subunits was functional.  Exogenous expression of p22phox, gp91phox, p47phox, and p67phox 
in CHO cells reconstitutes NADPH oxidase activity (Biberstine-Kinkade et al., 2002; 
Zhu et al., 2006).  Transient expression of 22YFP but not YFP in CHO cells stably 
expressing gp91phox, p47phox, and p67phox supported superoxide production similar to 
transient expression of untagged p22phox (Figure 9A, left panel).  CFP-tagged gp91phox but 
not CFP alone was also functional when transiently co-expressed with p47phox and p67phox 
in CHO-22 cells (Figure 9A, middle panel).  Transient co-expression of CFP91 and 
22YFP in CHO cells with stable expression of p47phox and p67phox also supported NADPH 
oxidase activity (Figure 9A, right panel).  Western blot analysis confirmed expression of 
p47phox and p67phox in CHO-47,67 cells (Figure 9B).  These results establish that 
fluorescently tagged gp91phox and p22phox form functional heterodimers with each other 
and with the untagged partners.    
 
2. Unassembled flavocytochrome b subunits localize to the ER in CHO cells 
The intracellular compartments in CHO cells where p22phox and gp91phox reside in 
the absence or presence of each other were not well characterized in previous studies 
(Biberstine-Kinkade et al., 2002; Zhu et al., 2006).  In promyelocytic PLB-985 cells, 
which are an undifferentiated neutrophil precursor cell line, unassembled gp91phox and 
p22phox reside in the ER membrane prior to heterodimer formation (DeLeo et al., 2000).  
To determine if the distribution of unassembled subunits in CHO cells is similar to 
neutrophil precursors and to examine whether placement of the fluorescent tag altered 
this distribution, the subcellular location of untagged and fluorescently tagged p22phox and  
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Figure 9.  Fluorescently tagged p22phox and gp91phox form functional heterodimers in CHO cells.  
NADPH oxidase activity was measured using isoluminol chemiluminescence in arachidonic acid 
stimulated CHO cells transiently and/or stably expressing p47phox and p67phox with untagged or 
fluorescently tagged flavocytochrome subunits as indicated.  Integrated RLU (relative light units) 
are shown.  (A) From left to right:  CHO-91-67-47 cells transfected with 22YFP (n=5), 
untagged p22phox (n=3), or YFP (n=2).  CHO-22 cells transfected with p47phox, p67phox, CFP91 
(n=2), or CFP (n=1).  CHO-47-67 cells transfected with 22YFP and CFP91 (n=5) or YFP and 
CFP (n=2).  Mean +/- standard deviation of data for the number of experiments listed above.    
(B) Cell lysates from CHO-91,67,47 and CHO-47,67 stable cell lines were analyzed by Western 
blotting using polyclonal anti-p47phox and monoclonal anti-p67phox antibodies. 
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gp91phox was evaluated by confocal microscopy.  Both untagged p22phox and gp91phox in 
CHO-22 and CHO-91 cell lines, respectively, had an intracellular reticular distribution as 
visualized by immunofluorescence microscopy (Figure 10A).  A similar distribution for 
22YFP and for YFP91 when each was transiently expressed in CHO-WT cells was 
detected in living cells (Figure 10B) and in cells fixed and permeabilized (Figure 10C, 
left panel). These results show that neither subunit localized predominantly to the plasma 
membrane and that neither the fluorescent tag nor cell fixation and permeabilization 
altered the apparent location of p22phox or gp91phox. 
The intracellular reticular distribution of p22phox and gp91phox shown in Figures 
10A and 10B is characteristic of the endoplasmic reticulum (ER).  Moreover, 22YFP and 
the ER marker calnexin strongly colocalized as shown in Figure 10C (merged image, top 
panel). Similar data were obtained for YFP91 and calnexin (Figure 10C, bottom panels).  
Thus, these data indicate that p22phox and gp91phox localize primarily to the ER when each 
is expressed individually in CHO-WT cells, consistent with studies performed using 
immature myeloid cells (DeLeo et al., 2000).   
 
3. Heterodimers of p22phox and gp91phox traffic to the plasma membrane 
Formation of heterodimers upon co-expression of p22phox and gp91phox in CHO 
cells correlates with a marked increase in gp91phox cell surface expression as detected by 
flow cytometry (Zhu et al., 2006).  Based on these studies and our current results 
localizing the individual subunits to the ER, we hypothesized that heterodimer formation 
may direct trafficking of flavocytochrome b to the plasma membrane.  To test this, we 
transiently expressed increasing amounts of a plasmid for 22CFP into CHO cells with  
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Figure 10.  The subunits of flavocytochrome b, gp91phox and p22phox, localize to the endoplasmic 
reticulum when expressed individually in CHO cells.  (A) CHO cells stably expressing untagged 
p22phox (top panel) or gp91phox (bottom panel) were fixed, permeabilized, and stained for p22phox 
(mAb 44.1) or gp91phox (mAb 54.1).  22YFP or YFP91 transiently expressed in CHO-WT cells 
were imaged 48 hr post transfection in (B) living cells and (C) cells fixed, permeabilized and co-
stained for calnexin.  Merged images show 22YFP and calnexin (top panel) and YFP91 and 
calnexin (bottom panel), and are single plane z stack slices acquired from the bottom of the cell. 
  
62 
stable expression of YFP91 (CHO-YFP91 cells).  Western blot analysis showed that 
increasing expression of 22CFP resulted in increasing amounts of the mature ~115 kDa 
form of YFP91 (Figure 11B), consistent with increasing formation of the 
flavocytochrome b heterodimer.     
We next evaluated the subcellular distribution of YFP91 and 22CFP following 
transient expression of increasing amounts of 22CFP in CHO-YFP91 cells.  As 
previously shown for transiently expressed YFP91, stably expressed YFP91 was present 
in a reticular pattern in the absence of 22CFP (Figure 11A), consistent with localization 
to the ER (Figures 10C).  The reticular distribution of YFP91 disappeared in parallel with 
increasing expression of 22CFP and was replaced by enrichment of YFP91 in the plasma 
membrane (Figure 11C, arrowheads and arrows).  The change in YFP91 distribution was 
dependent on the amount of 22CFP.  In transfections with only 1.0 µg of 22CFP plasmid 
DNA, cells showed localization of YFP91 to either the ER (asterisks), to the ER and 
plasma membrane (arrowheads), or to the plasma membrane (arrows) (Figure 11C).  In 
contrast, cells transfected with 4.0 µg of 22CFP plasmid DNA, YFP91 is almost always 
detected in the plasma membrane.    
Parallel effects were seen for the distribution of p22phox.  Unlike the ER 
localization of p22phox when expressed in the absence of gp91phox (Figures 10C), 22CFP 
expressed in the presence of YFP91 localized to the plasma membrane (Figure 11C, top 
panel).  In some cells overexpressing 22CFP, 22CFP was present both in the plasma 
membrane and a reticular distribution (Figure 11C, wide arrows), but only the plasma 
membrane protein colocalized with YFP91, suggesting the reticular pattern corresponded 
to unassembled 22CFP subunits expressed in excess of YFP91.  Thus, the  
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Figure 11.  Heterodimers of p22phox and gp91phox traffic to the plasma membrane, while the 
subunit in “excess” localizes to the ER.  CHO-YFP91 cells were transiently transfected with 0.5, 
1.0, 2.0, or 4.0 µg of the 22CFP vector.  (A) YFP91 stably expressed in CHO-YFP91 cells was 
imaged in living cells.  A single plane z stack slice acquired from the bottom of the cell is shown.  
(B) Cell lysates were analyzed for gp91phox, p22phox, and β-actin protein expression 48 hr post 
transfection (n=2 experiments in which protein expression was evaluated).  (C) Confocal 
microscopy of YFP91 (left column), 22CFP (middle column), and merged images (right column) 
following transient expression of 1.0 µg of 22CFP (top panel) or 4.0 µg of 22CFP (bottom panel) 
72 hr post transfection of CHO-YFP91 cells.  YFP91 localized to the ER in cells that lacked 
expression of 22CFP (asterisks), to the ER and plasma membrane in some cells expressing 
22CFP (arrowheads), and to the plasma membrane but not the ER in other CHO-YFP91 cells that 
co-expressed 22CFP (arrows).  22CFP localized to the plasma membrane in most CHO-YFP91 
cells (arrows), although present in both the plasma membrane and ER in some cells 
overexpressing 22CFP (wide arrows).  Single plane z stack slices acquired from the bottom and 
middle of the cell are shown.   
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partner in excess stays in the ER while the assembled heterodimer localizes to the plasma 
membrane.  Taken together, these results clearly illustrate a change in subunit location 
with their coexpression, and show that heterodimer formation is accompanied by 
trafficking to the plasma membrane.  These results also support a requirement for 
heterodimer formation, rather than determinants from one of the individual subunits, to 
efficiently traffic flavocytochrome b to the cell surface. 
Of interest, we also detected flavocytochrome b in CHO-YFP91 cells co-
expressing 22CFP in intracellular vesicles near the plasma membrane (Figure 12, top 
panel) and in a perinuclear location (Figure 12, bottom panel).  These findings suggested 
that a portion of flavocytochrome b in CHO cells resides in endocytic compartments that 
may recycle to the plasma membrane.  The perinuclear vesicles were best seen in images 
collected from the middle of the cell (Figure 12, bottom panel), consistent with the 
perinuclear accumulation of the endocytic recycling compartment characteristic for CHO 
cells (Ullrich et al., 1996).  
 
4. Heterodimer formation is required for trafficking of flavocytochrome b to 
the plasma membrane 
To exclude the alternative possibility that co-expression of gp91phox and p22phox 
and not heterodimer formation per se changed the subcellular distribution of the 
individual subunits, CHO-WT cells were transiently co-transfected with 22YFP and a 
H115L mutant of gp91phox (Biberstine-Kinkade et al., 2001).  This residue is believed to 
contribute to heme binding, and replacement with a leucine residue prevents heme 
incorporation and heterodimer formation with p22phox (Biberstine-Kinkade et al., 2001).   
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Figure 12.  YFP91 and 22CFP co-localize at the plasma membrane and a perinuclear 
compartment in CHO cells.  CHO-YFP91 cells transiently transfected with 0.5 µg 22CFP were 
imaged in fixed cells by confocal microscopy.  YFP91 and 22CFP colocalized at the plasma 
membrane and vesicles near the plasma membrane (top panel, insets) and a perinuclear 
compartment (bottom panel, insets).  Single plane z stack slices acquired from the bottom and 
middle of the cell are shown. 
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Western blot analysis showed that gp91phox H115L was expressed in CHO cells 
predominantly as the 58 kDa and 65 kDa forms with no apparent gp91phox maturation 
(Figure 13A), as seen previously in PLB-985 promyelocyte and COS7 cell lines 
(Biberstine-Kinkade et al., 2001).  Confocal analysis of 22YFP and gp91phox H115L 
showed both proteins localized to a reticular compartment that resembled the ER (Figure 
13B).  These results support the notion that heterodimer formation is required to 
efficiently traffic p22phox and gp91phox to the plasma membrane, while the unassembled 
subunits remain in the ER. 
 
5. Characterization of a CHO-91-22YFP cell line 
To characterize the intracellular compartments to which flavocytochrome b is 
trafficked in CHO cells (Figure 14), we developed a CHO-91 cell line that stably 
expressed 22YFP (CHO-91-22YFP cells) to allow simultaneous localization of 
flavocytochrome b and tagged markers of different membrane compartments.  Western 
blot analysis and flow cytometry showed increased gp91phox maturation to the 91 kDa 
form and increased gp91phox cell surface expression in CHO-91-22YFP cells compared to 
CHO-91 cells (Figures 14A and 14B).  However, some gp65 was still present (Figure 
14A), indicating that not all the gp91phox was incorporated into flavocytochrome b.  
Confocal microscopy of CHO-91-22YFP cells showed that 22YFP localized to the 
plasma membrane and intracellular vesicles near the plasma membrane, as well as a 
perinuclear compartment (Figure 14C, left panels), similar to CHO-YFP91 cells that 
transiently expressed 22CFP (Figure 11).  22YFP did not colocalize with the ER marker 
calnexin in CHO-91-22YFP cells (Figure 14C, middle panel), as shown in images  
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Figure 13.  Heterodimer formation and not co-expression changes the subcellular distribution of 
p22phox and gp91phox.  (A) Protein expression of gp91phox (mAb 54.1), 22YFP (mAb NS2), and β-
actin (mAb) in CHO-WT cells transiently expressing 22YFP and gp91phoxH115L or CHO-91 cells 
transiently expressing 22YFP.  (B) CHO-WT cells transiently transfected with gp91phoxH115L 
and 22YFP showed 22YFP and gp91phoxH115L (detected by immunofluorescent staining) to have 
an ER-like distribution with no detection of plasma membrane localization. 
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Figure 14.  Characterization of model cell line, CHO-91-22YFP, to investigate trafficking of 
flavocytochrome b.  (A) Immunoblots of cell lysates from CHO-91 and CHO-91-22YFP cells 
probed with mAb 54.1 and mAb NS2 to detect gp91phox maturation and 22YFP protein 
expression, respectively.  (B) Cell surface gp91phox detected by 7D5 (mAb) using flow cytometry 
in CHO-91 cells (grey) and CHO-91-22YFP cells (black line).  (C-E) CHO-91,22YFP cells were 
fixed, permeabilized and stained to detect calnexin (C), gp91phox (D), or gp91phox and calnexin (E).  
Arrowheads denote areas of colocalization.  Single plane z stack slices acquired from the bottom 
and/or middle of the cell are shown.  
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collected from the bottom of the cell.  In contrast, gp91phox was present in both a reticular 
pattern, which colocalized with calnexin (Figure 14E, arrowheads), and at the plasma 
membrane, where it colocalized with 22YFP (Figure 14D, arrowheads).  Taken together, 
these data indicate that gp91phox was expressed in excess of 22YFP in the CHO-91-
22YFP cell line, resulting in unassembled gp91phox accumulation in the ER, while 22YFP 
and gp91phox colocalized in the plasma membrane and intracellular compartments distinct 
from the ER.  Thus, we used 22YFP as an indicator of flavocytochrome b targeting in this 
cell line. 
 
6. Flavocytochrome b localizes to the endocytic recycling compartment  
 The CHO-91-22YFP cell line described above (Figure 14) was used to investigate 
trafficking of flavocytochrome b, via detection of the YFP tag on p22phox.  The 
perinuclear location of flavocytochrome b-containing vesicles (Figures 12 and 14) is 
characteristic of the endocytic recycling compartment in some cell types, including CHO 
cells (Maxfield and McGraw, 2004; Saraste and Goud, 2007), that is defined by the 
GTPase Rab11 (Ullrich et al., 1996).  As shown in Figure 15A, 22YFP strongly co-
localized with Rab11 near the nucleus of CHO-91-22YFP cells.  Transiently-expressed 
Rab11CFP and 22YFP also colocalized in CHO-91-22YFP cells (Figure 15B).  These 
results suggest that a portion of flavocytochrome b in CHO cells resides in the endocytic 
recycling compartment.     
Although widely used as a marker for recycling endosomes (Ullrich et al., 1996; 
Cox et al., 2000) Rab11 may also traffic between the trans-Golgi network (TGN) and the 
cell surface (Urbe et al., 1993).  Thus, to better define the Rab11-positive  
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Figure 15.  Flavocytochrome b localizes to the Rab-11 positive endocytic recycling compartment 
in CHO cells.  (A) CHO-91-22YFP cells were fixed, permeabilized and stained for Rab11.  Insets 
within the merged image (bottom panel) show colocalization of 22YFP and Rab11 at a 
perinuclear compartment.  (B) CHO-91-22YFP cells transiently expressing Rab11CFP were 
imaged in living cells 24 hr post transfection.  (C) CHO-91-22YFP cells were incubated with 
Alexa Fluor 647-conjugated mouse transferrin (Tfn, 20 µg/ml) for 5 min at 37°C followed by a 
25 min chase at 37°C to label the endocytic recycling compartment.  Living cells were imaged 
and colocalization of 22YFP and Tfn was evaluated in the merged image (n=2 experiments where 
22YFP and Tfn colocalization was evaluated).  Single plane z stack slices taken from the bottom 
and middle of the cell are shown.  
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perinuclear compartment in our studies, we also analyzed the extent to which 
flavocytochrome b colocalized with internalized transferrin, a marker for recycling 
endosomes that does not traffic to the Golgi.  Transferrin is endocytosed upon binding to 
the transferrin receptor, is subsequently delivered to the recycling compartment, and then 
traffics back to the plasma membrane (Yamashiro et al., 1984; Sonnichsen et al., 2000).  
Recycling endosomes in CHO-91-22YFP cells were loaded with tagged transferrin, Tfn-
AF647, using a 5 min pulse followed by a 25 min chase.  22YFP showed strong co-
localization with Tfn-AF647 in a perinuclear location as shown in the merged image 
(Figure 15C, inset).  In contrast, 22YFP expressed in CHO cells in the absence of 
gp91phox did not colocalize with Tfn-AF647 (Figure 16).  These findings provide 
additional evidence that flavocytochrome b recycles from the plasma membrane to the 
endocytic recycling compartment.   
 
7. Flavocytochrome b localizes to Rab5-positive early endosomes, but not 
Rab7-positive late endosomes or lysosomes 
   A recent model of endosome sorting (Seachrist and Ferguson, 2003) indicates 
Rab5-positive early endosomes branching into one of three pathways:  1) Rab4-positive 
endosomes that rapidly recycle to the plasma membrane without entering the Rab11-
positive compartment, 2) the Rab11-positive endocytic recycling compartment for slow 
trafficking back to the plasma membrane, or 3) Rab7-positive late endosomes that 
subsequently fuse with lysosomes for cargo degradation (summarized in Figure 4).  To 
determine if flavocytochrome b also accumulated on compartments in the degradative 
pathway, we evaluated the extent of flavocytochrome b colocalization with Rab7 and  
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Figure 16.  Unassembled 22YFP does not colocalize with the endocytic recycling compartment 
in CHO cells.  Colocalization of 22YFP and the transferrin-labeled endocytic recycling 
compartment was evaluated in CHO cells transiently expressing 22YFP.  Immediately following 
the addition of Alexa Fluor 647-conjugated mouse transferrin (Tfn, 20 µg/ml), a series of images 
of 22YFP and Tfn were collected over time in live cells at 37°C.  Tfn was found to localize to a 
perinculear compartment at 8 min (arrows), which did not colocalize with 22YFP (merged image, 
arrow) (n=1 experiment where 22YFP and Tfn colocalization was evaluated).  Single plane z 
stack slices taken from the bottom and middle of the cell are shown. 
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with lysosomes pre-loaded with Dextran.  To this end, 22RED and Rab7GFP were 
transiently co-expressed in CHO-91 cells, using only a small amount of each plasmid (1 
µg).  22RED localized to the plasma membrane in CHO-91 cells and had increased 
expression in the perinuclear compartment (Figure 17A), similarly to 22YFP in CHO-91-
22YFP cells (Figure 14).  However, 22RED did not co-localize with Rab7GFP (Figure 
17A).  Colocalization of flavocytochrome b with lysosomes was analyzed in CHO-91-
22YFP cells after a 50 min incubation with fluorescently tagged Dextran (Dex-AF647) to 
label lysosomes.  22YFP did not colocalize with Dex-AF647 (Figure 17B), further 
indicating that flavocytochrome b does not accumulate in organelles of the degradative 
pathway. 
 
8. Different combinations of fluorescently tagged and untagged p22phox and  
gp91phox subunits behave in a similar fashion in CHO cells 
 During the course of our studies, we generated a series of fluorescent-tagged 
p22phox and gp91phox constructs (listed in Table IV).  The localization of the different 
combinations in CHO cells was compared by confocal microscopy to determine whether 
these probes could be used interchangeably.  eCFP91, mCFP91 and mCIT91 (referred to 
as YFP91) when co-expressed with untagged p22phox in CHO-22 cells localized to the 
plasma membrane and the ERC (Figure 18A, arrows).  In addition, mCFP91 or YFP91 
co-expressed with CFP or YFP-tagged p22phox showed the same distribution (Figure 
18B), which showed the different combinations of untagged or fluorescently tagged 
subunits behaved similarly in combination with their heterodimer partner. 
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Figure 17.  Flavocytochrome b does not appear to accumulate on late endosomes or lysosomes in 
CHO cells.  (A) 22RED and Rab7GFP transiently expressed in CHO-91 cells did not co-localize 
in living cells.  (B) CHO-91-22YFP cells were incubated with 10 µg/ml Alexa Fluor 647-labeled 
Dextran (Dex647) for 50 min at 37°C.  22YFP and Dex647-labeled lysosomes, did not appear to 
colocalize in live cells.  (A-B) A single z stack section from the middle of the cell is shown. 
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Figure 18.  Different combinations of fluorescently tagged p22phox and gp91phox subunits behave 
in a similar fashion in CHO cells.  CHO-WT and CHO-22 cells were transiently transfected with 
eCFP91, mCFP91, or YFP91.  The distribution of eCFP91, mCFP91, and YFP91 in the presence 
of untagged or fluorescently tagged p22phox was evaluated by confocal microscopy in live cells.  
Fluorescently tagged gp91phox proteins localized to the plasma membrane and a perinuclear 
compartment (arrows) in the presence of untagged p22phox (A), YFP-tagged p22phox (B), and CFP-
tagged p22phox (C).  (A-C) A single z stack section from the middle of the cells is shown. 
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9. Nocodazole treatment  
The perinuclear localization of the Rab11-endocytic recycling compartment in 
Madin-Darby Canine Kidney (MDCK) cells has been shown to be dependent on the 
microtubule-based cytoskeleton (Casanova et al., 1999).  Thus, we evaluated whether 
localization of flavocytochrome b to the ERC was also dependent on microtubules.  We 
found treatment of CHOf-22-YFP91 cells with the microtubule-depolymerizing drug 
Nocodazole (10 µM for 30 min) led to a dispersal of 22YFP-positive vesicles throughout 
the cytoplasm (Figure 19B) and loss of the prominent perinuclear distribution seen in the 
absence of Nocodazole (Figure 19A, arrowheads).  A modest increase in 
flavocytochrome b expression at the cell surface was also observed (Figure 19B, arrows).  
These results suggest that trafficking of flavocytochrome b to the ERC is also dependent 
on microtubules. 
 
10. C-terminal deletion of p22phox does not affect localization of 
flavocytochrome heterodimer to the plasma membrane and recycling 
endosomes   
 Thus far, there are no identified motifs within gp91phox or p22phox that regulate 
trafficking of the flavocytochrome b heterodimer.  A current model of p22phox places both 
its N- and C-terminal domains in the cytoplasm, anchored in the membrane by a hairpin 
formed by two hydrophobic domains (Taylor et al., 2004).  The C-terminal cytoplasmic 
domain of p22phox is hydrophilic and also contains multiple proline residues, including a 
Pro-Xaa-Xaa-Pro SH3-binding motif around Pro156 that is a target of the tandem SH3 
domains of p47phox during assembly of the active NADPH oxidase (Nauseef, 2004).   
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Figure 19.  Nocodazole appears to decrease the endosomal distribution of flavcytochrome b in 
CHOf-22-YFP91 cells.  CHOf-22-YFP91 cells, which stably express human p22phox and YFP-
tagged human gp91phox, were imaged by video microscopy in the absence or presence of 
Nocodazole (30 min, 10 µM).  (A) YFP91 localizes to the plasma membrane and endosomes that 
cluster near the nucleus (arrowheads).  (B) Loss of prominent perinuclear endosomal distribution 
of YFP91 (arrowheads) and modest increase in YFP91 localization to the plasma membrane 
(arrows) in Nocodazole-treated cells.  Representative images collected from 1 experiment.
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Since deletion of C-terminal amino acids 142 - 195 of p22phox does not affect formation 
of the flavocytochrome b heterodimer (Zhu et al., 2006) we tested whether the Pro-Xaa-
Xaa-Pro motif or other signals in the p22phox C-terminus were required for targeting of 
flavocytochrome b to the plasma membrane and/or recycling endosomes.  
 YFP-tagged p22phox derivatives lacking amino acids 131-195 (131YFP), 149-195 
(149YFP) or 172-195 (172YFP), were transiently expressed in CHO-WT and CHO-91 
cells to evaluate their subcellular distribution in the absence of gp91phox and in the 
presence of excess gp91phox expression.  Flow cytometry and immunoblotting with an 
anti-YFP antibody showed the YFP-tagged proteins were expressed at similar levels 
(Figures 20A and 20B) and had increasing mobility in a SDS-PAGE gel with progressive 
removal of the C-terminus (Figure 20B).  Increased cell surface expression and 
maturation of gp91phox, consistent with heterodimer formation, was seen with co-
expression of 22YFP, 172YFP or 149YFP, but not 131YFP, (Figures 20A and 20B), as 
previously seen using untagged p22phox truncations (Zhu et al., 2006).  
Confocal microscopy showed all YFP-tagged p22phox mutants, in the absence of 
gp91phox, localized to the ER (Figure 20C).  When co-expressed with excess gp91phox, 
172YFP and 149YFP were present in both the perinuclear recycling compartment, best 
seen in live images (Figure 20D, arrows), and the plasma membrane, where they co-
localized with gp91phox, similar to full length 22YFP (Figure 20D, arrowheads in merge 
panels).  In contrast, 131YFP remained in the ER when co-expressed with gp91phox 
(Figure 20D), as expected from failure to form heterodimers.  Thus, C-terminal amino 
acids 149-195 in p22phox do not appear to contain localization signals required for  
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Figure 20.  p22phox C-terminal amino acids 149-195 are not required for trafficking of the 
heterodimer to the plasma membrane or to the perinuclear recycling compartment.  CHO-WT or 
CHO-91 cells were transfected with vectors for 22YFP, 172YFP, 149YFP, or 131YFP and 
evaluated 24 hrs post transfection (n=2 experiments where YFP-tagged p22phox C-terminal 
deletion proteins were evaluated).  (A) Top panel: Flow cytometry analysis of YFP shows 
similar transfection efficiency of all YFP-tagged p22phox constructs when transiently expressed in 
CHO-91 cells.  Bottom Panel: Analysis of gp91phox cell surface expression (mAb 7D5) by flow 
cytometry reveals increased gp91phox surface expression with co-expression of 22YFP, 172YFP, 
and 149YFP, but not 131YFP (bottom panel, black lines).  CHO-91 cells were used as the control 
(grey).  (B) Cell lysates were evaluated for gp91phox (mAb 54.1), YFP (anti-GFP), and β-actin 
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protein expression.  (C) Left column: Live imaging of YFP-tagged p22phox derivatives transiently 
expressed in CHO-WT cells.  Right columns: CHO-WT cells transiently expressing YFP-tagged 
p22phox derivatives were fixed, permeabilized, and stained for calnexin.  (D) Left column: Live 
imaging of YFP-tagged p22phox derivatives transiently expressed in CHO-91 cells.  Arrows show 
that 22YFP, 172YFP, and 149YFP associate with the endocytic recycling compartment, but 
131YFP did not.  Z stack slices collected from the middle of the cell are shown.  Right columns:  
CHO-91 cells transiently expressing YFP-tagged p22phox derivatives were fixed, permeabilized, 
and stained for gp91phox (mAb 54.1).  22YFP, 172YFP, 149YFP, but not 131YFP, colocalized 
with gp91phox at the plasma membrane (arrowheads).  
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trafficking of flavocytochrome b to the plasma membrane or to the perinuclear endocytic 
recycling compartment.  
 
II. Localization of flavocytochrome b in macrophages 
1. Rab11 and transferrin localize to a perinuclear compartment in  
RAW 264.7 cells that is distinct from the Golgi 
A previous report analyzing the distribution of transferrin and Rab11 in 
macrophages suggested Rab11-positive recycling endosomes do not accumulate to a 
prominent perinuclear compartment, but instead are more dispersed in this cell type (Cox 
et al., 2000).  Thus, we began our studies by determining whether Rab11 and/or 
transferrin localized to a perinuclear compartment in RAW 264.7 cells.  RAW 264.7 cells 
were pulsed for 15 or 30 min with Alexa Fluor 647-conjugated human transferrin.  
Transferrin localized to vesicles near the cell surface following a 15 min pulse (Figure 
21A, top panel), but then clustered near the nucleus following a 30 min pulse (Figure 
21A, bottom panel), suggesting that transferrin does localize to a perinuclear endocytic 
recycling compartment in RAW 264.7 cells.  In addition to transferrin, we also evaluated 
the distribution of endogenous Rab11 and transiently expressed fluorescently tagged 
Rab11 in RAW 264.7 cells.  The subcellular distribution of endogenous Rab11, detected 
by immunofluorescence microscopy (Figure 21B), was similar to Rab11GFP and 
Rab11CFP detected in live cells (Figure 21C).  In summary, Rab11 was found to localize 
to a prominent perinuclear compartment (Figure 21B and 20C), similar to transferrin 
(Figure 21A), and showed that RAW 264.7 cells do have a perinuclear endocytic 
recycling compartment.  
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Figure 21.  RAW 264.7 cells have a perinuclear Rab11-positive endocytic recycling 
compartment.  (A) RAW 264.7 cells were incubated with Alexa Fluor 647-conjugated human 
transferrin for 15 or 30 min, washed, fixed in 4% paraformaldehyde for 10 min, and then stained 
with the nuclear dye DAPI (10 µg/ml for 7 min, RT).  At 15 min (top panel), transferrin was 
found in vesicles near the cell surface, but at 30 min (bottom panel) transferrin accumulated in a 
perinuclear compartment (arrows).  (B) In RAW 264.7 cells, Rab11, detected by 
immunofluorescence microscopy, localized to vesicles throughout the cell with a prominent 
localization near the nucleus (arrows).  (C) Video microscopy of Rab11GFP and Rab11CFP 
transiently expressed in RAW 264.7 cells showed a similar distribution to endogenous Rab11 (B) 
and localization to a perinuclear compartment (arrows). 
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As described above, Rab11, but not transferrin has been found to traffic between 
Golgi compartments in addition to trafficking from the endocytic recycling compartment 
to the plasma membrane in polarized MDCK cells.  To further characterize the endocytic 
recycling compartment in RAW cells, we investigated colocalization of transferrin with a 
GFP-tagged mutant of GAD65 (γ-aminobutyric acid) (Kanaani et al., 2002) that localizes 
predominantly to the Golgi, and was used as our marker for the Golgi.  In COS cells, the 
recycling compartment was shown to be distinct from the Golgi by showing that 
transferrin localized within the Golgi “ring,” but did not colocalize with Golgi (Misaki et 
al., 2007).  We utilized this same technique to determine whether the endocytic recycling 
compartment was distinct form the Golgi in RAW cells. 
Trafficking of Alexa Fluor 647-conjugated human transferrin in RAW 264.7 cells 
transiently expressing the GFP-tagged mutant form of GAD65 (referred to as 
mGAD65GFP) was assessed in living cells by collecting a series of images over time 
following addition of transferrin.  Transferrin localized to vesicles near the cell surface at 
8 min (Figure 22, top panel), but localized to a perinuclear compartment at 20 min 
(Figure 22, bottom panel).  As expected, mGAD65GFP localized predominantly to the  
Golgi (Figure 22).  Colocalization analysis of transferrin and mGAD65GFP showed 
transferrin localized within the ring-shaped structure of the Golgi compartment or “Golgi 
ring” (Figure 22, merged image, insets), but did not colocalize with mGAD65GFP.  
Taken together, similar to CHO cells, Rab11 and transferrin localize to a perinuclear 
compartment, which is distinct from the Golgi in RAW 264.7 cells. 
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Figure 22.  Transferrin labeled endocytic recycling compartment localizes to a perinuclear region 
that is distinct from the Golgi in RAW 264.7 cells.  Alexa Fluor 647-conjugated human 
transferrin (Tfn, 20 µg/ml) was added to RAW cells transiently transfected with a Golgi marker 
mGAD65GFP, a GFP-tagged mutant form of GAD65 (γ-aminobutyric acid), and a series of 
images were collected over time using confocal microscopy.  Transferrin localized to vesicles 
near the cell surface at 8 min (top panel, insets) and localized to a perinuclear compartment at 20 
min (bottom panel, insets), which was found to localize within the Golgi “ring” (bottom panel, 
insets), but did not colocalize with the Golgi.   
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2. Flavocytochrome b localizes to Rab11-positive recycling  
endosomes in RAW  264.7 cells 
We next investigated the distribution of flavocytochrome b in RAW 264.7 cells 
using antibodies specific for endogenous gp91phox, and determined whether this included 
Rab11-positive recycling endosomes, as seen in the CHO cell model.  In RAW 264.7 
cells, transiently expressed Rab11GFP colocalized with endogenous gp91phox on vesicles 
near the plasma membrane (Figure 23A, top panel, arrowheads) and near the nucleus 
(Figure 23A, bottom panel, insets).  Of note, the distribution of gp91phox was similar in 
adjacent cells that did not express Rab11GFP (Figure 23A, bottom panel, arrows) 
indicating that overexpression of Rab11GFP did not alter gp91phox targeting.  
As a second approach to examine whether flavocytochrome b was associated with 
the endocytic recycling compartment in macrophages, we performed a pulse-chase 
experiment using fluorescently tagged transferrin (Tfn-AF647, 5 µg/ml) and RAW-WT 
cells transiently expressing Rab11GFP.  After a 5 min pulse with Tfn-AF647 followed by 
a 25 min chase, cells were fixed, permeabilized, and stained to detect endogenous 
gp91phox.  As shown in Figure 23B, Rab11GFP, gp91phox, and Tfn-AF647 colocalized in 
the perinuclear region (arrowheads) and in vesicles near the plasma membrane (insets, 
arrows).  Taken together with the colocalization with Rab11, these data demonstrate for 
the first time that a portion of macrophage flavocytochrome b localizes to the endocytic 
recycling compartment.   
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Figure 23.  In macrophages, flavocytochrome b associates with Rab11-positive recycling 
endosomes.  (A) RAW-WT cells transiently expressing Rab11GFP were fixed, permeabilized, 
and stained for gp91phox (mAb 54.1) 48 hr post transfection.  Colocalization of gp91phox  and 
Rab11GFP is shown in vesicles near the plasma membrane (top panel, arrowheads) and in the 
endocytic recycling compartment (bottom panel, insets).  Localization of gp91phox to the 
endocytic recycling compartment was not dependent on expression of Rab11GFP (top panel, 
arrows).  Single plane z stack slices taken from the bottom and middle of the cell are shown.  (B) 
RAW-WT transfected with Rab11GFP were incubated with Alexa Fluor 647-conjugated mouse 
transferrin (Tfn, 5 µg/ml) for 5 min at 37°C followed by a 25 min chase at 37°C to label the 
endocytic recycling compartment.  Cells were fixed, permeabilized, and stained for gp91phox.   
Co-localization of gp91phox and Rab11GFP (top panel) and gp91phox and Tfn (bottom panel) was 
observed at the perinuclear compartment (arrowheads) and near the plasma membrane (arrows).    
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3. Fcγ-receptors accumulate in the plasma membrane, but not in recycling  
endosomes 
While it is known that some surface receptors recycle while others are targeted for 
degradation in lysosomes (Lodish et al., 2008), the extent to which different plasma 
membrane proteins traverse the endocytic recycling compartment is unclear.  For 
comparison to flavocytochrome b, we investigated whether the Fcγ-receptor was present 
in the endocytic recycling compartment in RAW 264.7 macrophages.  Using both indirect 
immunofluorescence to detect endogenous Fcγ-receptors in RAW-WT cells and live-cell 
imaging to detect stably expressed FcγRllaGFP in RAW-FcR-GFP transfectants, we 
detected Fcγ-receptors in the plasma membrane but not in the endocytic recycling 
compartment, identified in a pulse-chase experiment using Tfn-AF647 (Figure 24).  
These results confirm published data (Amigorena et al., 1992) which suggest that Fcγ-
receptors do not recycle, and as such, indicate selective accumulation of plasma 
membrane proteins in the endocytic recycling compartment.  
 
4. GFP-tagged Rab5 and Rab7 validate distinct trafficking pathways in RAW  
264.7 cells 
 The degradative pathway has been described to be distinct from the recycling 
pathway.  As described above, Rab5 mediates trafficking of early endosomes to late 
endosomes (Rab7-positive) or recycling endosomes (Rab11-positive), but not lysosomes 
(Ullrich et al., 1996).  In addition, Rab7-positive endosomes traffic to lysosomes but not 
recycling endosomes.  We evaluated whether trafficking of proteins to these subcellular 
pathways could be distinguished using GFP-tagged Rab7 or Rab5 in RAW 264.7 cells.   
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Figure 24.  In contrast to flavocytochrome b, FcγRIIa-receptor does not accumulate in recycling 
endosomes near the nucleus.  (A) RAW-WT cells were fixed, permeabilized, and stained to detect 
the Fcγ-Receptor (anti-CD16/32-PE).  (B) FcγRGFP localizes to the plasma membrane in live 
RAW-FcγRGFP cells.  Single z stack slices taken from the bottom of the cell (left) and the 
middle of the cell (right) are shown in (A) and (B).  (C) RAW-FcγRGFP cells were labeled Alexa 
Fluor 647-conjugated mouse transferrin (Tfn), as described in Figure 23.  Simultaneous imaging 
of FcγRGFP and Tfn was performed in living cells.  A single z stack section from the middle of 
the cell is shown.   
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We found transferrin-labeled recycling endosomes did not colocalize with Rab7GFP 
(Figure 25A) and dextran labeled lysosomes did not colocalize with Rab5GFP (Figure 
25B).  These data further support Rab7 and Rab5 localize to distinct endocytic pathways. 
 
5. Macrophage flavocytochrome b also colocalizes with the plasma 
membrane and early (sorting) endosomes, but not late endosomes 
Flavocytochrome b was also present at the periphery of RAW 264.7 cells (Figures 
23A and 23B).  To verify that this represented targeting to the plasma membrane, we 
stably expressed a GFP-labeled PH domain of phospholipase C (Botelho et al., 2000) to 
mark the inner leaflet of the plasma membrane of RAW 264.7 cells.  As shown in Figure 
26A, PH-GFP colocalized with endogenous gp91phox at the cell surface.    
In addition to Rab11-positive structures, flavocytochrome b was detected in other 
vesicular populations (Figure 23A).  The extent of flavocytochrome b targeting to early 
(sorting) endosomes and late endosomes was therefore evaluated by comparison with 
Rab5GFP and Rab7GFP transiently expressed in RAW-WT cells.  Flavocytochrome b 
exhibited modest colocalization with Rab5GFP in vesicles near the plasma membrane 
(Figure 26B, top panel, insets) and near the perinuclear compartment (Figure 26B, 
bottom panel, arrows).  In contrast, the distribution of flavocytochrome b had little, if 
any, overlap with the late endosome marker Rab7GFP, which accumulated on large 
vesicles dispersed throughout the cell (Figure 26C, arrowheads), but not in the 
perinuclear compartment (Figure 26C, arrows).  
Collectively, these data indicate that flavocytochrome b in macrophages resides in 
both early endosomes and the endocytic recycling compartment, suggesting that  
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Figure 25.  Validation of the specificity of Rab7 and Rab5 to label distinct endosomal pathways 
in RAW 264.7 cells.  (A) RAW cells transiently expressing Rab7GFP were incubated with Alexa 
Fluor 647-conjugated mouse transferrin (Tfn, 5 µg/ml) for 40 min and then imaged in live cells 
using confocal microscopy.  Transferrin localized to the perinuclear endocytic recycling 
compartment (arrows), while Rab7GFP did not (merged image).  (B) Lysosomes in RAW cells 
transiently expressing Rab5GFP were labeled with Alexa Fluor 647-conjugated Dextran (60 min) 
and analyzed for colocalization with Rab5GFP by confocal microscopy in live cells.  Rab5GFP 
and Dextran did not appear to colocalize (merged image, insets).  A single z stack section from 
the middle of the cell is shown for (A) and (B).  Experiments in both (A) and (B) were performed 
only once.   
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Figure 26.  In macrophages, flavocytochrome b is present in plasma membrane and some Rab5-
positive sorting endosomes, but not in Rab7-positive late endosomes.  (A) RAW-PH-GFP cells 
were fixed, permeabilized, and stained for endogenous gp91phox (mAb 54.1).  Colocalization of 
gp91phox and the plasma membrane marker, PH-GFP, was seen at the cell surface in RAW-PH-
GFP cells (insets).  A single plane z stack slice taken from near the bottom of the cell is shown 
(n=2 experiments where colocalization of gp91phox and PH-GFP was evaluated).  RAW-WT cells 
transfected with Rab5GFP (B) or Rab7GFP (C) were fixed, permeabilized, and stained for 
gp91phox (mAb 54.1) 48 hr post transfection.  (B) gp91phox and Rab5GFP showed some 
colocalization in vesicles near the plasma membrane (top panel, arrowheads) and near the 
nucleus (bottom panel, arrows).  (C) Rab7GFP accumulated on large vesicles dispersed 
throughout the cell, that did not colocalize with gp91phox near the plasma membrane (top panel) or 
near the nucleus (bottom panel, arrowheads). 
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flavocytochrome b under homeostatic conditions undergoes recycling from the plasma 
membrane. 
 
6. Unassembled fluorescently tagged gp91phox and p22phox subunits localize 
to the ER in RAW 264.7 cells, while the heterodimer does not  
To visualize flavocytochrome b trafficking in macrophages using live cell 
imaging, 22YFP and YFP91 were stably expressed in RAW cells to generate RAW-
22YFP and RAW-YFP91 cell lines.  22YFP and YFP91 protein expression in RAW-
22YFP and RAW-YFP91 cells was examined using flow cytometry and Western blotting 
(Figures 27A and 27B).  However, the distribution of the fluorescently tagged subunit in 
each of these two cell lines was reticular (Figure 27C and 27D), suggesting the 
fluorescently tagged subunits accumulated in the ER and were expressed in excess of 
their endogenous partner.  Colocalization with calnexin confirmed ER localization of 
YFP91 in RAW-YFP91 cells (Figures 27D).  To determine whether the ER-like 
distribution of 22YFP reflected unassembled 22YFP in excess of endogenous gp91phox, 
CFP91 was transiently expressed in RAW-22YFP cells.  Coexpression of CFP91 in 
RAW-22YFP cells resulted in loss of the reticular distribution of 22YFP seen in Figure 
26D, and a shift to the cell surface and intracellular vesicles that had a perinuclear 
distribution (Figure 27E).  Colocalization of 22YFP and CFP91 was detected in the 
plasma membrane and intracellular vesicles (Figure 27E).  Taken together, these data 
indicate that, similar to CHO cells, unassembled monomers localize to the ER in RAW 
264.7 cells while p22phox/gp91phox heterodimers traffic to the plasma membrane and the 
endocytic recycling compartment.   
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Figure 27.  Unassembled fluorescently tagged flavocytochrome b subunits localize to the ER in 
RAW 264.7 macrophages while assembled subunits localize to endosomes and the plasma 
membrane.  Protein expression and subcellular targeting of 22YFP and YFP91 were analyzed in 
RAW-22YFP and RAW-YFP91 cells.  22YFP and YFP91 protein expression in RAW-22YFP 
and RAW-YFP91 cells was examined using flow cytometry to detect YFP (A) and using Western 
blotting to detect p22phox (mAb NS2) or gp91phox (mAb 54.1) (B).  RAW-WT cells were used as 
controls for analysis by flow cytometry (filled grey) and Western blot (labeled RAW).   
(C) Subcellular distribution of 22YFP in living cells.  (D) RAW-YFP91 cells were fixed, 
permeabilized, and stained for calnexin (n=2 experiments where YFP91 and calnexin 
colocalization was evaluated.  (E) Live RAW-22YFP cells transfected with CFP91 were 
examined 24 hrs post transfection.  Single z stack slices from the bottom and/or middle of the 
cells are shown as indicated. 
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It has been shown by Western blot analysis that the monoclonal antibody 54.1 can 
also detect the ER-resident protein GRP 58 (Baniulis et al., 2005), also known as ERp57.   
To determine whether immunofluorescent staining of RAW 264.7 cells can also detect 
this protein, we co-stained RAW 264.7 cells with mAb 54.1 and calnexin.  As shown in 
Figure 28, immunofluorescent staining with 54.1 shows a predominant vesicular 
distribution with clustering near the nucleus (arrows), while calnexin showed a much 
different intracellular distribution that did not appear as punctate.  In addition, 
immunofluorescent staining with 54.1 showed a more peripheral distribution (Figure 28, 
arrowheads) than the calnexin staining.  Most importantly, immunofluorescent staining 
with 54.1 did not colocalize with calnexin, further establishing 54.1 as a valid antibody 
for localizing endogenous gp91phox in RAW 264.7 cells.  
 
7. Flavocytochrome b localizes to recycling endosomes in primary murine 
BMDMs 
 We next examined the localization of flavocytochrome b in BMDMs by confocal 
microscopy of live cells.  To minimize potential problems in balancing expression of a 
fluorescently tagged subunit with endogenous flavocytochrome b subunits, we utilized 
the recently characterized p22phox-deficient nmf333 mouse (Nakano et al., 2008) to 
express 22YFP in BMDMs.  The nmf333 mouse harbors a missense mutation in the 
p22phox gene that prevents expression of the p22phox subunit.  nmf333 BM progenitor cells 
were transduced with a retroviral vector for expression of 22YFP, and then differentiated 
into macrophages.  Western blot analysis of BMDMs (Figure 29A) confirmed the 
absence of p22phox in mock-transduced nmf333 BMDMs, and that 22YFP was expressed.   
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Figure 28.  Endogenous gp91phox does not localize to the endoplasmic reticulum in RAW 264.7 
cells.  Cells were fixed, permeabilized, and stained for gp91phox (mAb 54.1) and calnexin (1:400 
dilution).  gp91phox localized to vesicles near the cell surface (left, arrowheads) and vesicles that 
appeared to cluster near the nucleus (left, arrows), which was distinct from the intracellular 
distribution of calnexin (merged image, arrowheads and arrows).  A single z stack section from 
the middle of the cell is shown. 
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Figure 29.  22YFP expressed in p22phox-deficient (p22def) bone marrow derived macrophages 
localizes to the plasma membrane and endocytic recycling compartment.  p22def bone marrow 
(BM) cells were transduced with MSCV-22YFP and differentiated into macrophages for 6-7 
days.  (A) Lysates of WT, p22def, and 22YFP-expressing p22def BMDMs were probed to detect 
p22phox (mAb NS2), gp91phox (mAb 54.1), and β-actin (mAb).  Top bar graph shows the relative 
density of p22phox protein, normalized to β-actin.  Bottom bar graph shows the relative density of 
gp91phox protein normalized to β-actin.  Data shown is representative of 3 independent 
experiments.  (B) 22YFP expressed in p22phox-deficient BMDMs was imaged in living cells.  
22YFP localizes to vesicles near the plasma membrane (insets, arrows) and vesicles that cluster 
near the nucleus (arrowheads).  (C) 22YFP-expressing p22phox-deficient BMDMs were incubated 
with Alexa Fluor 647-conjugated mouse transferrin (Tfn647, 5 µg/ml) for 5 min at 37°C followed 
by a 25 min chase at 37°C to label the endocytic recycling compartment.  22YFP and Tfn647 
colocalized in vesicles near the plasma membrane (top panel, insets) and near the nucleus (bottom 
panel, insets).
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The relative level of the YFP-tagged p22phox was 43 +/- 14% of endogenous p22phox in 
mock-transduced wild type C57Bl/6J BMDMs (N = 3 experiments where densitometry 
was performed).  As previously mentioned, formation of flavocytochrome b in 
phagocytic leukocytes increases the stability of each of its constituent subunits (Nauseef, 
2004).  A small amount of residual gp91phox expression was detected in nmf333 BMDMs, 
which increased upon expression of 22YFP by 39 +/- 12% (N = 3 experiments where 
densitometry was performed) (Figure 20A), consistent with the stabilization of 
endogenous gp91phox by heterodimer formation.   
We utilized confocal microscopy to localize flavocytochrome b in nmf333 
BMDMs transduced with 22YFP.  As shown in Figure 29B, much of 22YFP in living 
macrophages was associated with intracellular vesicles (arrows) that appeared to cluster 
near the nucleus (arrowheads).  In fixed cells, 22YFP and endogenous gp91phox showed a 
very similar distribution and colocalized at the plasma membrane, on vesicles near the 
plasma membrane, and on perinuclear vesicles that clustered in the middle of the cell 
(Figure 30A).  A similar distribution was observed for endogenous gp91phox in WT 
BMDMs (Figure 30B).  To verify that flavocytochrome b localized to the endocytic 
recycling compartment in primary macrophages, recycling endosomes were labeled with 
Alexa Fluor 647-conjugated murine transferrin, as described above.  Imaging of live 
p22phox-deficient BMDMs transduced with 22YFP revealed colocalization of 22YFP and 
transferrin in vesicles near the plasma membrane (Figure 29C, top panel, insets) and in a 
perinuclear distribution (Figure 29C, bottom panel, insets).  These data indicate that 
flavocytochrome b is present in the endocytic recycling compartment of primary 
BMDMs.  
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Figure 30.  Endogenous gp91phox in 22YFP transduced p22def and WT BMDMs localizes to the 
plasma membrane and endosomes that cluster near the nucleus.  BMDMs were fixed, 
permeabilized, and stained for endogenous gp91phox.  (A) 22YFP expressed in 22def BMDMs co-
localized with gp91phox primarily on intracellular at vesicles near the cell surface (top panel, 
insets) and vesicles near the nucleus (bottom panel, insets).  (B) Endogenous gp91phox localizes to 
intracellular vesicles near the plasma membrane (inset, arrows) and near the nucleus 
(arrowheads). 
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III. Flavocytochrome b localizes to the phagocytic cup and vesicles near nascent 
phagosomes in “resting” macrophages 
1. Flavocytochrome b trafficking during phagocytosis in BMDMs 
We next investigated trafficking of flavocytochrome b during phagocytosis.  
While use of YFP- and CFP-tagged p22phox and gp91phox would have allowed 
simultaneous imaging of both heterodimer subunits during phagocytosis, the CFP-tagged 
proteins were only weakly fluorescent and not suitable for collecting a series of images 
over time.  Thus, we evaluated colocalization of 22YFP and endogenous gp91phox, 
visualized by indirect immunofluorescence, in p22phox-deficient BMDMs expressing 
22YFP after 2 and 15 min of phagocytosis of SOZ particles.  22YFP and gp91phox showed 
a very similar distribution in the phagocytic cup (Figure 31A, top panel, arrowheads) and 
nascent phagosomes (Figure 31A, top and bottom panels, asterisks).  We also observed 
the presence of 22YFP and gp91phox in discrete patches near the phagocytic cup and near 
phagosomes (Figure 31A, arrows), which appeared vesicular. We hypothesize that these 
regions might be endosomes involved in trafficking of flavocytochrome b between 
phagosomes and internalized membranes.  
Importantly, evaluation of immunofluorescent staining of gp91phox in p22def 
BMDMs lacking 22YFP (Figure 31B, outlined in white) showed that gp91phox in the 
absence of p22phox did not localize to the phagocytic cup (Figure 31B, white arrow) or 
nascent phagosomes (Figure 31B, white arrowheads).  
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Figure 31.  Flavocytochrome b localizes to the phagocytic cup and vesicles near nascent 
phagosomes in BMDMs.  (A) Colocalization of 22YFP and gp91phox, detected by 
immunofluorescence, in p22phox-deficient BMDMs following 2 min (top panel) and 15 min 
(bottom panel) of synchronized phagocytosis.  A series of z stack planes (0.16 µm) were 
collected.  5 single planes (total = 0.8 µm) were merged using the Z stack projection tool in 
ImageJ.  Arrowheads denote phagocytic cups and asterisks indicate nascent phagosomes.  Arrows 
indicate discrete foci of increased 22YFP and gp91phox colocalization near phagocytic cups and 
nascent phagosomes.  (B) gp91phox, detected by immunofluorescence, in a p22phox-deficient 
BMDM lacking 22YFP expression (outlined in white) did not localize near phagocytic cups 
(white arrows) or nascent phagosomes (white arrowheads) following 15 min of synchronized 
phagocytosis.  Representative images from 2 independent experiments in which at least 10 cells 
were evaluated at each time point.   
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2. Flavocytochrome b colocalizes with Rab11GFP at vesicles near the  
phagocytic cup and sealed phagosomes  
Rab11-positive recycling endosomes can be detected in the vicinity of nascent 
phagosomes and forming phagocytic cups (Cox et al., 2000), and can deliver proteins 
such as TNFα to forming phagosomes (Murray et al., 2005).  Our finding that 
flavocytochrome b localizes to the Rab11 endocytic recycling compartment in both RAW 
264.7 and BMDMs and that flavocytochrome b appeared to accumulate in discrete foci 
near the phagosome at different time points during phagocytosis suggested that recycling 
endosomes may serve as an intracellular reservoir from which additional 
flavocytochrome b can be delivered to the plasma membrane or phagosome.  Therefore, 
we examined the localization of endogenous gp91phox and Rab11GFP during phagocytosis 
of SOZ particles in RAW 264.7 cells.  Staining of gp91phox was evident on the plasma 
membrane, the phagocytic cup, and nascent phagosomes, as well as intracellular vesicles 
(Figure 32, left column), similar to BMDMs.  Some gp91phox also appeared to be 
subjacent to the plasma membrane in colocalization with Rab11GFP (Figure 32, right 
column, block arrows), consistent with the role of Rab11-positive endosomes in 
trafficking intracellular membrane to the cell surface (Ullrich et al., 1996).  Interestingly, 
gp91phox was also detected on nascent phagosomes, which lacked Rab11GFP (Figure 32, 
asterisks), suggesting that some flavocytochrome b was targeted directly to phagocytic 
cups as they formed from the plasma membrane.  Concordant with published data (Leiva 
et al., 2006), Rab11GFP was also detected on vesicles near the base of forming 
phagocytic cups and on the membranes of newly formed phagosomes, where it 
colocalized with gp91phox (Figure 32, right column, arrowheads and arrows,  
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Figure 32.  Flavocytochrome b colocalizes with Rab11GFP in or near phagocytic cups and 
nascent phagosomes.  RAW 264.7 cells transiently expressing Rab11GFP were fixed, 
permeabilized, and stained to detect gp91phox (mAb 54.1) 15 min after synchronized phagocytosis 
of serum opsonized zymosan.  Arrowheads indicate colocalization of gp91phox and Rab11GFP 
near a forming phagocytic cup (merged image).  Arrows show colocalization on or near nascent 
phagosomes.  Wide arrows indicate gp91phox in the plasma membrane subjacent to Rab11GFP, 
and asterisks mark a recently sealed phagosome that is gp91phox-positive, but Rab11GFP-
deficient. 
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respectively).  These data thus also suggest that Rab11-positive recycling endosomes may 
be involved in trafficking of flavocytochrome b between intracellular membranes and 
forming or nascent phagosomes.   
 
3. Frustrated phagocytosis does not increase flavocytochrome b localization 
to the cell surface in RAW 264.7 cells 
 Following phagocytosis of SOZ, we found flavocytochrome b to modestly 
increase at the cell surface (Figure 32).  This observation suggested that binding of 
phagocytic receptors may initiate signals leading to recruitment of intracellular 
membranes containing flavocytochrome b to the plasma membrane.  Using immune 
complex coated coverslips, we sought to test whether activation of the Fcγ-receptor 
would increase localization of flavocytochrome b to the cell surface.  Engagement of the 
Fcγ-receptor on immobilized immune complex-coated surfaces is a model system for 
analyzing membrane receptor mobilization and polarization to the plasma membrane 
(Eng et al., 2007), called “frustrated phagocytosis” since the macrophage attempts to, but 
can not “eat” the coverslip.  Immunofluorescent staining of gp91phox in RAW 264.7 cells 
following 15 or 60 min incubation on BSA-IgG-coated coverslips showed gp91phox did 
not appear to increase at the cell surface during frustrated phagocytosis (Figures 33A and 
33B).  Spreading of RAW 264.7 macrophages was observed (Figure 33A, arrows), 
consistent with the behavior of primary macrophages during frustrated phagocytosis 
(Takemura et al., 1986). 
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Figure 33.  Frustrated phagocytosis does not increase flavocytochrome b localization to the cell 
surface in RAW 264.7 cells.  Following incubation on BSA-IgG-coated coverslips for 15 min (A) 
or 60 min (B), gp91phox, detected by immunofluorescence, was found mostly in vesicles that 
clustered near the nucleus and showed little localization to the cell surface (arrows) in RAW 
264.7 cells.  This experiment was performed only once. 
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IV. Flavocytocrome b protein expression increases in IFNγ, but not LPS, activated  
macrophages 
1. Duration of IFNγ stimulation increases protein expression of  
flavocytochrome b subunits  
Quiescent or “resting” macrophages are essential to innate immunity due to their 
ability to phagocytose and destroy pathogens in the absence of any required co-
stimulation.  However, in the presence of co-stimulatory factors, such as the T cell helper 
Type-1 (Th1) cytokines, IFNγ and/or TNFα, the antimicrobial activity of macrophages is 
greatly enhanced (Mosser and Edwards, 2008).  IFNγ stimulation of both macrophages 
and neutrophils increases NADPH oxidase activity, which has been linked to increased 
protein expression of gp91phox and p67phox (Schroder et al., 2004).  300 U/ml (~ 30 ng/ml) 
IFNγ is sufficient for maximum expression of the major histocompatibility complex class 
II (MHCII) in BMDMs (Gonalons et al., 1998), and 1000 U/ml (~ 100 ng/ml) IFNγ 
results in maximum killing of S. typhimurium in BMDMs (Gordon et al., 2005), 
suggesting 100 ng/ml is a “saturating” amount of IFNγ for these biological responses.   
Thus, we evaluated the protein expression of flavocytochrome b and NADPH 
oxidase subunits p47phox, p67phox and p40phox by Western blotting in RAW 264.7 cells 
stimulated with 100 ng/ml IFNγ for 24, 48, and 72 hr.  As expected from previous studies 
showing that IFNγ increases transcription of CYBB (Newburger et al., 1991; Eklund et 
al., 1998), we observed increased gp91phox expression over time (Figure 34).  p22phox 
mRNA is not tightly regulate (Newburger et al., 1988), but p22phox protein expression is 
dependent on heterodimer formation with gp91phox for stability (DeLeo et al., 2000).  
Thus, in addition to gp91phox, a concomitant increase in p22phox protein expression was  
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Figure 34.  Duration of IFNγ activation of RAW 264.7 cells increases protein expression of 
flavocytochrome b, but not NADPH oxidase subunits p47phox, p67phox, or p40phox.  RAW 264.7 
cells were stimulated with 100 ng/ml IFNγ for 24, 48, or 72 hr.  Cells were harvested by 
trypsinization and cell lysates were analyzed for protein expression of NADPH oxidase subunits 
gp91phox (mAb 54.1), p22phox (mAb NS2), p47phox (Rb poly), p67phox (mAb), and p40phox (Rb poly) 
by Western blotting.  For better comparison, double the protein of lysates from cells cultured in 
the absence of IFNγ was loaded in each well.  The density of each sample was normalized to β-
actin and then the relative density of each protein from lysates cultured in the absence of IFNγ for 
24 hr was calculated, with the exception of iNOS.  iNOS density is reported relative to samples 
cultured in the presence of IFNγ for 24 hr.  Densitometry was analyzed for n=3 independent 
experiments except for p47phox, p40phox and iNOS where n=2 independent experiments. 
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also detected (Figure 34).  No change in protein expression was observed for the NADPH 
oxidase subunits p47phox, p67phox, and p40phox (Figure 34).  Due to the substantial increase 
in protein expression of flavocytochrome b following IFNγ stimulation, 10 µg of total 
protein from IFNγ stimulated samples and 20 µg of non-stimulated samples were loaded 
to each well for better comparison.  Analysis by densitometry of 3 independent 
experiments showed gp91phox and p22phox increased, respectively, 5.2 [±1.0] and 2.4 
[±0.3]-fold at 24 hr, 7.2 [±0.6] and 7.8 [±]-fold at 48 hr and 9.1 [±1.7] and 10.2 [±3.5]-
fold at 72 hr (Figure 34).   
IFNγ activation of macrophages also increases iNOS protein expression (Lin et 
al., 2008), which in addition to the NADPH oxidase, enhances macrophage antimicrobial 
activity.  Thus, iNOS protein expression in RAW 264.7 cells following IFNγ (100 ng/ml) 
activation for 24, 48, and 72 hr was evaluated by Western blot analysis.  In the absence of 
IFNγ, iNOS protein expression was undetectable (Figure 34).  In the presence of IFNγ, a 
strong signal was detected for iNOS that was similar in 24 and 48 hr IFNγ activated cells, 
but appeared to decrease in 72 hr IFNγ activated cells (Figure 34), consistent with a 
previous study (Gonalons et al., 1998).  Our results support differential regulation of 
iNOS and flavocytochrome b protein expression by IFNγ in RAW 264.7 cells, which has 
also been reported by others (Bastian and Hibbs, 1994). 
IFNγ activation of macrophages is frequently assessed by evaluating the cell 
surface expression of MHCII (Mosser, 2003).  To test whether the duration of IFNγ also 
increased protein expression of MHCII, MHCII surface expression was evaluated by flow 
cytometry.  MHCII expression was undetectable in the absence of IFNγ in RAW 264.7 
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cells, but was induced after 24 hr of IFNγ stimulation at a dose of 100 ng/ml, which 
appeared to reach maximal expression at 48 hr (Figure 35), confirming previous results  
(Gonalons et al., 1998).  At 24 hr, MHCII was not expressed following activation with a 
low dose of 10 ng/ml IFNγ, but this dose was sufficient to increase MHCII expression by  
48 hr, at which point MHCII expression was similar in cells activated with 10, 100, or 
500 ng/ml IFNγ.    
 Next, we analyzed flavocytochrome b expression following 24 and 72 hr IFNγ 
(100 ng/ml) activation in WT C57/Bl6 and gp91phox-deficient (CGD) BMDMs.  Similar 
to RAW 264.7 cells (Figure 34), gp91phox and p22phox protein expression was found to 
increase over time in WT BMDMs (Figure 36).  Densitometric analysis of one 
experiment found IFNγ activation to increase the protein expression of gp91phox and 
p22phox in unstimulated cells approximately 2-fold at 24 hr and dramatically increase 
approximately 7-fold at 72 hr (Figure 36), similar to RAW 264.7 cells. 
 
2. Maximum increase in flavocytochrome b expression following                
10 ng/ml IFNγ activation in RAW 264.7 cells  
 As mentioned above, 100 ng/ml IFNγ is a “saturating” concentration of IFNγ for 
MHCII expression and killing of the intracellular pathogen S. typhimurium, but whether 
flavocytochrome b protein expression is maximal at this concentration has not been 
shown.  RAW 264.7 cells were stimulated with serial dilutions of IFNγ (0.1 – 100 ng/ml) 
to evaluate protein expression of flavocytochrome b at 24, 48, and 72 hr.  gp91phox and 
p22phox were found to increase in RAW 264.7 cells stimulated with as little as 0.1 ng/ml 
IFNγ (Figure 37) and continue to increase until 10 ng/ml IFNγ, at which point,  
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Figure 35.  Increased MHCII surface expression following IFNγ stimulation is dependent on the 
time and dose of IFNγ stimulation in RAW 264.7 cells.  Following 24, 48, or 72 hr, unactivated 
or IFNγ (10 – 500 ng/ml) activated RAW 264.7 cells were evaluated for the cell surface 
expression of MHCII (black line) by flow cytometry.  The isotype control, rat IgG2b, is shown in 
grey fill.
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Figure 36.  Duration of IFNγ activation also increases flavocytochrome b protein expression in 
BMDMs.  Day 8-differentiated BMDMs (WT C57Bl/6 and CGD) were plated onto 100 mm Petri 
dishes in the presence (+) or absence (-) of IFNγ (100 ng/ml) in αMEM with 10% HI FCS and M-
CSF  (25 ng/ml) for 24 or 72 hr.  BMDMs were collected using cold PBS and cell lysates were 
analyzed for flavocytochrome b protein expression using mAbs 54.1 (anti-gp91phox), NS2 (anti-
p22phox), and anti-β-actin.  This experiment was performed only once. 
 
  
111 
 
Figure 37.  Maximum increase in flavocytochrome b protein expression following 10 ng/ml IFNγ 
in RAW 264.7 cells.  RAW 264.7 cells were stimulated with IFNγ (0.1 - 100 ng/ml) for 24, 48 
and 72 hr.  Flavocytochrome b protein expression in cell lystates was analyzed by Western 
blotting using mAbs 54.1 (anti-gp91phox) and NS2 (anti-p22phox).  Representative immunoblot 
from of 1 of 2 independent experiments.  * denotes 20 µg protein was loaded to this lane, while 
10 µg protein was added to all other lanes. 
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flavocytochrome b expression appeared to reach a plateau.  We also compared 
flavocytochrome b protein expression following 100 and 500 ng/ml IFNγ and found no 
further increase in protein expression in cells activated with the higher dose of 500 ng/ml 
IFNγ (see Figure 39).  Thus, similar to MHCII (see Figure 35), a marker for macrophage  
activation, flavocytochrome b expression also appeared to be reach maximum levels 
within the range of 10 -100 ng/ml IFNγ.  
 
3. In contrast to IFNγ, LPS stimulation only modestly increases 
flavocytochrome b protein expression in RAW 264.7 cells  
 In addition to inflammatory cytokines released by cells of the adaptive and innate 
immune system, LPS is also known to activate macrophages (Guha and Mackman, 2001).  
While considerable data exist on the IFNγ stimulated increase in NADPH oxidase 
activity in macrophages, less is known about LPS stimulation.  Notably, while LPS has 
been shown to increase gp91phox mRNA levels approximately 2-fold after 2 hr LPS        
(1 µg/ml) stimulation in neutrophils (Cassatella et al., 1990) little to no data exist on LPS 
regulation of gp91phox in monocytes and/or macrophages.   
Flavocytochrome b protein expression was evaluated in RAW 264.7 cells 
following LPS (20 and 250 ng/ml) stimulation at 24, 48, and 72 hr.  Following 24 hr LPS 
stimulation, an increase in gp91phox and p22phox protein expression was detected, which 
appeared to be dose dependent (Figure 38A).  gp91phox and p22phox protein expression 
appeared to continue to slightly increase at 48 and 72 hr.  Densitometric analysis of one 
experiment found LPS stimulation (250 ng/ml) to increase the protein expression of 
gp91phox and p22phox measured in unstimulated cells by approximately 1.8- and 2.6-fold at  
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Figure 38.  In contrast to IFNγ, LPS appears to only modestly increase flavocytochrome b 
expression following 24 - 72 hr in RAW 264.7 cells.  Unstimulated and LPS (20 or 250 ng/ml) 
stimulated RAW 264.7 cells were harvested following 24, 48 and 72 hr, lysed, and analyzed for 
protein expression of (A) flavocytochrome b using mAbs 54.1 (anti-gp91phox) and NS2 (anti-
p22phox) or (B) iNOS.  Western blots and densitometry from 1 of 2 independent experiments are 
shown for (A) and representative Western blots and densitometry from 1 of 2 independent 
experiments are shown for (B).  
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24 hr, 2.5- and 3-fold at 48 hr, and 3- and 3.4-fold at 72 hr, respectively (Figure 38A).  
However, in a second experiment, 72 hr LPS (250 ng/ml) stimulation increased gp91phox 
and p22phox expression approximately 1.3- and 2.4-fold (not shown), suggesting the 
increase in protein expression was variable following LPS stimulation.  In summary, LPS  
appears to increase flavocytochrome b protein expression, but the increase is modest 
compared to the 5 - 10 fold increase induced by IFNγ. 
iNOS protein expression was evaluated to serve as our positive control since LPS 
is a potent inducer of iNOS in RAW 264.7 cells (Lin et al., 2008).  As expected, iNOS 
expression was induced following 24, 48, and 72 hr of LPS stimulation (Figure 38B).    
 
4. Combination of IFNγ and LPS additively increases iNOS protein 
expression, but not flavocytochrome b  
Next, we evaluated the protein expression of iNOS and flavocytochrome b 
following 24 - 72 hr of activation with IFNγ alone and both IFNγ and LPS since the 
expression of iNOS has been shown to increase synergistically following stimulation 
with the combination of IFNγ and LPS (Gao et al., 1997; Lin et al., 2008).  While the 
protein expression of iNOS was found to be greater in cells stimulated with the 
combination of IFNγ (10 ng/ml) and LPS (20 ng/ml) than with IFNγ alone (Figure 39), 
the expression of flavocytochrome b did not increase with the addition of LPS (Figure 
39).  Thus, the combination of IFNγ and LPS did not appear to additively increase 
flavocytochrome b protein expression in RAW 264.7 cells. 
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Figure 39.  Combination of IFNγ and LPS additively increases protein expression of iNOS, but 
not flavocytochrome b.  RAW 264.7 cells cultured in the presence or absence of IFNγ or the 
combination of IFNγ and LPS for 24, 48, and 72 hr were harvested, lysed, and evaluated for 
protein expression of (A) gp91phox (mAb 54.1) and (B) iNOS by Western blot analysis.  * denotes 
30 µg of total protein added to well, while all other wells had 10 µg protein loaded.  This 
experiment was performed only once. 
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V. In macrophages, IFNγ activation increases localization of flavocytochrome b to 
the plasma membrane  
1. Sustained IFNγ stimulation increases the surface localization of  
flavocytochrome b in RAW 264.7 cells 
 The distribution of flavocytochrome b in RAW 264.7 cells stimulated with 100 
ng/ml IFNγ for 24 and 72 hr was evaluated by confocal microscopy.  RAW 264.7 cells 
were fixed, permeabilized and then stained for gp91phox, which we utilized as our marker 
for flavocytochrome b.  While no significant change in the distribution of gp91phox was 
seen following 24 hr IFNγ activation, a dramatic change was observed at 72 hr (Figure 
40).  At 72 hr, gp91phox localized mostly to the cell surface (Figure 40, bottom panel, 
arrowheads), which was in marked contrast to the intracellular distribution seen in the 
absence of IFNγ (Figure 40, top panel) and in the presence of IFNγ for 24 hr  (Figure 40, 
middle panel).  Notably, gp91phox localization to the perinuclear endocytic recycling 
compartment was prominent in the absence of IFNγ and following 24 hr of IFNγ (Figure 
40, arrows), but appeared to be absent following 72 hr IFNγ activation. 
The distribution of gp91phox was also evaluated in RAW 264.7 cells activated with 
lower doses of IFNγ (5 and 10 ng/ml).  As seen for 100 ng/ml IFNγ (Figure 40), 10 ng/ml 
IFNγ appeared to increase gp91phox localization to the cell surface (Figure 41A).  
However, the distribution of gp91phox following 5 ng/ml of IFNγ was highly variable 
(Figure 41B).  Following 5 ng/ml IFNγ activation, 3 different distributions of gp91phox 
were observed.  Some cells showed gp91phox to accumulate in a perinuclear compartment 
with little localization to the plasma membrane (Figure 41B, top panel), some showed 
gp91phox to be present in the plasma membrane and endosomal compartments (Figure  
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Figure 40.  72 hr IFNγ activation changes the subcellular distribution of flavocytochrome b in 
RAW 264.7 cells.  RAW 264.7 cells cultured in the presence or absence of IFNγ (100 ng/ml) for 
24 and 72 hr were fixed, permeabilized, and immunostained for gp91phox (mAb 54.1).  The 
distribution of gp91phox was evaluated by immunofluorescence microscopy.  gp91phox localized to 
a prominent perinuclear compartment in the absence of IFNγ and following 24 hr IFNγ 
stimulation (arrows).  In contrast, following 72 hr IFNγ activation, gp91phox was found at the cell 
surface (arrowheads) and lacked both the perinuclear (arrows) and vesicular-looking distribution 
seen in unactivated and 24 hr IFNγ activated cells. 
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Figure 41.  Similar increase in gp91phox surface expression following 10 ng/ml IFNγ, but not       
5 ng/ml IFNγ activation in RAW 264.7 cells.  72 hr IFNγ (5 or 10 ng/ml) activated RAW 264.7 
cells were fixed, permeabilized, and the distribution of gp91phox (mAb 54.1) was evaluated by 
immuno-fluorescence microscopy.  (A) gp91phox was found at the cell surface in RAW 264.7 cells 
activated with 10 ng/ml IFNγ.  (B) Distribution of gp91phox was highly variable in RAW 264.7 
cells activated with 5 ng/ml IFNγ.  gp91phox localized either to a predominant perinculear 
compartment (top panel, arrows), to vesicular-looking structures dispersed throughout the cell 
(middle panel), or to the plasma membrane and vesicular-looking structures (bottom panel).   
Representative images from 2 independent experiments are shown in which at least 50 cells were 
evaluated.
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41B, middle panel), and others showed gp91phox to localize mostly to the cell surface.  
From 2 independent experiments, it appeared that approximately 30% of cells had each of 
these distributions.  
 
2. Decreased colocalization of flavocytochrome b with the transferrin-
labeled endocytic recycling compartment following IFNγ activation in 
RAW 264.7 cells 
 We showed flavocytochrome b colocalizes with Rab11 and transferrin at the 
endocytic recycling compartment in “resting” RAW 264.7 cells and BMDMs (Figures 23 
and 29).  To further investigate the change in distribution of flavocytochrome b following 
IFNγ activation, colocalization of gp91phox with subcellular markers for the endocytic 
recycling compartment and the plasma membrane was evaluated in IFNγ activated RAW 
264.7 cells.  To label the endocytic recycling compartment and early endosomes, RAW 
264.7 cells were incubated with Alexa Fluor 647-conjugated human transferrin for 25 
min.  In IFNγ activated cells, gp91phox did not appear to colocalize with transferrin at the 
endocytic recycling compartment (Figure 42, bottom panel, insets), in contrast to the 
colocalization observed in the absence of IFNγ (Figure 42, top panel, insets).  In addition 
to the loss of a prominent perinuclear compartment in IFNγ activated RAW 264.7 cells, 
an increase in colocalization of gp91phox with PH-GFP was observed (Figure 43).  
Changes in colocalization with these subcellular markers further suggested IFNγ induces 
a change in the distribution of flavocytochrome b.   
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Figure 42.  Loss of localization of gp91phox to the transferrin-labeled endocytic recycling 
compartment in 72 hr IFNγ stimulated RAW 264.7 cells.  RAW 264.7 cells cultured in the 
presence or absence of IFNγ (100 ng/ml) for 72 hr were incubated with Alexa Fluor 647-
conjugated human transferrin (Tfn, 5 µg/ml) for 25 min at 37°C to label the endocytic recycling 
compartment and early endosomes.  Cells were fixed, permeabilized, and stained for gp91phox.  In 
the absence of IFNγ, colocalization of gp91phox and Tfn was observed at the perinuclear 
compartment (top panel, insets) and near the plasma membrane.  In the presence of IFNγ, 
colocalization of gp91phox and Tfn was not seen at a perinuclear compartment (bottom panel, 
insets), but was seen in vesicles near the plasma membrane. 
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Figure 43.  Increased colocalization of flavocytochrome b with the plasma membrane marker 
PH-GFP following 72 hr IFNγ activation in RAW 264.7 cells.  RAW-PH-GFP cells cultured in 
the presence or absence of IFNγ (100 ng/ml) for 72 hr were fixed, permeabilized, and stained for 
endogenous gp91phox (mAb 54.1).  In the absence of IFNγ, colocalization of gp91phox and the 
plasma membrane marker, PH-GFP, was seen at the cell surface in RAW-PH-GFP cells in 
discrete patches (top panel, insets).  In the presence of IFNγ, colocalization of gp91phox and PH-
GFP was increased and more uniform around the plasma membrane (bottom panel, arrows).  A 
single plane z stack slice taken from near the bottom of the cell is shown (n=2 experiments in 
which colocalization of gp91phox and PH-GFP was evaluated). 
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3. IFNγ activation does not change the cell surface expression of CD16 or 
F4/80, or the subcellular distribution of Mac1   
The change in the distribution of flavocytochrome b (Figure 40) could be the 
result of a “global” change in protein trafficking.  Thus, we evaluated additional proteins 
known to localize to the cell surface in macrophages to see whether the surface  
expression of these proteins changed following IFNγ activation.  The cell surface 
expression of FcγRIIIa (CD16) and F4/80, a marker for macrophage activation (van den 
Berg and Kraal, 2005), did not appear to increase following exposure to IFNγ for 24, 48, 
or 72 hr (Figures 44A and 44B) as detected by flow cytometry.  In addition, the 
distribution of the integrin αMβ2, or Mac1, which has been shown to recycle in murine 
peritoneal macrophages using biochemical assays (Bretscher, 1992), was evaluated by 
immunofluorescence microscopy.  Mac1 localized to the plasma membrane in 
unstimulated and 72 hr IFNγ stimulated RAW 264.7 cells (Figure 45).  In summary, IFNγ 
did not change the cell surface expression of CD16 or F4/80 and did not change the 
distribution of Mac1.   
 
4. Blocking TNFα did not alter the change in distribution of  
flavocytochrome b due to IFNγ in RAW 264.7 cells 
The protein expression of flavocytochrome b was found to increase after 24 hr of 
IFNγ stimulation (Figure 34), but the change in the distribution of flavocytochrome b was 
not observed until 72 hr (Figure 40).  Due to this delay, we hypothesized that the change 
in distribution of flavocytochrome b may be a secondary effect of IFNγ stimulation.   
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Figure 44.  No increase in the surface expression of CD16 and F4/80 in response to IFNγ 
activation at 24 - 72 hr.  Following 24, 48, or 72 hr, unactivated or IFNγ (10 – 500 ng/ml) 
activated RAW 264.7 cells were evaluated for the cell surface expression of (A) CD16 (black 
line) and (B) F4/80 (black line) by flow cytometry.  Isotype controls are shown as grey fill. 
 
  
124 
 
Figure 45.  Mac1 does not change distribution in the presence of IFNγ (72 hr) in RAW 264.7 
cells.  RAW 264.7 cells cultured in the absence or presence of IFNγ (100 ng/ml) for 72 hr were 
fixed, permeabilized, and immunostained for Mac1 using a FITC-conjugated anti-Mac1 antibody.  
The distribution of Mac1 was evaluated by immunofluorescence microscopy in unactivated (top 
panel) and IFNγ activated cells (bottom panel).   
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IFNγ increases protein expression of several proinflammatory cytokines, such as TNFα 
(Collart et al., 1986; Vila-del Sol et al., 2007), IL-1β (Collart et al., 1986; Marecki et al., 
2001), and IL-12 (Wang et al., 2000).  Among these cytokines, TNFα is known to 
increase macrophage activation (Mosser and Edwards, 2008).  Recently, IFNγ-induced 
expression of TNFα was shown to regulate iNOS protein expression in an autocrine 
manner in IFNγ activated RAW 264.7 cells (Vila-del Sol et al., 2007).  Thus, the role of 
TNFα in changing the distribution of flavocytochrome b was evaluated by confocal 
microscopy in RAW 264.7 cells activated with IFNγ (100 ng/ml) in the presence or 
absence of a mAb against TNFα (10 µg/ml), which was added in combination with IFNγ 
for 72 hr.  Flavocytochrome b localized predominantly to the cell surface in RAW 264.7 
cells activated with IFNγ in the presence or absence of the TNFα blocking antibody 
(Figure 46).  These results suggest IFNγ does not change the distribution of 
flavocytochrome b via TNFα.  In addition, blocking TNFα did not change the surface 
expression of MHCII (Figure 47).  However, it should be noted that the activity of the 
TNFα blocking antibody was not confirmed in our experiments, and that we did not 
determine whether RAW 264.7 cells were releasing TNFα under our conditions. 
 
5. Change in distribution does not appear to be reversible within 24 hr 
following removal of exogenous IFNγ 
  The distribution of flavocytochrome b was found to change following 48 and 72 
hr IFNγ activation (Figure 38 and not shown), which was also the time at which MHCII 
reached maximum surface expression.  As a preliminary experiment to evaluate the  
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Figure 46.  Blocking TNFα did not alter the change in distribution of flavocytochrome b 
following IFNγ activation in RAW 264.7 cells.  RAW 264.7 cells cultured in the presence of 
IFNγ (100 ng/ml) or the combination of IFNγ (100 ng/ml) and a blocking antibody for TNFα (10 
µg/ml) for 72 hr were fixed, permeabilized, and immunostained for gp91phox using the mAb 54.1. 
Evaluation by immunofluorescence microscopy showed gp91phox localized predominantly to the 
cell surface in IFNγ stimulated (top panel) or IFNγ stimulated in the presence of a TNFα blocking 
antibody (bottom panel). 
 
  
127 
 
Figure 47.  Blocking TNFα did not prevent the increase in MHCII surface expression in IFNγ 
activated RAW 264.7 cells.  Following 24 or 72 hr stimulation with IFNγ (100 ng/ml) in the 
presence or absence of a TNFα blocking antibody (10 µg/ml), RAW 264.7 cells were evaluated 
for the surface expression of MHCII (black line) by flow cytometry.  Isotype controls are shown 
as grey fill.  This experiment was performed once.  
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mechanism responsible for this change in distribution, RAW 264.7 cells were activated 
with IFNγ for 48 hr, washed, and cultured for an additional 24 hr in the absence of IFNγ.   
Confocal microscopy showed gp91phox localized mostly to the cell surface and did not 
show a predominant perinuclear distribution (Figure 48A).  These results suggest the 
change in distribution could not be reversed within 24 hr by removing exogenous IFNγ, 
although it is possible that RAW 264.7 cells are producing endogenous IFNγ at this time 
point.  Similar to flavocytochrome b, MHCII surface expression did not change after 
removing exogenous IFNγ for 24 hr (Figure 48B).   
 
6. Isolation of surface gp91phox by biotin labeling further establishes that 
IFNγ changes the distribution of flavocytochrome b 
 To quantify and compare the cell surface expression of flavocytochrome b in 
RAW 264.7 cells cultured in the presence and absence of IFNγ, we used biotin to label 
cell surface gp91phox followed by precipitation with Neutravidin.  This method was 
utilized since currently an antibody to detect an extracellular epitope of murine 
flavocytochrome b does not exist.  In addition to the cell surface, total cell lysates were 
also labeled with biotin to serve as an internal control.  Densitometric analysis was 
performed following immunoblotting for gp91phox to quantify the ratio of gp91phox 
expression at the cell surface compared to the total cell lysate in both unactivated and 
IFNγ activated cells.  The relative amount of biotinylated cell surface gp91phox was 
approximately 13-fold greater in cells activated by IFNγ (Figure 49).  Analysis of 
biotinylated gp91phox isolated from cell lysates showed only a 3-fold increase (Figure 48) 
following IFNγ stimulation compared to unactivated cells.  The ratio of gp91phox  
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Figure 48.  Change in distribution of flavocytochrome b following IFNγ stimulation does not 
appear to be reversible.  (A) Immunofluorescent staining of gp91phox in RAW 264. 7 cells 
stimulated with IFNγ for 48 hr, washed to remove exogenous IFNγ, and cultured for an additional 
24 hr.  (B) Western blot analysis of RAW 264.7 cells stimulated with 3 different conditions of 
IFNγ:  72 hr IFNγ (i), 48 hr IFNγ, then washed to remove exogenous IFNγ, and cultured for an 
additional 24 hr in the presence of “new” IFNγ (ii), or the absence of any additional IFNγ (iii).  
No change in protein expression was observed.  Representative blot from 1 of 2 independent 
experiments.  (C) Surface expression of MHCII (black line) or rat IgG2b isotype control (grey fill) 
was evaluated in RAW 264.7 cells cultured for 72 hr under the following conditions: no IFNγ, 
IFNγ, IFNγ for 66 hr followed by removal of IFNγ, and IFNγ for 48 hr followed by removal of 
IFNγ.  
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Figure 49.  Isolation of surface gp91phox using biotin shows IFNγ increases both the surface 
localization of gp91phox and total gp91phox expression.  RAW 264.7 cells were cultured for 72 hr in 
the presence or absence of IFNγ (100 ng/ml).  Biotinylated gp91phox was isolated from the cell 
surface following biotinylation of living cells or biotinylation of the cell lysate.  Western blot 
analysis was utilized to compare the amount of gp91phox (mAb 54.1) isolated from the cell surface 
in unstimulated cells to that of IFNγ stimulated cells.  Biotinylated gp91phox isolated from cell 
lysates was used as the internal control.  Sample volumes were optimized for better comparison 
of gp91phox expression since approximately 15 times more gp91phox was isolated from the surface 
of IFNγ stimulated cells than unstimulated cells.  
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expression at the surface compared to the total cell lysate cultured in the absence of 
IFNγ was 0.9, while a ratio of 4.5 was measured in cells cultured in the presence of IFNγ.   
These results indicate that IFNγ stimulation of RAW 264.7 cells increased the cell 
surface expression of gp91phox approximately 5-fold.  
 
7. Shift in distribution of flavocytochrome b in murine BMDMs following  
72 hr activation 
We also investigated whether IFNγ treatment changes the distribution of 
flavocytochrome b in primary murine BMDMs.  Utilizing confocal microscopy, the 
distribution of flavocytochrome b in both WT (C56/BL6) and 22YFP-expressing p22def 
BMDMs in the presence or absence of IFNγ (72 hr) was evaluated.  IFNγ activated 
BMDMs showed an increase in gp91phox and 22YFP to the cell surface (Figure 50A and 
50B, bottom panels) and a loss of the prominent perinuclear compartment seen in un-
activated BMDMs (Figure 50A and 50B, arrows).  Colocalization analysis was  
performed in 22YFP-expressing p22def BMDMs instead of colocalization of endogenous 
gp91phox and p22phox due to the lack of two antibodies of different isotypes that are 
sensitive enough to be used for immunofluorescent staining.  Similar to wild-type 
BMDMs, endogenous gp91phox and 22YFP in 22YFP-expressing p22def BMDMs 
colocalized at vesicles that clustered around the nucleus in the absence of IFNγ (Figure 
51A, insets) but, following 72 hr IFNγ stimulation, colocalized at the cell surface 
(Figures 51A and 51B).  These data further establish that 72 hr IFNγ stimulation changes 
the distribution of the heterodimer flavocytochrome b in macrophages.  
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Figure 50.  IFNγ activation increases localization of flavocytochrome b to the cell surface in 
wild-type (C57/BL6) and 22YFP-expressing p22phox-deficient (p22def) BMDMs.   
(A) Immunofluorescent staining of gp91phox in unactivated or 72 hr IFNγ (100 ng/ml) activated 
WT BMDMs.  (B) In both unactivated and 72 hr IFNγ activated 22YFP-expressing p22def 
BMDMs, the distribution of 22YFP was evaluated in living cells.  Arrows denote the location of 
the endocytic recycling compartment (ERC).   
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Figure 51.  Colocalization of 22YFP and endogenous gp91phox in BMDMs further shows IFNγ 
activation changes the distribution of the heterodimer flavocytochrome b.  Colocalization of 
endogenous gp91phox, detected by immunofluorescence, and 22YFP in 22YFP-expressing p22def 
BMDMs was evaluated following (A) no stimulation or (B) IFNγ (100 ng/ml) stimulation for    
72 hr. 
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8. Shift in distribution of flavocytochrome b is independent of p47phox and  
Rac2 in BMDMs 
Activation of the NADPH oxidase requires p47phox translocation.  Thus, we 
evaluated whether an intact oxidase was required for the redistribution of 
flavocytochrome b following IFNγ activation.  Utilizing confocal microscopy, we 
evaluated the distribution of endogenous gp91phox in BMDMs from p47phox-/- mice plated 
for 72 hr in the presence or absence of IFNγ (100 ng/ml).  As shown in Figure 52A, the 
absence of p47phox did not prevent the change in distribution of gp91phox suggesting 
activation of the NADPH oxidase was not required.   
gp91phox was recently shown to be present on intracellular vesicles, by 
immunofluorescent staining in wild-type CD8+ DCs, but was localized predominantly on 
the cell surface in Rac2-/- CD8+ DCs (Savina et al., 2009).  Thus, we hypothesized that 
Rac2 may regulate the distribution of flavocytochrome b in macrophages.  The 
distribution of endogenous gp91phox in BMDMs from Rac2-/- mice plated for 72 hr in the 
presence or absence of IFNγ (100 ng/ml) was evaluated by immunofluorescence  
microscopy.  As shown in Figure 52B, the absence of Rac2 did not prevent the IFNγ 
induced change in distribution of gp91phox. 
 
9. Cell surface localization of flavocytochrome b does not increase in RAW 
cell lines overexpressing flavocytochrome b subunits from transgenes 
 The change in distribution of flavocytochrome b correlated with a substantial 
increase in protein expression.  To determine whether increased protein expression of 
flavocytochrome b subunits in and of itself could induce a change in the distribution of  
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Figure 52.  IFNγ-induced change in the distribution of flavocytochrome b in macrophages is not 
dependent on p47phox or Rac2.  Immunofluorescent staining of gp91phox was evaluated by confocal 
microscopy in unactivated or 72 hr IFNγ (100 ng/ml) activated (A) p47phox-/- BMDMs or (B) 
Rac2-/- BMDMs.  Arrows denote localization of gp91phox to a prominent perinuclear compartment 
and arrowheads denote localization in the plasma membrane. 
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flavocytochrome b, we generated a RAW-91,22 cell line that stably expressed human 
gp91phox and p22phox.  Western blot analysis showed stable expression of human gp91phox 
in RAW-91,22 increased total gp91phox expression by approximately 5.5-fold and p22phox 
expression by 11-fold (Figure 53A), which closely mimicked the increase in gp91phox and 
p22phox expression following IFNγ activation in RAW cells at 72 hr (Figure 53A).   
 Confocal microscopy was utilized to determine whether increasing protein 
expression of gp91phox and p22phox would change the distribution of flavocytochrome b in 
RAW-91/22.  As shown previously in both RAW 264.7 and bone marrow derived 
macrophages (Figures 23 and 30), we found gp91phox in RAW-91,22 cells to localize to 
endosomes and the endocytic recycling compartment, shown by colocalization with 
transferrin (Figure 53C, arrows).  In contrast to gp91phox, p22phox did not appear to 
localize to the ERC and showed a reticular distribution (Figure 53B), reflecting that 
transgenic p22phox is relatively more expressed compared to transgenic gp91phox. 
 
10. Deletion of p22phox C-terminal amino acids 149 - 195 does not prevent the 
change in distribution of flavocytochrome b following IFNγ activation 
We found that removal of p22phox C-terminal amino acids 149 - 195 did not alter 
flavocytochrome b distribution in the plasma membrane and endocytic recycling 
compartment in CHO cells (Figure 20).  Further removal of C-terminal amino acids 131 -
195 prevented heterodimer formation of this mutant with gp91phox, and this mutant was 
localized to the ER (Figure 20).  We generated RAW-22CIT, RAW-149CIT, and RAW-
131CIT cells that stably expressed CIT-tagged versions of p22phox and the two C-terminal 
deletion mutants to investigate whether regions within the C-terminus of p22phox may  
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Figure 53.  Increasing gp91phox expression in RAW-91,22 cells does not change the distribution 
of flavocytochrome b in the absence of IFNγ.  (A) Immunoblots of cell lysates from unstimulated 
RAW 264.7 cells and RAW,91,22 cells and from IFNγ (100 ng/ml, 72 hr) stimulated cells probed 
with mAbs 54.1 (anti-gp91phox), CL5 (anti-human gp91phox), NS2 (anti-p22phox), and anti-β-actin.  
(B) RAW-91,22 cells were fixed, permeabilized, and stained to detect gp91phox (mAb 54.1) and 
human p22phox (mAb 44.1).  (C) RAW-91,22 cells were incubated with Alexa Fluor 647-
conjugated human transferrin for 25 min at 37°C, then fixed, permeabilized and stained for 
gp91phox (mAb 54.1).  Arrows denote localization to the endocytic recycling compartment. 
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regulate the change in distribution of flavocytochrome b following IFNγ activation.  In 
the absence of IFNγ, 22CIT, 149CIT, and 131CIT localized to the ER (Figure 54A) in 
RAW-22CIT, RAW-149CIT and RAW-131CIT cell lines.  This suggested the 
fluorescently tagged 22CIT and 149CIT subunits were expressed in excess of 
endogenous gp91phox (Figure 27).  However, 131CIT is incapable of heterodimer 
formation (Figure 20) and thus is expected to be in the ER.  In the presence of IFNγ, 
endogenous gp91phox expression increases dramatically (Figure 34).  Thus, we 
hypothesized that in IFNγ stimulated cells, the otherwise “excess” 22CIT or 149CIT 
derivative would no longer be expressed in excess of gp91phox and would be incorporated 
into flavocytochrome b heterodimers.  As shown in Figure 54B, 22CIT and 149CIT were 
found to localize to the cell surface in IFNγ activated RAW cells, suggesting amino acids 
149 - 195 were not required for the change in distribution of flavocytochrome b to the 
plasma membrane.  Importantly, 131CIT, which lacks the ability to form heterodimers 
with gp91phox, remained in the ER in IFNγ activated RAW-131CIT cells, establishing that  
the change in distribution of 22CIT and 149CIT to the plasma membrane was dependent 
on heterodimer formation with endogenous gp91phox.   
 
VI. In contrast to IFNγ, LPS stimulation does not increase flavocytochrome b 
localization to the plasma membrane 
1.  LPS stimulation does not increase surface localization of  
flavocytochrome b 
We also investigated the distribution of flavocytochrome b in RAW cell 
macrophages following stimulation with LPS alone or LPS in combination with IFNγ.   
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Figure 54.  Deletion of p22phox C-terminal amino acids 149-195 does not prevent the 
change in distribution following IFNγ activation in RAW 264.7 cells.  (A) Protein 
expression, assessed by fluorescent intensity of YFP/CIT using flow cytometery, of 
fluorescently tagged flavocytochrome b subunits stably expressed in RAW-YFP91 (black 
line), RAW-22CIT (black line), RAW-22C149CIT (black line), and RAW22C131CIT 
(black line) was similar.  RAW 264.7 cells (grey fill) were used as the negative control.  
(B) In the absence of IFNγ stimulation, fluorescently tagged gp91phox and p22phox subunits 
localized to the ER (top panel).  In the presence of IFNγ, fluorescently tagged subunits, 
YFP91, 22CIT, and 22C149CIT localized to the cell surface (bottom panel) but 
22C131CIT resided in the ER. 
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RAW 264.7 cells activated with LPS for 24 or 72 hr were evaluated by confocal 
microscopy.  Following 24 or 72 hr of LPS stimulation, flavocytochrome b appeared to 
lose the prominent perinuclear distribution (Figure 55, top panel, arrow) and was 
localized to vesicles that were more dispersed throughout the cell (Figure 55, middle and 
bottom panels).  Notably, there was no apparent increase of flavocytochrome b in the 
plasma membrane.  LPS stimulation appeared to increase cell spreading, which may be of 
relevance to the more dispersed distribution for flavocytochrome b since stabilization of 
microtubules has been shown to disperse Rab11-positive endosomes (Yoon et al., 2005).  
In addition, MHCII surface expression did not change in response to LPS (Figure 56A).   
To confirm that our LPS preparation was active, TLR4 surface expression was evaluated 
in RAW 264.7 cells that were either unstimulated or stimulated for 24 hr with 250 ng/ml 
LPS or 100 ng/ml IFNγ.  As expected (Nomura et al., 2000), 250 ng/ml LPS decreased 
TLR4 expression, while no change was observed in IFNγ activated or unstimulated cells 
(Figure 56B), establishing the activity of our LPS preparation.  
 
2. Addition of LPS to IFNγ activated macrophages reverses the predominant  
surface distribution of flavocytochrome b seen in macrophages activated 
with only IFNγ  
A standard protocol for generating classically “primed” macrophages involves 
stimulating cells with both IFNγ and LPS (Mosser and Zhang, 2008), which prompted us 
to investigate the distribution of flavocytochrome b in RAW 264.7 cells stimulated with 
IFNγ (10 ng/ml) and LPS (250 ng/ml) for 24 and 72 hr.  Following 24 hr stimulation with 
IFNγ and LPS, flavocytochrome b showed a predominant perinuclear distribution  
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Figure 55.  LPS stimulation does not appear to increase the cell surface expression of 
flavocytochrome b in RAW 264.7 cells.  Unstimulated or LPS (250 ng/ml) stimulated 
RAW 264.7 cells were fixed, permeabilized, and stained for gp91phox (mAb 54.1).  The 
distribution of gp91phox was evaluated in unstimulated cells (top panel), 24 hr LPS 
stimulated cells (middle panel), and 72 hr LPS stimulated cells (bottom panel).  Arrows 
denote the perinuclear endocytic recycling compartment.  Representative images from 2 
independent experiments.  
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Figure 56.  In contrast to IFNγ, LPS does not increase MHCII surface expression.  RAW 264.7 
cells were stimulated with IFNγ (100 ng/ml) or LPS (250 ng/ml) for 24 or 48 hr.  Surface 
expression of (A) MHCII (black line) and (B) TLR4 (black line) was evaluated by flow 
cytometry.  Isotype controls are shown as dark grey fill. 
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(Figure 57, middle panel, arrows) and localized to vesicles throughout the cytosol, 
similar to the distribution of 24 hr IFNγ activated cells (Figure 57, top panel).  
Interestingly, in contrast to IFNγ alone, many of the cells treated with the combination of 
IFNγ and LPS for 72 hr appeared to be dead (not shown) and not many cells were found 
on the coverslips (approximately less than 10% cells compared to IFNγ stimulated only).  
In addition, the cells present on the coverslips were filled with large vacuoles (Figure 
57A, bottom panel); thus, we could not evaluate the distribution of flavocytochrome b.  
We hypothesize that the simultaneous administration of IFNγ and LPS for 72 hr caused 
the cells to die due to cytotoxicity related to high LPS and/or “over”-activation (Ma et al., 
2003).   
In addition, we examined the distribution of flavocytochrome b in RAW cells 
activated with IFNγ (100 ng/ml) for 72 hr with LPS (250 ng/ml) added only for the last 
24 hr.  As shown previously, flavocytochrome b localized predominantly to the cell 
surface in IFNγ (72 hr) activated RAW 264.7 cells (Figure 57B, top panel).  In marked 
contrast, flavocytochrome b showed an endosomal or vesicular-looking distribution in 
cells stimulated with both LPS and IFNγ and little presence in the cell surface (Figure 
57B, bottom panel).  Similar to LPS alone (Figure 55), flavocytochrome b appeared 
dispersed in vesicles and did localize to a prominent perinuclear compartment in cells 
stimulated with the combination of IFNγ and LPS for the last 24 hr.  These results 
suggest LPS can reverse the change in distribution of flavocytochrome b following IFNγ 
activation. 
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Figure 57.  LPS in the presence of IFNγ appears to reverse the change in distribution of 
flavocytochrome b due to IFNγ alone.  Unstimulated or stimulated with IFNγ (100 ng/ml) and/or 
LPS (250 ng/ml) RAW 264.7 cells were fixed, permeabilized, and stained for gp91phox.  (A) From 
top to bottom: Localization of gp91phox in cells that were unstimulated, stimulated for 24 hr, or 
stimulated for 72 hr with both IFNγ and LPS.  (B) Localization of gp91phox in cells stimulated 
with IFNγ only for 72 hr or stimulated with IFNγ for 72 hr with the addition of LPS for the last 24 
hr.  Representative images from 2 independent experiments in which at least 50 cells were 
analyzed, except for (A) bottom panel, in which only 20 cells were analyzed.    
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VII. Flavocytochrome b localization to phagocytic cups is more visible in IFNγ  
activated RAW 264.7 cells and BMDMs 
1. IFNγ pre-stimulation of RAW 264.7 cells appears to increase presence of 
flavocytochrome b in the phagocytic cup and nascent phagosomes  
 We next performed synchronized phagocytosis assays to evaluate whether the 
enhanced surface expression of gp91phox following 72 hr IFNγ activation would increase 
localization of flavocytochrome b to phagosomes.  Following 5 min of phagocytosis of 
SOZ, flavocytochrome b presence in phagocytic cups was evaluated in RAW 264.7 cells 
plated in the absence of IFNγ (72 hr) or in the presence of IFNγ for 24 or 72 hr, by 
immunofluorescence microscopy.  gp91phox was present in phagocytic cups in 
unstimulated cells (Figure 58A, left panel), which did appear to be increasingly more 
visible after 24 (Figure 58A, middle panel) and then 72 hr (Figure 58A, right panel) of 
IFNγ stimulation.  Further evaluation in nascent phagosomes present 15 min after 
initiation of phagocytosis showed localization of gp91phox in vesicles that appeared to 
cluster near phagosomes in the absence of IFNγ (Figure 58B, left panel, asterisks), but in 
24 hr IFNγ stimulated cells gp91phox showed less of a “patchy” distribution and more of a 
uniform “ring” around the phagosome (Figure 58B, middle panel, asterisks), which  
appeared even more evident in cells stimulated with IFNγ for 72 hr (Figure 58B, right 
panel, asterisks).  However, it was difficult to assess whether the increase in the visibility 
of gp91phox in phagocytic cups and nascent phagosomes was due to IFNγ-induced 
changes in the distribution of flavocytochrome b or simply reflected the marked increase 
in gp91phox protein expression in IFNγ stimulated cells. 
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Figure 58.  Localization of gp91phox to phagocytic cups and nascent phagosomes appears more 
visible in IFNγ pre-stimulated RAW 264.7 cells.  RAW 264.7 cells were fixed, permeabilized, 
and stained to detect gp91phox (mAb 54.1) following 5 or 15 min synchronized phagocytosis of 
serum opsonized zymosan.  Top panel (5 min): Localization of gp91phox to phagocytic cups 
(arrows) was evaluated in unstimulated, 24 hr IFNγ stimulated, and 72 hr IFNγ stimulated cells.  
Bottom panel (15 min): Localization of gp91phox to nascent phagosomes (asterisks) was 
evaluated in unstimulated, 24 hr IFNγ stimulated, and 72 hr IFNγ stimulated cells.  Shown are 
representative images from 2 independent experiments in which at least 50 cells were evaluated.  
Single z stack sections from the middle of the cell are shown. 
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2. More uniform distribution of 22YFP in phagocytic cups in IFNγ activated  
22YFP-expressing p22def BMDMs 
Next, we evaluated trafficking of flavocytochrome b during phagocytosis in 
unstimulated and IFNγ (72 hr) pre-stimulated BMDMs.  We utilized our 22YFP-
expresssing p22phox-deficient BMDMs to evaluate localization of flavocytochrome b, 
using 22YFP, during phagocytosis in living cells.  Localization of 22YFP in p22phox-
deficient BMDMs was evaluated following 5 and 20 min of phagocytosis of SOZ 
particles by video microscopy.  As described previously in fixed cells (Figure 31), 22YFP 
was found in phagocytic cups (5 min) and nascent phagosomes (20 min) in unstimulated 
BMDMs (Figure 59, top panel) and appeared to cluster in discrete patches near the cup 
and phagosomes.  In IFNγ pre-stimulated BMDMs, 22YFP appeared more uniform in 
phagocytic cups (Figure 59, bottom panel, left image) and less punctate, but no difference 
in the localization of 22YFP on nascent phagosomes (Figure 59, bottom panel, right 
image) was observed.  Thus, flavocytochrome b localization to phagocytic cups appeared 
to increase in both BMDMs and RAW 264.7 cells activated with IFNγ, but a more 
uniform localization to nascent phagosomes was only observed in IFNγ activated RAW 
264.7 cells. 
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Figure 59.  More uniform localization of 22YFP to phagocytic cups in IFNγ activated 22YFP-
expresing p22def BMDMs.  Localization of 22YFP in 22YFP-expressing p22phox-deficient 
BMDMs following 5 min (left panel) and 20 min (right panel) of synchronized phagocytosis in 
unstimulated cells (top panel) and 72 hr IFNγ (100 ng/ml) activated cells was assessed by 
confocal microscopy in living cells.  Arrows denote phagocytic cups and arrowheads indicate 
discrete foci of increased 22YFP colocalization near nascent phagosomes.  Single plane z stack 
sections from the middle of the cells are shown. 
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VIII. Increase in NADPH oxidase activity is dependent on the duration and dose of 
IFNγ stimulation in RAW 264.7 cells and BMDMs  
1. Duration of IFNγ stimulation increases SOZ and PMA stimulated 
superoxide production in RAW 264.7 cells 
IFNγ was first identified as the macrophage activating factor based on its ability 
to enhance secretion of hydrogen peroxide by macrophages (Nathan et al., 1983), 
although surprisingly few studies have systematically analyzed the effects of dose and 
time dependency of IFNγ stimulation on NADPH oxidase activity and its correlation with 
gp91phox expression.  Thus, we measured NADPH oxidase activity under our conditions, 
and found that superoxide release by IFNγ activated RAW 264.7 cells and BMDMs was 
generally correlated with gp91phox expression.  Unexpectedly, we also found IFNγ 
activated macrophages produced superoxide in the absence of exogenous stimulus.   
Importantly, we wanted to know the optimal conditions of IFNγ stimulation for 
enhancing NADPH oxidase activity in macrophages.  Thus, we evaluated the effect of the 
duration and concentration of IFNγ on NADPH oxidase activity in macrophages.  We 
assessed both the kinetics of the release of superoxide and total superoxide produced 
following SOZ or PMA stimulation using the chemiluminescent substrate luminol. 
Following SOZ stimulation, little superoxide was detected in unactivated cells, 
but increased in 24 hr IFNγ activated cells and continued to rise at 48 hr, but seemed to 
plateau, since 72 hr IFNγ activated cells did not produce much more superoxide (Figure 
60A).  In contrast to SOZ, 24 hr IFNγ activated cells produced little superoxide in 
response to PMA (Figure 60B), but the response gradually increased in 48 hr IFNγ 
activated cells and continued to increase substantially in 72 hr IFNγ activated cells  
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Figure 60.  Duration of IFNγ stimulation increases SOZ and PMA stimulated superoxide in 
RAW 264.7 cells.  RAW 264.7 cells cultured in the presence or absence of IFNγ (100 ng/ml) for 
24, 48 or 72 hr were evaluated for NADPH oxidase activity by luminol.  (A) SOZ stimulated 
superoxide production was measured for 30 min.  (B) PMA stimulated superoxide production was 
measured for 50 min.  Bar graphs show average +/- standard deviation of 4 (A) or 3 (B) 
independent experiments. 
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(Figure 60B).  Evaluation of total superoxide released from unactivated and IFNγ 
activated cells following SOZ and PMA stimulation showed IFNγ activation increased 
superoxide production in RAW 264.7 cells, respectively, by 33- and 86-fold at 24 hr, 
260- and 273-fold at 48 hr and 230- and 780-fold at 72 hr (N = 4 independent 
experiments for SOZ and N = 3 for PMA).  In addition to the total increase in PMA 
stimulated superoxide production following 72 hr IFNγ activation, a change in the 
kinetics in response to PMA was observed in which the curve appeared to shift to the left 
(Figure 60B), suggesting a quicker response to PMA in the 72 hr IFNγ activated 
macrophages.  In summary, we found prolonged IFNγ stimulation of RAW 264.7 cells 
increases both flavocytochrome b protein expression and NADPH oxidase activity. 
 
2. Maximum increase in NADPH oxidase activity following 10 ng/ml IFNγ  
activation in RAW 264.7 cells  
We next investigated the effect of the concentration of IFNγ on NADPH oxidase 
activity in RAW 264.7 cells.  PMA and SOZ stimulated superoxide production was 
measured in RAW 264.7 cells stimulated with 0.1 – 100 ng/ml IFNγ for 24, 48 or 72 hr.  
We found that, similar to flavocytochrome b protein expression, NADPH oxidase activity 
increased in response to IFNγ in a dose-dependent manner in response to IFNγ.  In 
response to SOZ or PMA, superoxide production seemed to plateau in cells activated 
with 10 ng/ml IFNγ (Figures 61A and 61B), the same concentration at which we 
observed flavocytochrome b protein expression to reach its maximum (Figure 37).  Thus, 
we found that a dose of at or above 10 ng/ml IFNγ (100 U/ml) results in maximum 
flavocytochrome b protein expression and NADPH oxidase activity, which is  
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Figure 61.  IFNγ dose response to SOZ and PMA stimulated superoxide in RAW 264.7 cells. 
RAW 264.7 cells were activated with increasing concentrations of IFNγ (0.1 – 100 ng/ml) for 24, 
48, or 72 hr.  NADPH oxidase activity in unactivated and IFNγ activated cells was assessed by 
luminol.  (A) SOZ stimulated superoxide production was measured for 30 min (B) PMA 
sitmulated superoxide production was measured for 50 min.  Bar graphs show mean of 2 
independent experiments. 
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within the range of IFNγ (30 – 100 ng/ml) previously described to be a “saturating” 
concentration for IFNγ-induced MHCII cell surface expression (Gonalons et al., 1998) 
and for enhanced killing of S. typhimurium (Gordon et al., 2005). 
 
3. SOZ and PMA stimulated superoxide is inhibited by SOD, but not NO  
inhibitor L-NMMA   
Luminol can permeate the cell membrane and thus, allows for the detection of 
intracellular and extracellular superoxide production; however, the reaction requires a 
peroxidase (Dahlgren and Karlsson, 1999).  Extracellular superoxide can be measured by 
adding exogenous HRP, but intracellular superoxide requires endogenous expression of a 
peroxidase.  Neutrophils have azurophilic granules containing MPO (see Table II), which 
allows for intracellular detection of superoxide.  It is generally believed that mature 
macrophages lack expression of MPO; thus, we can not compare the amount of 
intracellular vs. extracellular superoxide produced in IFNγ activated macrophages.  
However, we can confirm luminol is detecting extracellular superoxide by utilizing SOD, 
which catalyses the dismutation of superoxide to hydrogen peroxide and, when added 
exogenously, can prevent the detection of extracelluar superoxide by luminol due to the 
conversion to hydrogen peroxide.  Superoxide production was measured in 72 hr IFNγ 
(0.1 - 500 ng/ml) activated RAW 264.7 cells stimulated with SOZ (Figure 62A) or PMA 
(Figure 62B) in the presence or absence of SOD.  Luminol-enhanced chemiluminescence 
following SOZ or PMA stimulation was substantially reduced in the presence of SOD, 
suggesting that we are detecting predominantly extracellular superoxide release by 
macrophages in the absence of SOD (Figures 62A and 62B).   
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Figure 62.  SOZ and PMA stimulated superoxide in IFNγ activated RAW 264.7 cells is reduced 
by superoxide dismutase (SOD).  Superoxide production following SOZ (left panel) or PMA 
(right panel) stimulation in the presence (black bars) or absence (grey bars) of SOD was 
evaluated in RAW cells activated with 0.1 – 500 ng/ml IFNγ for 72 hr.  Bar graphs are 
representative of 1 of 2 independent experiments.  Arrows denote the decrease in superoxide 
detected by luminol in the presence of SOD. 
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As mentioned previously, IFNγ increases gene expression of iNOS and iNOS 
activity (Mosser and Edwards, 2008).  Luminol has been suggested to also detect other 
ROS, including peroxynitrite (Radi et al., 1993), which is generated from the 
combination of NO and superoxide.  To determine whether luminol was detecting NO in 
our system, we also measured superoxide production in the presence of a NO inhibitor, 
NG-monomethyl-L-arginine (L-NMMA).  In contrast to SOD, blocking NO activity did  
not substantially decrease SOZ stimulated superoxide production in IFNγ (72 hr) 
activated RAW 264.7 cells (Figure 63).  
 
4. SOZ and PMA stimulated superoxide production in IFNγ activated 
BMDMs is dependent on gp91phox, p22phox, and p47phox 
gp91phox (NOX2) is one member of a family of NADPH oxidases (NOXs) that are 
found in many tissues and contribute to a wide range of physiological functions such as 
vascular tone and angiogenesis, but all are capable of producing superoxide (Nauseef, 
2008).  It was of interest to determine whether the increase in superoxide production 
following IFNγ was specific to NOX2 and likewise dependent on gp91phox, p22phox, and 
p47phox.  Comparison of SOZ stimulated superoxide production in 72 hr IFNγ activated 
wild-type BMDMs to gp91phox-, p22phox-, and p47phox-deficient BMDMs (Figures 64A, 
64B, and 64C) showed superoxide production was dependent on all three of these 
NADPH oxidase subunits.   
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Figure 63.  In contrast to SOD, the NO inhbitor L-NMMA did not dramatically decrease SOZ 
stimulated superoxide production in IFNγ activated RAW 264.7 cells.  SOZ stimulated 
superoxide was measured in 72 hr IFNγ stimulated (100 ng/ml) RAW 264.7 cells in the presence 
or absence of L-NMMA (500 µM final).  This experiment was performed one time. 
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Figure 64.  Increase in SOZ stimuated superoxide in 72 hr IFNγ activated BMDMs is dependent 
on gp91phox, p22phox, and p47phox.  SOZ stimulated superoxide production in (A) wild-type and 
gp91phox-null (CGD) BMDMs or (B) wild-type and p22phox-deficient BMDMs in the presence or 
absence of IFNγ (100 ng/ml) for 72 hr in αMEM, 10% HI FCS, and M-CSF (25 ng/ml).  (C) SOZ 
stimulated superoxide in wild-type and p47phox-knockout BMDMs was measured following 72 
IFNγ (100 ng/ml) stimulation in αMEM and 10% HI FCS (no M-CSF).  In (C) only, 2.5x104 cells 
were plated in each well vs. 1x105 cells used for all other experiments. 
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5. LPS alone or in combination with IFNγ did not appear to increase 
NADPH oxidase activity in RAW 264.7 cells 
 We observed a small increase in flavocytochrome b protein expression in LPS 
stimulated RAW 264.7 cells (Figure 38).  Thus, we investigated whether LPS also 
increased NADPH oxidase activity.  RAW 264.7 cells were stimulated for 24 and 48 hr 
with LPS (250 ng/ml) or IFNγ (100 ng/ml), and superoxide production was evaluated in 
SOZ stimulated cells.  In comparison to unstimulated cells, 24 and 48 hr LPS stimulation 
only resulted in a 7- and 31-fold increase in SOZ stimulated superoxide production, while  
IFNγ activation resulted in a 31- and 237-fold increase (Figure 65).  Our results confirm a 
previous report by C. Nathan (Nathan et al., 1983) that LPS alone is a less potent 
activator of the NADPH oxidase than IFNγ is in macrophages.  
As mentioned earlier, the combination of IFNγ and LPS are used frequently to 
generate “classically” activated macrophages (Mosser and Edwards, 2008).  Thus, we 
also investigated NADPH oxidase activity in RAW cells activated with the combination 
of IFNγ and LPS.  The addition of LPS (20 ng/ml) to two different concentrations of 
IFNγ (10 and 100 ng/ml) did not additively increase superoxide production in RAW 
264.7 cells stimulated with SOZ (Figures 66A and 66B, bottom panels) and did not 
appear to change the kinetics of superoxide release (Figures 66A and 66B, top panels).  
However, as described above (page 140), the combination of IFNγ and LPS did appear to 
kill the cells by 72 hr since the number of cells harvested following the combination of 
IFNγ (10 ng/ml) and LPS (20 ng/ml) were reduced approximately 80% and the 
combination of IFNγ (10 ng/ml) and LPS (250 ng/ml) approximately 90% from those 
cells treated with IFNγ (10 ng/ml) alone at 72 hr. 
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Figure 65.  In contrast to IFNγ, LPS does not dramatically increase SOZ stimulated superoxide 
production in RAW 264.7 cells.  SOZ stimulated superoxide production was measured in RAW 
264.7 cells cultured for 24 or 48 hr with no stimulus, IFNγ (100 ng/ml), or LPS (250 ng/ml).  
Integrated chemiluminescence detected for 30 min is shown.  This experiment was only 
performed one time. 
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Figure 66.  Combination of IFNγ and LPS does not additively increase SOZ stimulated 
superoxide production in RAW 264.7 cells.  SOZ stimulated superoxide production was 
measured in RAW 264.7 cells activated with (A) 10 ng/ml IFNγ or (B) 100 ng/ml IFNγ with or 
without 20 ng/ml LPS for 24 - 72 hr.  Each experiment was performed only once. 
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6. Blocking TNFα did not appear to decrease SOZ or PMA stimulated  
superoxide production  
We also investigated whether TNFα played a role in inducing NADPH oxidase 
activity in IFNγ activated cells.  SOZ and PMA stimulated superoxide production was 
evaluated in unstimulated RAW 264.7 cells and cells stimulated with IFNγ in the 
presence of absence of a blocking antibody for TNFα.  In comparison to unstimulated 
cells, the increase in NADPH oxidase activity in IFNγ activated cells did not appear to be  
altered in the presence of a low (200 ng/ml) or a high (10 µg/ml) concentration of TNFα 
blocking antibody (Figure 67).  These data suggest TNFα does not contribute to IFNγ-
induced NADPH oxidase activity in macrophages.  However, as described above, it 
should be noted the activity of the blocking antibody was not tested. 
 
IX. Extracellular superoxide detected by luminol and NBT in the absence of 
exogenous stimulus in IFNγ stimulated RAW 264.7 cells and BMDMs 
1. Superoxide production detected by luminol in IFNγ activated RAW 264.7 
and BMDMs in the absence of exogenous stimulus  
Unexpectedly, we also found that IFNγ activated cells produced superoxide in the 
absence of any exogenous stimulus, as evidenced by detection of ROS in cells suspended 
in buffer alone (PBSG).  Following 24 hr of IFNγ activation, little superoxide was 
detected in the absence of an added stimulus (Figure 68), but dramatically increased in 48 
and 72 hr IFNγ activated RAW 264.7 cells and BMDMs (Figure 68).  ROS detected by 
chemiluminescence in the absence of exogenous stimulus ranged from 7 - 20% of that 
detected following SOZ stimulation.  Similar to the SOZ and PMA stimulated superoxide  
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Figure 67.  Blocking TNFα did not appear to decrease SOZ or PMA stimulated superoxide 
production in IFNγ activated RAW 264.7 cells.  (A) SOZ stimulated superoxide production in 
RAW cells activated with IFNγ (100 ng/ml) in the presence or absence of anti-TNFα (200 ng/ml) 
for 72 hr.  (B) PMA stimulated superoxide production in RAW 264.7 cells activated with IFNγ 
(100 ng/ml) for 72 hr in the presence or absence of anti-TNFα (10 µg/ml).  Each experiment was 
performed once. 
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Figure 68.  Extracellular superoxide in the absence of exogenous stimulus is detected by luminol 
in IFNγ activated RAW 264.7 cells and BMDMs.  RAW 264.7 cells and BMDMs were activated 
with IFNγ (100 ng/ml) for 24, 48, or 72 hr.  NADPH oxidase activity in unactivated or IFNγ 
activated cells was assessed by luminol in the absence of any exogenous stimulus (labeled as 
PBSG for buffer only).  In addition, superoxide production was evaluated in the presence of SOD.  
Relative light units were monitored for 30 min.  Total superoxide is shown (integrated 
chemiluminescence) and is the mean of 5 independent experiments (left panel) or 2 independent 
experiments (right panel).   
  
164 
in IFNγ activated cells (Figure 62), superoxide production in the absence of stimulus was 
also inhibited by SOD (Figure 68). 
 
2. Dose dependent production of superoxide in the absence of exogenous 
stimulus in IFNγ activated RAW 264.7 cells  
To further investigate the induction of superoxide production by IFNγ, we 
evaluated superoxide production in response to increasing concentrations of IFNγ (0.1 -  
500 ng/ml).  As shown in Figure 69, a dose dependent increase in superoxide production 
was observed which appeared to reach a plateau at a concentration of 100 ng/ml IFNγ  
(Figure 69).  Next, we also evaluated whether the production of superoxide in the absence 
of stimulus in IFNγ activated BMDMs was dependent on p22phox.  As shown in Figure 
70, no superoxide was detected in p22phox-deficient BMDMs in the presence or absence 
of exogenous stimulus (SOZ), showing the ROS detected in IFNγ activated cells is due to 
the NADPH oxidase.  
 
3. Superoxide detected at the cell surface by NBT in IFNγ activated BMDMs 
in the absence of exogenous stimulus 
Nitroblue tetrazolium (NBT) assays were performed to further investigate the 
production of superoxide in the absence of exogenous stimulus in IFNγ activated 
BMDMs.  Similar to luminol, superoxide was also detected by NBT, in the absence of 
stimulus in 72 hr IFNγ activated wild-type BMDMs, but not unactivated BMDMS or 
IFNγ activated gp91phox-deficient BMDMs (Figure 71), further establishing the ROS 
detected was dependent on gp91phox and IFNγ stimulation.  Interestingly, 72 hr IFNγ  
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Figure 69.  Dose and time-dependent increase in superoxide produced in the absence of 
exogenous stimulus following IFNγ stimulation in RAW 264.7 cells.  RAW 264.7 cells were 
activated with increasing concentrations of IFNγ (0.1 – 100 ng/ml) for 24, 48, or 72 hr.  NADPH 
oxidase activity in unactivated and IFNγ activated cells was assessed by luminol in the absence of 
any exogenous stimulus.  Relative light units were monitored for 30 min.  Total superoxide from 
1 experiment is shown (integrated chemiluminescence), which is representative of 3 independent 
experiments. 
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Figure 70.  Superoxide production in the absence of exogenous stimulus is p22phox dependent.  
Superoxide production is increased following IFNγ activation in BMDMs.  BMDMs were plated 
on 100 mm Petri dishes in the absence or presence of IFNγ (100 ng/ml) in MEM, 10% HI FCS, 
and M-CSF (25 ng/ml) for 72 hr.  Cells were collected using cold PBS, and superoxide was 
measured using luminol in the presence or absence of SOZ with or without SOD, or PBSG alone 
(i.e. no stimulus).  Average of 2 independent experiments is shown.    
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Figure 71.  IFNγ activated BMDMs show NBT-positive superoxide production at the plasma 
membrane in the absence of exogenous stimulus.  Day 6 differentiated BMDMs (wild-type and 
gp91phox-null CGD) were plated in the absence or presence of IFNγ (100 ng/ml) in MEM and 10% 
HI FCS (no M-CSF) for 72 hr onto 8-well chamber slides.  Following 72 hr, nitroblue tetrazolium 
(NBT) was added to cells without any exogenous stimulus and incubated for 30 min at 37°C.   
Cells were then counterstained with safrinin, and the conversion of NBT to insoluble purple 
formazan deposits was evaluated by microscopy.  Arrows denote localized production of 
superoxide. 
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activated BMDMs showed localized production of superoxide at the cell surface (Figure 
71, arrows), which was the same location where we found flavocytochrome b (Figure 
40).  
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DISCUSSION 
 
I. Macrophage NADPH Oxidase flavocytochrome b localizes to the plasma 
membrane and Rab11-positive recycling endosomes 
In these studies, we show for the first time that the NADPH oxidase 
flavocytochrome b is localized to both the plasma membrane and the endocytic recycling 
compartment in macrophages.  We used a combination of fluorescently tagged probes for 
gp91phox and p22phox and indirect immunofluoresence of the corresponding endogenous 
proteins to examine the subcellular distribution of each subunit in living and fixed cells.  
While our study is the first to show localization of macrophage flavocytochrome b to 
recycling endosome compartments, human peripheral blood monocytes also contain 
intracellular vesicles enriched in flavocytochrome b, but the nature of these structures and 
whether they recycle remains to be determined (Ginsel et al., 1990; Calafat et al., 1993).  
Of note, FcγRs did not accumulate in recycling compartments, thereby indicating 
selectivity in this process despite the fact that these receptors decline in the membranes of 
nascent phagosomes following ingestion of IgG-coated particles (Pitt et al., 1992).  
Additional results from our experiments demonstrate that individual subunits of 
flavocytochrome b, either when expressed alone or when one subunit is expressed in 
excess of its partner, remain in the ER, thereby confirming previous studies in neutrophils 
which demonstrated that heterodimer formation is an essential prerequisite of, and 
provides an important signal for, efficient trafficking to more peripheral membrane 
compartments (Yu et al., 1999; DeLeo et al., 2000; Zhu et al., 2006).  Similar data were 
obtained using murine RAW 264.7 macrophages, primary BMDMs, and the CHO cell 
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model system.  Our demonstration that a portion of the flavocytochrome b in 
macrophages is present in Rab11-positive endosomes suggests that the endocytic 
recycling compartment may act as a reservoir of flavocytochrome b which cycles 
between this compartment and the cell surface.  
This study is also the first to indicate a relationship between relative expression 
levels of gp91phox and p22phox and their accumulation in different subcellular 
compartments.  In CHO cells, where each flavocytochrome b subunit is relatively stable 
in the absence of its partner, both gp91phox and p22phox accumulated in the endoplasmic 
reticulum when expressed individually.  In addition, a small fraction of gp91phox is 
present in its mature 91 kDa glycosylated form and traffics to the cell surface (Biberstine-
Kinkade et al., 2002; Zhu et al., 2006).  These data suggest that some maturation and 
trafficking to the cell surface of unassembled gp91phox occurs as an inefficient default 
pathway, or, alternatively, it is possible that another protein is capable of directing some 
gp91phox to the cell surface in CHO cells in the absence of p22phox.  Titration experiments 
in CHO cells showed that when co-expressed at similar levels, p22phox and gp91phox no 
longer accumulate in the ER, and instead colocalize at the cell surface and in the 
endocytic recycling compartment.  However, in both CHO cells and macrophages, if one 
subunit is overexpressed compared to its partner, the “excess” subunit remains in the ER.  
Previous studies examining localization of p22phox and gp91phox in transfected cells have 
not addressed the importance of the ratio of the two subunits or clearly shown that the 
location of the heterodimer may be distinct from the location of the individual subunits 
(Ambasta et al., 2004; Murillo and Henderson, 2005). 
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In neutrophils, specific granules carrying flavocytochrome b can serve as a 
storage pool and a mechanism by which flavocytochrome b is recruited to the plasma 
membrane and phagosomes.  Our findings localizing flavocytochrome b to Rab11-
positive and Rab5-positive endosomes in macrophages suggest recycling endosomes may 
serve a similar function.  Macrophages have the capacity to rapidly ingest many large 
particles or microbes, and it has long been known that cell surface area increases during 
phagocytosis (Hackam et al., 1998; Cox et al., 1999; Di et al., 2003).  Membrane 
compartments mobilized for expansion of the cell surface include but are not limited to 
Vamp3- and/or Rab11-positive endosomes (Bajno et al., 2000; Cox et al., 2000; Allen et 
al., 2002; Murray et al., 2005; Leiva et al., 2006; Manderson et al., 2007).  However, the 
nature of the compartments mobilized in response to any one stimulus remains 
controversial, and the extent to which vesicles fuse directly with forming phagosomes as 
compared with the ‘uninvolved’ plasma membrane is not well defined (Di et al., 2003; 
Rogers and Foster, 2008).  Thus, it is also possible that fusion of recycling endosomes 
with the cell surface provides a mechanism to replenish plasma membrane 
flavocytochrome b during phagocytosis or macrophage activation as has been described 
for TNFα (Murray et al., 2005; Manderson et al., 2007).  Alternatively, it is also possible 
that recycling endosomes remove flavocytochrome b from the membranes of phagosomes 
as they mature.  In either case, it is interesting to hypothesize that macrophages, which 
unlike neutrophils are long-lived cells, may utilize this compartment to retain and 
conserve the use of flavocytochrome b.  
S. typhimurium is a facultative intracellular pathogen of macrophages.  An 
essential aspect of virulence is the ability of S. typhimurium to introduce bacterial effector 
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proteins into the cytosol of host cells using Type III secretion (T3SS) that disrupt 
membrane trafficking and prevent phagosome maturation.  Previous studies by us and 
others have shown that effectors of the S. typhimurium pathogenicity island-2-encoded 
T3SS are also required to prevent accumulation of NADPH oxidase components, 
including flavocytochrome b, on S. typhimurium compartments in primary murine and 
human macrophages (Gallois et al., 2001; Vazquez-Torres et al., 2001).  Although the 
mechanisms of action of T3SS effectors are not well defined, it is attractive to predict that 
targeting Rab11 may allow selective depletion of flavocytochrome b from the                 
S. typhimurium phagosome as has recently been reported for CD44 (Smith et al., 2005). 
 
II. IFNγ increases flavocytochrome b localization to the cell surface  
During an infection, macrophages become activated by cytokines, such as IFNγ or 
TNFα, or bacterial LPS, to enhance antimicrobial killing, referred to as “classical” 
activation.  Notably, activated macrophages have an increased ability to kill intracellular 
pathogens, which has been linked to an increased ability to release superoxide (Nathan et 
al., 1983) and increased expression of gp91phox (Newburger et al., 1988).  In resting 
macrophages, we found flavocytochrome b localized mostly inside the cell to recycling 
endosomes.  We next examined whether IFNγ activation affected the distribution of 
macrophage flavocytochrome b.  We also investigated the change in protein expression 
of NADPH oxidase subunits and NADPH oxidase activity following stimulation with 
IFNγ, LPS, or a combination of the two in macrophages. 
In IFNγ activated RAW 264.7 macrophages, the protein expression of gp91phox 
and p22phox was found to continually increase from 24 - 72 hr following IFNγ activation 
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and to plateau at a concentration of 10 ng/ml IFNγ (100 U/ml).  We detected no change in 
the protein expression of NADPH oxidase subunits p47phox, p67phox, or p40phox.  In 
neutrophils, IFNγ downregulates p47phox approximately 50% following 2 hr IFNγ 
stimulation  (Cassatella et al., 1990; Amezaga et al., 1992), and the protein expression of 
p67phox during differentiation of the promyelocytic cell line HL-60 increases 
approximately 3- to 4-fold following 4 days IFNγ stimulation  (Gupta et al., 1992).  Thus, 
the regulation of p47phox or p67phox protein expression by IFNγ may be different between 
neutrophils and macrophages.  In comparison to IFNγ, LPS only modestly increased 
gp91phox and p22phox expression by 3-fold, which was dependent on the dose and duration 
of LPS stimulation.   
NADPH oxidase activity was evaluated in both RAW 264.7 cells and murine 
bone marrow derived macrophages following activation with IFNγ, LPS, or the 
combination.  As expected, IFNγ activation increased NADPH oxidase activity, as 
detected by luminol-enhanced chemiluminescence, in both cell types.  The increase in 
NADPH oxidase activity correlated with increased gp91phox and p22phox protein 
expression.  In the presence of SOD, luminol-detected superoxide was reduced 75 - 90%, 
indicating that the signal largely reflected extracellular superoxide.  In contrast to IFNγ  
alone, LPS alone or in combination with IFNγ did not increase NADPH oxidase activity 
in RAW 264.7 cells.  
As mentioned, LPS only resulted in a modest increase in both the protein 
expression of gp91phox and p22phox and NADPH oxidase activity.  These results support 
previous reports that LPS alone is not a major activator of the NADPH oxidase in 
macrophages (Nathan et al., 1983).  In our experiments, the simultaneous activation with 
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LPS and IFNγ did not additively enhance superoxide production and in fact appeared 
cytotoxic to cells following 72 hr.   
We found that inhibition of TNFα using a blocking antibody did not substantially 
decrease NADPH oxidase activity in IFNγ activated cells.  TNFα is described as the 
second most important cytokine (IFNγ being the first) for “classical” activation of 
macrophages (Mosser and Edwards, 2008).  Pre-treatment of human monocytes with 
TNFα has been shown to increase PMA stimulated superoxide approximately 2- to 5-fold 
(Gauss et al., 2007) and BMDMs greater than 10-fold (Phillips et al., 1990).  TNFα 
secretion by activated macrophages is generally thought to require LPS stimulation 
(Mosser, 2003); however, recently it was shown that IFNγ (2.5 ng/ml) activation alone 
can increase TNFα secretion in a time-dependent manner in RAW 264.7 cells (Vila-del 
Sol et al., 2007).  Taken together, our results suggest IFNγ-induced TNFα secretion does 
not contribute to increased NADPH oxidase activity in IFNγ activated RAW 264.7 cells,   
but further studies are required since we did not measure TNFα secretion and the activity 
of the blocking antibody in our experiments.     
Remarkably, in addition to the overall increase in flavocytochrome b protein 
expression, a shift in the distribution of flavocytochrome b was observed following 72 hr 
IFNγ activation in both RAW 264.7 and primary murine BMDMs.  This shift resulted in 
a substantial increase in the presence of flavocytochrome b in the plasma membrane and 
a marked decrease of endosomal flavocytochrome b.  Importantly, overexpressing 
gp91phox and p22phox from transgenes in RAW-91,22 cells did not increase localization of 
flavocytochrome b to the cell surface in the absence of IFNγ.  These data suggest IFNγ 
induces a change in distribution of flavocytochrome b independent of the change in 
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protein expression.  Interestingly, addition of LPS for only the last 24 hr of 72 hr of IFNγ 
activation cells appeared to reverse the predominant surface localization of 
flavocytochrome b seen in 72 hr activated cells with IFNγ alone.  These results suggest 
LPS stimulation may also regulate trafficking of flavocytochrome b either by inhibiting 
signaling pathways leading to the IFNγ-induced change or by activating an additional 
pathway.   
Our finding that IFNγ activation results in increased localization of 
flavocytochrome b to the plasma membrane suggests IFNγ may increase antimicrobial 
defense by mobilizing flavocytochrome b to the cell surface.  Localization of 
flavocytochrome b to the plasma membrane would strategically place flavocytochrome b 
at the site where a phagocyte would first encounter a pathogen and would allow for 
immediate incorporation into a newly forming phagosome.  We evaluated whether the 
shift in distribution of flavocytochrome b would enhance its relative incorporation into 
newly forming phagosomes.  While localization of flavocytochrome b on phagocytic 
cups and nascent phagosomes was more visible and appeared less “patchy” in IFNγ 
activated macrophages compared to unactivated, we could not conclude that the IFNγ-
induced change in distribution increased the amount of flavocytochrome b in nascent 
phagosomes relative to the total amount in the cell.  However, it still remains possible 
that during an infection with a live pathogen, increased trafficking of flavocytochrome b 
to a phagosome could occur in IFNγ activated macrophages and warrants further studies.   
Increased localization of flavocytochrome b in the plasma membrane could enable 
macrophages to release superoxide directly into the extracellular environment or into 
newly forming phagosomes.  In neutrophils, little flavocytochrome b is found in the 
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plasma membrane, but upon activation, specific granules and secretory vesicles fuse with 
the plasma membrane (and phagosomes depending on the stimulus) and deliver 
flavocytochrome b to the cell surface.  IFNγ activated macrophages have increased 
NADPH oxidase activity, as detected by luminol.  The majority was shown to be SOD-
sensitive, suggesting we are detecting predominantly extracellular superoxide release by 
macrophages under our conditions.  Note that since luminol-enhanced 
chemiluminescence requires a peroxidase (Dahlgren and Karlsson, 1999), we added 
exogenous HRP.  In contrast to neutrophils, macrophages are generally believed to have 
little to no expression of myeloperoxidase (MPO) and thus, our studies may be limited in 
their ability to detect intracellular superoxide.  However, Adachi and colleagues (Adachi 
et al., 2006) recently showed that IFNγ stimulation of RAW 264.7 cells and human 
monocytes increased localization of MPO at the cell surface, by immunofluorescence 
microscopy, suggesting MPO was being secreted at the cell surface.  Additional 
investigations evaluating NADPH oxidase activity using luminol-based assays in IFNγ 
activated macrophages in the absence of HRP could determine whether MPO is being 
secreted and contributing to luminol-detected ROS.  Taken together, we hypothesize that 
the increase in surface expression of gp91phox and p22phox in IFNγ activated cells may 
serve as a new “priming” mechanism for increasing NADPH oxidase activity at the cell 
surface in macrophages. 
Notably, we found macrophages exposed to IFNγ for sustained periods produced 
superoxide in the absence of an exogenous stimulus.  Most interesting was that localized 
production of superoxide in the absence of an exogenous stimulus was detected at the cell 
surface in BMDMs activated with IFNγ for 72 hr, but not 24 hr.  This time course 
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correlated with the IFNγ-induced increase in surface localization of flavocytochrome b.  
These results further support our hypothesis that redistribution of flavocytochrome b to 
the cell surface is important for endowing macrophages with the capacity to produce 
superoxide at the cell surface.  
p47phox activation is required for NADPH oxidase activity.  Evaluation of 
NADPH oxidase activity and the distribution of flavocytochrome b in p47phox-/- BMDMs 
activated with IFNγ showed p47phox was required for IFNγ-induced NADPH oxidase 
activity, but was not required for the change in distribution of flavocytochrome b, 
confirming that ROS production is mediated by the assembled NADPH oxidase complex 
and also suggesting the redistribution of flavocytochrome b was not regulated by 
NADPH oxidase assembly.  
In resting macrophages, it is known that the entire plasma membrane is 
completely turned over every 33 min and that this turnover is enhanced following IFNγ 
activation (Cohn, 1978; Mellman et al., 1983).  To our knowledge, the change in the 
“global” rate of endocytosis due to IFNγ has not been shown to enhance or concentrate 
localization of a plasma membrane protein to the cell surface independent of increased 
protein expression in macrophages.  IFNγ activation has been reported to decrease 
localization of the Tfn-Receptor (Hamilton et al., 1984) to the cell surface, and it is 
interesting to speculate that the increase in flavocytochrome b localization to the plasma 
membrane might be specific to proteins important in antimicrobial activity.  
The redistribution of flavocytochrome b occurred following prolonged exposure 
to IFNγ, suggesting IFNγ does not directly regulate the change in distribution of 
flavocytochrome b.  IFNγ is known to control gene expression, which may indirectly 
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regulate the trafficking of flavocytochrome b.  Changes in gene expression following 
dendritic cell (DC) maturation regulate trafficking of MHCII (van Niel et al., 2008).  
During DC maturation, the synthesis of MHCII is downregulated yet the cell surface 
expression increases.  The increase in surface expression of MHCII is due to changes in 
trafficking regulated directly by ubiquitination.  In immature DCs, ubiquitination of 
MHCII targets MHCII to MVBs (multi-vesicular bodies) which traffic to lysosomes for 
degradation, but upon DC maturation, ubiquitination ceases and MHCII stays at the cell 
surface (Shin et al., 2006; van Niel et al., 2006).  Ubiquitination ceases due to changes in 
gene expression of a ubiquitin E3 ligase, MARCH1, which is down regulated upon DC 
maturation (De Gassart et al., 2008).  While a role in ubiquitination of flavocytochrome b 
has not been investigated, the studies in MHCII provide one mechanism of how changes 
in gene expression can lead to changes in trafficking of a surface protein.  Notably, there 
are many other possibilities and future goals will be to identify the mechanism by which 
IFNγ changes the trafficking of flavocytochrome b. 
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CONCLUSIONS 
 
We generated functional fluorescently tagged gp91phox and p22phox subunits and in 
combination with immunofluorescence microscopy characterized the subcellular 
distribution of flavocytochrome b in “resting” macrophages.  We developed a CHO cell 
model in which trafficking of flavocytochrome b was evaluated by live imaging.  
Additionally, we established a system for investigating trafficking of flavocytochrome b, 
using p22phox-deficient primary bone marrow derived macrophages for expression of a 
fluorescently tagged p22phox probe.  Utilizing these approaches, we showed for the first 
time that flavocytochrome b localizes primarily to the Rab11-positive endosome 
recycling compartment in “resting” macrophages (Figure 72).  We also found 
flavocytochrome b to localize to Rab5-positive early endosomes and the plasma 
membrane, suggesting flavocytochrome b is internalized from the cell surface and 
recycles through these endosomal compartments before trafficking back to the cell 
surface (Figure 72).  These findings expand our knowledge of the subcellular distribution 
and trafficking of flavocytochrome b in macrophages. 
Our data suggests that recycling endosomes, which are in close proximity to the 
phagocytic cup and to nascent phagosomes, might be involved in targeting 
flavocytochrome b to phagocytic cups and/or recycling flavocytochrome b from 
phagosomes back to the plasma membrane.  Currently, it is not known how  
flavocytochrome b is targeted to phagosomes.  While the plasma membrane is an obvious 
source, we showed that little flavocytochrome b resides in the plasma membrane  
in “resting” macrophages and thus, Rab11-positive recycling endosomes may be 
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Figure 72.  A model illustrating the subcellular distribution of flavocytochrome b in “resting” 
and IFNγ activated macrophages.  Left panel: Flavocytochrome b is found in the plasma 
membrane and Rab5-positive endosomes, but appears to predominantly localize to the Rab11-
positive endocytic recycling compartment in “resting” macrophages.  Localization of 
flavocytochrome b to these endocytic compartments suggests flavocytochrome b is internalized 
from the cell surface, traffics to early Rab5-positive endosomes, and then to the Rab11-positive 
endocytic compartment before trafficking back to the cell surface (arrows).  Right panel: The 
amount of flavocytochrome b increases and its distribution shifts from endocytic compartments to 
the cell surface following sustained IFNγ (72 hr) activation. 
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important for trafficking of flavocytochrome b to phagosomes during phagocytosis.  
Thus, our data suggests recycling endosomes may be one mechanism by which 
macrophages localize superoxide production for microbial killing. 
We found the distribution of flavocytochrome b changed from a prominent 
perinuclear compartment in “resting” macrophages to a predominant localization to the 
plasma membrane following sustained IFNγ activation (Figure 72).  This shift in 
distribution strategically positions flavocytochrome b at the outside of the cell which 
would allow for the extracelluar release of superoxide without phagocytosis and also 
before a phagosome is sealed.  At the same time at which the distribution of 
flavocytochrome b changed following IFNγ stimulation, we also found IFNγ stimulated 
cells to produce superoxide in the absence of an exogenous stimulus.  Taken together, our 
results suggest the IFNγ-induced redistribution of flavocytochrome b may be important 
for enhancing the production of superoxide at the cell surface and may be a potential new 
mechanism by which IFNγ enhances antimicrobial activity in macrophages.   
In conclusion, we found the subcellular distribution of flavocytochrome b to be 
distinct in “resting” and IFNγ activated macrophages.  These distinct locations provide 
new insight of how macrophages may localize superoxide production for microbial 
killing.  
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FUTURE STUDIES 
 
 Future goals of our studies include (I) to confirm Rab11-positive endosomes 
deliver flavocytochrome b to phagocytic cups during phagocytosis, (II) to define a 
mechanism(s) that regulates trafficking of flavocytochrome b to the cell surface 
following IFNγ stimulation, (III) to determine if the SPI-2 virulence factor SpiC alter 
trafficking of flavocytochrome b, and (IV) to determine the biological importance of the 
change in distribution of flavocytochrome b following prolonged exposure to IFNγ. 
 
I. Confirmation that Rab11-positive endosomes deliver flavocytochrome b to the 
phagocytic cup using electron microscopy (EM) and video microscopy 
 Colocalization of flavocytochrome b with Rab11-positive endosomes in discrete 
patches near phagocytic cups was observed during phagocytosis of opsonized zymosan 
particles in macrophages using immunofluorescence light microscopy.  While these 
observations suggest Rab11-positive endosomes may deliver flavocytochrome b to 
phagocytic cups, there are two experiments that would be required to prove this.  First, 
time lapse video microscopy showing trafficking of flavocytochrome b in Rab11-positive 
endosomes (i.e., colocalization) directly to the phagocytic cup would be needed.  Second, 
confirmation that flavocytochrome b and Rab11 colocalize in the same vesicles and that 
these vesicles actually fuse with the phagocytic cup would require immunogold labeling 
and electron microscopy.  These sets of experiments would best be performed in CHO-
91,22YFP cells stably expressing the Fcγ-receptor for two main reasons: 1) CHO cells 
transgenically expressing the Fcγ-receptor are a model system for evaluating protein 
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trafficking during Fcγ-mediated phagocytosis (Downey et al., 1999) and 2) we have 
already shown colocalization of Rab11CFP and 22YFP by video microscopy in this cell 
line.   
 
II. Changes in the recycling pathway may be the mechanism by which IFNγ changes 
trafficking of flavocytochrome b in macrophages 
1. Rab4B 
 Prolonged exposure to IFNγ was found to change the trafficking of 
flavocytochrome b in macrophages and increase flavocytochrome b surface localization.  
MHCII expression is upregulated following IFNγ through transcription coactivator 
CIITA.  Chromatin immunoprecipitation (CHIP) assays evaluating additional genes 
regulated by CIITA identified Rab4B (Krawczyk et al., 2007).  Rab4B regulates 
endosomal trafficking from early endosomes (Rab5) to the cell surface and is believed to 
be important for recycling of endosomes back to the cell surface via the “fast” track, in 
contrast to “stopping” at the Rab11 compartment.  Increasing endosomal recycling back 
to the cell surface and preventing it from trafficking to the Rab11 compartment could 
lead to the increased localization of flavocytochrome b to the cell surface.  The role of 
IFNγ-induced expression of Rab4B in changing trafficking of flavocytochrome b could 
be investigated by knocking down Rab4B via siRNA (Fernandez et al., 2009) or by 
inhibiting IFNγ-induced transcription of CIITA (Tooze et al., 2006).  Increased protein 
expression and subsequently increased Rab4B activity could change the trafficking of 
flavocytochrome b and prevent it from trafficking to the Rab11 compartment and thus, 
would result in a net increase in flavocytochrome b cell surface localization.  
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Interestingly, maximum Rab4B expression was detected following 48 hr IFNγ treatment 
(Krawczyk et al., 2007), which was the same time at which we observed the change in 
distribution of flavocytochrome b.   
In addition to Rab4, changes in expression and/or activity of other Rab family 
members could regulate trafficking of flavocytochrome b.  While preliminary studies 
utilizing a GFP-expressing Rab11 did not show a change in distribution of 
flavocytochrome b (not shown), many Rab members regulate trafficking to the plasma 
membrane.  Recently, a less characterized Rab member, Rab10, was shown to regulate 
trafficking of GLUT4 from the ERC to the plasma membrane (Sano et al., 2008) by 
knocking down Rab10 by shRNA.   
 
2. Rab11 and/or VAMP3 
 In addition to Rab4B, Rab11 protein expression has also been shown to increase 
following IFNγ (0.5 ng/ml) treatment from 0 to 18 hr  (Murray et al., 2005), but was not 
examined at 48 or 72 hr.  I performed preliminary experiments to compare (i) the protein 
expression of Rab11, by Western blot and (ii) and the localization of Rab11, by 
immunofluroescent staining, in unactivated to IFNγ (72 hr) activated RAW 264.7 cells, 
but these experiments were unsuccessful.  Changes in protein expression of Rab11 could 
potentially lead to an increase in the cell surface expression of flavocytochrome b and 
thus, these experiments should be repeated.   
Another attractive hypothesis is that VAMP3 may also regulate trafficking of 
flavocytochrome b.  VAMP3, or cellubrevin, is a SNARE (soluble N-ethylmaleimide-
sensitive factor attachment protein receptor) protein found on vesicles (v-SNARE) that 
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forms a complex with a target SNARE (t-SNARE) protein on the plasma membrane 
(Proux-Gillardeaux et al., 2005).  As described earlier in the discussion, IFNγ-induced 
upregulation of VAMP3 (Murray et al., 2005) has been shown to increase secretion of 
TNFα to the phagocytic cup.  Interestingly, theses studies also showed that both 
knockdown of VAMP3 via siRNA and transient expression of the inhibitory domain of 
VAMP3 (amino acids 1 to 81) decreased TNFα trafficking in Tfn-positive endosomes to 
the cell surface, showing VAMP3 can regulate trafficking of recycling endosomes to the 
cell surface.  Since flavocytochrome b also localizes to recycling endosomes, we can 
speculate that VAMP3 may regulate flavocytochrome b trafficking to the cell surface, 
which may be upregulated in IFNγ activated macrophages.   
 
III. Determine if SpiC alters trafficking of flavocytochrome b 
It is not known how Salmonella interrupts the localization of flavocytochrome b 
to the Salmonella-containing phagosome.  Investigations of individual virulence factors 
could provide answers.  SpiC is a virulence factor that alters host protein trafficking and 
is necessary for inhibiting phagosome-lysosome fusion by Salmonella (Uchiya et al., 
1999).  SpiC, encoded in the SpI-2 locus, inhibits vesicular trafficking of both the 
endocytic and degradative pathways (Holden, 2002) by hindering fusion events, 
internalization, and recycling (Uchiya et al., 1999).  Transient expression of SpiC from a 
plasmid into host cells also alters endocytic trafficking (Shotland et al., 2003).  Our 
studies showed flavocytochrome b localizes to recycling endosomes, providing a 
potential link between SpiC and Salmonella’s ability to alter trafficking of 
flavocytochrome b.  Thus, evaluation of changes in trafficking of flavocytochrome b 
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using live imaging in macrophages following transgenic expression of SpiC or other 
Salmonella virulence factors would provide useful tools for determining if these 
individual virulence factors could disrupt trafficking of flavocytochorme b in the 
presence or absence of IFNγ.  Notably, understanding how Salmonella excludes the 
flavocytochrome would not only explain the mechanism by which Salmonella evades 
destruction by superoxide, but would also provide a better understanding of the 
mechanism by which macrophages regulate the location of the flavocytochrome during 
“normal” phagocytosis. 
 
IV. Determine the biological importance of the change in distribution of 
flavocytochrome b following sustained exposure to IFNγ 
The increase in flavocytochrome b at the cell surface following IFNγ stimulation 
and the release of superoxide in the absence of an exogenous stimulus suggests these 
changes may facilitate the ability of macrophages to kill pathogens BEFORE they enter 
the cell through phagocytosis.  To test this hypothesis, bacterial killing by IFNγ activated 
macrophages either in the presence or absence of SOD, and inhibitors of phagocytosis, 
such as Cytochalasin D, could be utilized.  If killing was reduced in the presence of SOD 
and Cytochalasin D, this suggests that extracellular superoxide production was important 
for killing.   
Alternatively, the change in distribution of flavocytochrome b may increase 
localization of flavocytochrome b into newly forming phagosomes.  While we did not see 
a prominent increase in localization of flavocytochrome b to phagosomes by live imaging 
using our 22YFP-expressing p22def BMDMs during the phagocytosis of serum opsonized 
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yeast particles, we did observe a more uniform distribution in phagocytic cups.  It is quite 
possible that additional stimulants from a live pathogen may yield a much different result.  
Thus, additional studies evaluating flavocytochrome b trafficking during phagocytosis of 
live pathogens are warranted.   
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